var title_f9_32_9728="Mondini malformation";
var content_f9_32_9728=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F62888&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F62888&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mondini malformation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 358px; height: 303px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEvAWYDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDxmMfLwTu9MUIxwVzgN1qSOMhiQcf1FEiqxAQYwOoNdNjEcq7eOqknj19KgIAfjkA1JuOAncjvSGIjo2R6Y5osBIzhsgDjtg0ixtG4P44B5qJFJOR2qZdxXLnn60WuA5Zdx7YHYiozsMnQ7sjoaWJXMZC460uSDkkbvX/69OwChz0HA7cdqHADfKOG9Digjdgjr2xxikQjLdcr60gDbICNpOScnB9qVsksw3bsenftStn05pMbcEZznFOwCLv24CqD05HAp4GBvYZf8u1IzHIwCSR1zTiMHGTszSsAoy5Bz8w6CkJO84I9gO9Mwc5yakIYbT1PHPWnawByCQBgH8KfjcCRjHt1qMD5hilYMSSSOMilYBrc7sk85PXNMXcpU7s9c8Hg06RW6AHnjI4xTMlkAGfT/wDVQA/duGPlGPXjNPQALweAKjThjy2emD6U/OEIIyR0NFgGv1JI7Y5FKqkkZ6dMcijuAy/h0puTnqR7U7ALJuK8NjuOKbAz7juGSOcnrxTsMFJP3uetCsXjwQTxzmkBtaH4gvNIuY2t5sbSD15FezeE/i6wRIdTAYD+PJG32r59C/MDuJPep1faTknFP1IlBSPr6w8YaNqSqyXKKxGdrHp17/ga0I7zTrsMokhbI5AbPWvjmK9mjYGGVga1LLxJqFpIrJO6YGMqcUrIxdF9GfV02iWLvmKKIcdB2544/OsDXfC6zRPNYYEo7evtXi1j8StStwFaXcg52ngfhivRPAfj1dQuFivZF3k8c4GP8/561ST6MzlTcdbFeTUNQ0a5WOdmVf0P+f8APWvR9CmlubJJkbKlauappNnrNvyBubowqppcA0ZhDz5HGM84FJyTRDVnc3oXE8RV8Hggg8/5618/fGnw2bDUhdxIdkuWb5cYNfQsaqTvTof/ANVcp8TtLXU/Ds67P3oHy5xwfr+lRF62N78vvHyW8ZGSx5qE7gDg8mtbULKW2eQOpABPashgSSA3HqKqz6nR6Ecg3ZUcnHNZtwqrL+7Oa20AC7e3c1Q1CL5cqOMmk9RohjCzWpi6nrXM3UflTOhzxXR2MvlsQO9Utet03eZFycZOO9TJXRS0ZiHr9OtKR6Ype1B9D0rBjEOf4etFKufoKKVwOtVyrhVII9aaymM53DHXFOSIDDMePTpSFd4GOTXYQSABl7g9c5pHZgo4zSxkFc8gdsUvzb+MY4/OgBsGZCeAPpUh3EDI56cU3kKAMjHT2p8odozxgH8DQBGWbAC4wevNO2MVLKQfamRghOeKkjcr05FMBMEjqc5H0poOCcDn1POf84ol3k5Xr3p45BAXOO4oAQNjJIFNQtk7lGOeKcoO7G0/lS8ocg5oAXBOXH0xntSeYT36e9PLYQEAZ9KiAJIJPJ7UCHLlnI459qlQncQQT2Ge1Mj+Q5YYpyOSSccUhjMNvYk7f6VGwPGMk/WpckliQKHORwBkmgQhLCI9OPwFQwZxyTjp17VaGdu1uM8U07FUgjmmBDJEGcc9f0qR8gAg8URqex57YpApyQx/+tQMVdzqcYoXIbvTgCoDIQR6e9BYyHHQ+tIBoU78E8e1MYfPkE+mc9aeqsDtP60BcNtOc9KAHBM4z/KmPg564A4OOfrTirKcHoabgY45/SgAjUMCOjAUu4hRgnNNG5DnkZ9qegVkySevJFACKCTg5xV3Tb2W1lVo3ZSDwRwRVMsd3HT1qQqc5VsUC3PfvhX41lm8uzuWL4OF5PQ9a9X1mI3Nksi5BGDn2r5S8DXr2urWzKG3Bxxn8jX1Zozm70hGfgkD8Pw/z0ol0kck42bj3JtFkJswp3ZUcZ7Uupxi5jMbAFT2PQ/hWX5j2Vxs3Yyec9x61qxTRyoAjdu3GahqzuTGV1ys4TXfAtlqdvJGY9sh4Vl659T+dfP3inQJ9Hv3hkQqV4wa+uioM2QuQe2cV5p8ZvDi3Gm/b4YwGj5arTvoyqcnB+R88sFYYGAPWqd7E2C3RfTNXJoDG5B4OeO1Qy5I+bknoKSOsw5Mh84wBVySFZrBgANw60y4UjOfvHnNJZOQTGO/fNHUrc5mWMxyMCckHmmnrnmtPXLcxTbgMKazMZOTWE42ZV76hj5s8UUg3Z9B60Vn6gdk4IUBumO9RqARnHBPTH507OF/edadk7Pk5/xrtIAACPAJz6UgBAG1mx703y+csTkinH5OvT+VADiuFBBH0p25l4PT0prdBtOaWXhlUntQIVl3AHORjv8Ayph2gjGcU6Nf4XIHp7U7YhOA1ADSRsGAc96Rck8Hn69aV1AJ5+lAOOnX6UAOwxOGX8cUuxlBYHnvTSxIAJ470MhUZDZHfHegBdg25B59KQDpnj+lJ2XBJPoKlmI2++aAELpIqY6EZB9QaUhWTCUxU6bvyqUEDC0ARNuVRkAc0rLvwy/lST9R6YqTBABTFACSHC520mFcZIAPrTwNyjcOaayMBwSfagBCFXBxgZ9adhSuTjvUWACAQfyp4VGXbjB60AEZODkH86GAVs8An3pY125zyTSsAwyOopAR+Ydoxgn1pC2CCy5570+Mdcj8aJFzggE0ARs+77wx6U9QCMDGfemsFwAc896Xywv0ApgJyzAdeop5ynygLjqOMUkbAHp7HFSpGWYkgkelIBFyO3HNK5JAxxTSu2ToMDt0qyYlbBj69DQK5seEo86hAdoJLjtnvX1b4YZl02LcScjPTpkV81eDLaKG4We6KqiYPzHA/GvYtJ8bafK6WsDq2wBOucnFU43jY5qsveuuh0niZpEZWx35NcVc61fadqMbK7PAxDfSvQtSsTqGmLsyJGGc561zUOhFmEd4MsG7c/5//XRFq2pzve51WjXovIVkBJDcjIxVzU7VLy1aKZQ8ZXGD3pulWEdparGgIUf5xV0Jt6E5A4JrJvW6NoxbjZnzx8VPAkel2xv7LcEJ+ZduAvoa8emUrnOQw9K+y/G2ljUfD1zFsBbbkDGT/I18f6wnkXkqr0yQD0q07q5tSv8ACzLkTcp68dveqinY+F4FXtuVJJ49qoudp/nQzcfq0Zn0/f6A9RXL9Dgda7FCZrN0HGK5GdCkzA9jWVRdSkMxycYoobp3/A4orG/cdjrwoIBYZxQSycIMj60qhgvzdaUds8V2ECq++LDDBHGaTgg5pzR4Gc9fzoULtx0agAMZ25QjFKBG7Zc/NSRICcdgKQpGz8ZyPagRJhVY5GAOmM0xCMH17VIDuQqRj3p20FQAMUAQ4ywCnNI4KHkVOqrtyBzmogu8kng0APXBjy4/HvUaEdD0qdANoGPao9hjcnHFAXJCRgnt/OmNGCcg9RxUikMvI60xRkj5QfTFAhU3E89B3xzRKhPA7UoUo2c0deRyKQxdoYc9qAeg7UjKQ45/ClyAcd6YhNvOe1GN69yKdGyhTvXJx+RqISMvGDg+2OKAFiCu2enP5U5yuDnBPXFJGhIZh0PNM2kSZ4IJoAehJXOBg06NFLEg8mkDHHyrwfartjbtKyYA57etIGV0gc87Wq5a6TPOjOqOfpXp3gfwSNRKvOCE65x9K9g0vwfp1rDtEKc8H5QB0/8A11TSW5g6utonymdBuB1R+enFV206aIj5WA6jIxX1pfeHrEDYsSheuAMY+nb/APXWTc+FtInJkliUZGO2APT6UaPYn6w1uj5ca1b+6c/pUkUUqrwueeM16x4msNE0mcqArZJwQc8epplhpek3dl5wIBAzz6+/60+TzK9srXseYw6fI8uQpOTwAK24tFks4PtNwhERyeRTLzXl0vVhE6ptz0Hp9ai8c+No7/SxbQBSSm1sHOKPdRfvNqy0OV8T+Jmz9nsmwoPOD0p/w91uaz1hJZpHKA+vX1/yK45YnnlJx35NW3n+xxCOL72OSKxU3e7N+VW5T6x8N/FCzuLyC0Y7QSF3cnPp7+tepwpFdRpOpDAkEMO/evhLwS882tQBSxGRux6f5xX254PaWPRLVLhsy7Bz+FU9VzI46lNQaRt+aVUDHQ4yalQqwOMZHoKbs4JB5PQ1z1/rq6dfrFJ/qyBjA4/zxUKN9gcuXc27xvNtpom6FSODjFfIfxH082Ou3CYIUSEKSO1fW0U0d5CJYX+VxxXzp8c9P8rWjLuOXH5VpHawU5e+eUYAjBGM1SkwWOBWgIwFJUk+lUZCC5oOtFqzJCcVi32nPJOzIOc963ogBFk5zVaWQo5x+tDSYJnK3ELwHDj2BorpJ7ZLkA8DvzRWTp6lplpMuCeaQAspwDmpCpVQQRn2oiOSQcfWtjMj5AGR+nWngBCrAg01mPAY8VIIxtDFwM0AQkv5uRjFSSBQwYHr2ojHOcjinttLjcMYGKAFBLZ7Dv2xSllVfnPb1pfMVsBR09qaQG6/4YoAaylDlOhqRR3Yc0KMLgU1XJfBGO9AgKk/MvBPanbty4P3vepYyoBz16j61GMZJ70gEK/LhTz2pYWwQHXIFHoakeTzIyDjd645oYMjxkjJ4FNIwpC8Uy2BEhMpOKmfAYgcgUw2G8hRk89KakYUgk5xUjH2FJ1I5/8Ar0ANk2gDPHPGKVTvXIzzSNg8MTQhJjGOO2aBkgcquCvWlAAjJwCTx9KW1jaTO/t71Ils7SbRnH86QiOOMuPl7V2/gXQZtUv4wqHyx1JU4o8J+DrrVJlSONivU+31r6B8J+GYNEtUXy13Y+Zsck1Xw6swqVPsxLOmWsOj2UYfaoUAnnvisrUPiFpFtcG2a4TzQcYHOfUdf/rda5/46axcaZ4bP2ceXuzl/THP+H518j3Wr3ct2ZnmdnznJOTUtpasmlSc07M+ydS8Wxxac12CrQ4+X3zn8K8J8Y/FS5e7lWxlcjkelYg8RXVz4KaNJW3JwQvGR7V5qxLuS3UnJonPlXumlLDpXctTro/Fd5qN7uvZN5OM570uq+J7qA+RZSbVHcda5O3fymZuN2MDNMYl23N396ydR23OnlSLF7f3F5IXndiSc9ahErsdrEkfWmcZ56VJbD9/Hu5+YVCbe4zsPCukfbEJICgDOSO+OaxNY02WLUWiUEknj+lejWkYs9BjmtUOWXkjP+e9ZtjHHJOZ7pQXBzyK6HBWsZKbu2V/ANmNNvobi5Xqw4J7V9geG5Y7rT4ZYyDwMnHfFfHN/qRh1FCg2qp6CvUtH+KEuhaVboygoQFzk56e/wDnj607K1jGrFyaaPoe9vFtoQzHA9e1eZ+Lrs3V4obOBwCK2fDXiGLxh4b+07RvT7yg9x+P+fzrk7i7R3eKVf3itjOR0GaqnGxyybbO70C7At4kViWAGc8gf5/z0rzj46QecIJX28rjrznP+Fd/4QsxLGGYk4GQWOcD2rifjfnbGrjgH5aNOZjpX5keCPAUjO09T0rOI/e/ORWlOxJbGRyetUdoDc1J6CLKuEjyTxVNwGkPPX9Kts22L5+ciq/lFzuB4IzQAwIwJ2niipguOOOKKBkrKPvbqbtBUEZ6+lPUAoQFOKYFYAnHFAiRVBX5h3oMW4/KMYpsZYAjtU8ZUocNz0x60CISxBwq8/SgGQAEr8tPR1ZsAHPSnPKWCxkcAUAN9+lAzgnik2Moz1HoacybhnPI6UANJIUnHTtSxkPkkY/rTXcLxg80oYEcdKA2BfvHDcj0pzcKPQ1Edom70+QkEFR36UBYfKnyAHg0xAUXb1BqSQ71DNjimFvl+X+dIBUyw796dCy+biQcYph4XOc4FAO5Q3GaAFkJMpx0pshIX5T70YY5AIxQFXHPNAxEJbJIGKlVC5woqxZWMkzqI14Ndv4f8C3+oTJtgIUnGemKaTZEpqO5zWjaPPeSBYVZj6gE1654H+G4mjWe+4yc4zz1+n+c9K7/AMG+C7XTLBTLColZMnIGVPGenHWtjxJqsOhaY85AXA445Jo5ukTCcpPXZEukaRbaTGqQxqqrwBxik1fV7exBMrhce9eV6F8Sr3XdfS38vEbHaB/X+dbHxMgmXS0lRzwAduevTofWhRu9TKTcfdSsc78crtNS0Tbb5dQG7jPSvla5hMcjKwI5716lqninDtbTndjI55qnbWGk36lp1Vd3PTr+VKcVKyR10k4LU4nQ74wrLbu37uTjBqhfWzW8xwMoe+K0fEmmJp143kOrxkkjHUVTF8TbGKUbuwbrWT091m67lInuOaPrigj8KMcHrWQw6ChWyw9e9PgCeYvmn5O9LPLHJITEu1BxVJdQPRfDPiGFdPFtelSvbNQardxszfZGBGTnb6VwUTuoOGI+hxXR+FG867WJ/mLEgA963U29GQ4JalOefE4aXjmuzs7GHxJYRw2h/fLx05qz4i8EPJZ/bF+RB/EBx+Nc/wCE9TTRNRAfI5Ge+Ofemlyu0iebmV4n0R8IdDu/D3h24F3j5vu9sAZ9elYd9Ns1g5Qhd2Oue/TP4V6B4GvzrmgKdwYkEflWZqPh3deEgY+fG7HH+f8ACtVZOx57bvdndeF44l02MqBgqMjj0rzH47qqrDIpO7pjHGMdq9J0CF7eCOM/dUYPavL/AI5SYMSluD27ZrNfEy4P4UeGXKCSNmwQazRsWQ5BzWhdZQt8xIPaspdrT/e/OkjtRYOHcDAwPWrAWOOPI4z2qs5CyAce3vVkqGj569xTBldpCenH0oqtLlGIGRRQUW1U8lSKXeVT5uvammRmIwBmldWIGSMUCJBgjKnINRNgn5cgnqKmjIRcD86FHzZ4GO9AgjREBIADenrUZkLyg7OCfTpUhHzZzTl2qpbjNIBXkYL+FR9BUc7B24OakEbKB82c0wEYjowPPemurLIMLgH2p0i5AA6iljeTYUY5A9qAEABbdigYPbj3pd4X5SetOi2gjPI7YoEM3K+c80uBt4zSYAfdnrxikLbWHFAxygYwM01AxBzwP51JGdjZ5p8EXmvhDyaQCQwmWUImST6DNdv4T+H2oa3MCsbJF13P3+n+fWuk+F3w+bU7hbq7QpAOfmHP/wBf6f5P0RYabb6fbpFBHtRQAMelDajuZOTbtE4Dwl8NNP0sBrpBKeuCM5/Gu9itre1QCKJVHoBS3l2tvGSR16VzVxrDXN0IUVtrDH51PvTMZSjDzZvT34jwqpkfSsXXNJTxDbNb3EX7phjpj/61bWnWWIlMpO7r0xitURIM460ubl2GoSnrI4zw38P9I0W5a6t4cysOC5yFrQ8VaUt/YPBIoZGBGfQ+tdMBjJ70yeMSIcjmlzu92aSpJo+IPiR4Xn0rWJWJDDcOnf3qro0EF9Zi3L+XKBgEkDn617r470GO48SOl0+I2HynqP8AP+FeAfEi2fQ9faK0JCqeHHQ8n9elaySXvDpVOdcr3KniTw/c6bCWmbev3l5zxgYrj/u8VpXut319CsVxKzKvAyc1m/zrCbTeh0q6VmH48UH9PWgeooPSsxi5yP500AdvrRgcnnNSRIHlVT3OKatsA1m+XHGMc113w2spbzXoVjDgZz8oz07e1UE8L6hMA8EDPGQDkc17P4W0Wx8F+EJ9SviVvXGEU/L9cjHb/IrenB3uzGrUUY2W7MX4r+MPsjpp1nglBg+3UH6//Wryhp/tCtNj5x1qPX9QbU9TlnboxOOc1d8J20d1cNHLwpocnOVioQVONj339m3xE03m6dcE8r8pbvjt/n0r1XW3aLUgYj8pOCBxxXjfwks4NH1MlXIDAjAPHWvfIIre9KksDJjnBzj3rS3LqzhrWlJpD7G5Xy1weCMgntXjPxzm/wBPiQgY25BH+favahp3lSK8Z7fhXhPxpkA1bYy4YYGPTrSjbVoKaamkzyW5RnRnG3GPTFZFucXAyOM9a1ZMqSMjNZjDZKGxgUjuiWLtSQGHUVcsmEkODjceeBUEo3wZAFR6fLskOeDTFuguUBf5hyKK0mjjlfO1c45z1/KilcEyi6ps4H5ClzhDimIgKg84NPJAwCcUwGqwwRyD69adGWAy3OeKaoG/OOKHYdOfTigBTGCScnBpcYBJ5pUJTB2/QZpqs4cjAwaAGoVZ/u4x0pxZt4AHA70rnC9OTxSwPIuTwD70AxJVJI65Bpyn1HPTNDEk5prE5A25oAUgMORnFOgjySo6dacSNoAHPXJqMY6ikIil+V+Mcc0/OVDH+dIxV2245+tC5CH5eRTGLcK+wEDtnmuv+HXh99X1aCJAOWBOemK5FXJdFKtz2r3X4HaTuuWu9pJHHTp0/pTXcipJqOh7fodhHYWkcUagYHbArTC5zkY/GokbaANuc8ZGOOO/+e9TA5PFc71YRSSsjM1OwNx0IC4/Om2elRQ4KKu4HOa1T90559abtCtyvHrT5nsT7KN7iIoUDbg8daZPL5MbMzYUDOfSpcew46Cq97a/aImQ8Aj0pIcrpaHnl78UbW219rCWE7FbbuB7/wD669F0+5S8tY5oz8rLmvPJfhhZ3GqNdTsSjHOOpz/hXoWm2q2dnHAgwqDAHpVz5baEU+a+pwvxU0x57MXNrtE8IJ9yK+PfiHfTXmrFZyCyEgkDv/nH5V9r/EfzI9BuJoiNyjpjtXw141unuteuZJB8xY9se39KbfuFUV78jAHNJ296XPNDelc/U6haO/rSelHr+VCAB6Ve0awnvr2OOFGYk9QKojgV7N8DZNJigumvNon8tiCwHXHua0pxUpEVJ8kXI0dA8TWPhPTxb3aCWfA2g9iK47x/4ul1lGSKQ/Z85C44H0rD8cGafX5yCWUucYHGPpXR+C/AN54gtThDjGRgjp/ntW7cpe6jJRhD95I80AywAGSa6PRNMvoSs0UbgH/P9a273wxBod+VvHBKnGPQ/Wups9e08WvlJCmQMA8Z/wA9amFO25cpu3uq5H/bQ0DT1k3kT9cen4Vl6H8TtWt9bSQTybA2AN3Ynp9K5jxhePf37GMkoOwzSeD/AA1eaxqMaRRMec8U3OTdoi5I2vJH2p4F8Q/29o8VyRtLjp0APf8AnXkfxyhA1YENnd8xHp2/wNeofDzRjomjxW0hzKVyxxzmvMPjdJu1GI7sgj8s/wD6qa3ZyQfvI8gu4xy3PTnvmsaVwZufWtV2ZsgscHmsy4j2uTk/jSOyJcAPl/JggiqzARSbgSOal09xuw+StT30aqBjlT0ph1H282FJUDn2zRWdDIVBG7H1ooHYtRlg+GPvz3pDtkc5zn2qRc7Bkc0gUKTgUCEd9mARmhFQcqR/hSyqCuT26UxVQKCT+NACtKQen60/IflTiogV2ncBnPYU6NSq845oAGRcE7j9aWIkoTu5p5CkEEUwI6vkDC/zoAWCMEMztgjp70qsGztOaecEYwc47UxYxEwGSN3Q0gByQoI5xSBx34/GnyABsHofxoTazY6imAzbtYtye1PhGT82fWlCkHuav2Nu8sqgD7xyBjpS3E2RJb+YwbHHXGO1e/fA91S0kjbAkyOCO2P16Vz3gj4eSX4Wa4XER68df84r1XRvCC6WQ8DNnjOePrVO0VZnPUnzaRR1n0ODVmLhMmqdurogDNzjmrMK+Uu2R2fJJy2M8nOOOwHH5dTzWBpElPqelIzhe/0qK5nWFSSQAASRXivjv4nm1kubWwOByu8HofanGDkEp2dket6p4h0/TVzdXUSEHoW/pXO6l8SdCtNyC5MjggYjGR+f5fnXzHrPiC8vy0s1zI5bnDMSf89az1d2+ZmJz7VpyRQWl1Z9aaH8QND1W48iK6KzkkKjDqPUH+ldehDKCrZHrXw+ss8UscsDlWQg8GvdvhJ8Q2lji03VHJY/LG39OtTKCfwhdx1ex3/xRZ4/B9/JGpLLGTx6V8Fa5KJ9SncA4LHHriv0S1e0h1bR7i2lIMU8RGcZxkdcV+fHjGxk0/xDfW8oIdJWBBGMHPIwah/CaU/ifmYnekJI4zSnt/Sl7c1k9DYQdfakJI6Glx61paLp7XlymVOzOTx29aqKu7AU4LaSYbgPl7mtjRNRksGK2zMGPHBxWlr93b2tibSBQH7ketY2i20lw5ZeT24rVLldkTutTsNG0a51e8SZkD7mHavZbXUZPCfh3yYlRZ3Gdp9Pz96434Z/a7SQGdcqR09vX9K6DxJbyXjNPP8AKg4ArpitDiqy5p8r2PK9eE2p3jz3D8EkkmsGW1mkm2QKzY9K7HV7GWaRUt1+U4zgd69N+GXw7W4t0ur+LAGGUY5OM8/5/wD1ZuPc3dRQRxvw0+HUuuSA3UB8vuxHHX3r6K8N+D9L8PQj7Jbr5p/jYZb86bb3Wl+H0S33RRbflAGBXQRXEV1CssJBVuQamTfTY53PnbbGSpkfKABjnNeA/Gd2k1XDDBAz+HrXv5DA8Hj0rwX40RbNQGBjjJNOHUmHxo8fnwGOBzVCZdzHditAxNuIGTVG8Q529COtCR2xG2+VwGq8o8wbCAT79qoxrkgMauRjnHagGUrmDax2gdaK0Z4QADnr2IooC5AGBUHt70Z6YFNkGB8vNEbFhk8D+dADmXIwelRjy/u8/WkxI0/XgVKUXI45oDYQxIU44alXAXrkCkZhkruwaYFQMVJOTQBLnqRQrFl54+tNXCKRkn2zS4wOABQA+JiGBKgn0NLeRuWDqOOvFIBuO0CmuXRwvVfSgQkZEh2vx2NTwoqTkcY/nxQsKH51b/GkCebIArfp0oC5chi81gqqCfYV638NfBLXTxXN1GDGef8ACsj4a+FH1O7ikdCY0YE/4Zr6L0nT4rG1jihQKo4AA6U2+ReZhKTk+VGZPr/hnwxJFY6trmj6ZP5YkSK7vI4WKEkBgrMDjII/A1b0vxh4X1Rp00zxHot40ELXEy299FIY41xudsNwoyMk8DIrxr4//BbxB8RPF1jq+h3ulQQQ2C2jpdySI25ZJGyNqNkYcflWZ8KPgP4p8IXviKbUNQ0SRNR0W502MQSysRJJsKk5jGF+XkjJ9vTmbdzeMYqOhxnxP+MHiTw38X9WvPCuvwX2hzeQ0NsbmO8tXRY1VgAjN5eXDkhSjcgnGRXpXgT9pnwxq4MPiq2l0C6A+WUbriB/ugDKruViSxwVwAv3snFeBePPg7feBYN/iPxT4WguGXdHaR3E8k8gIbBEaw5AJRhuOFzwSK5261TStT8NaLoGkeFY5NeQeQ2pq8hnuWeUuqLCh2lgXMYZg7MoXG3AAm7NeWLR97+KbmK88OPcWM8c0FxBvimikBR1ZcqysOCMYOR1FfKGvQyjUZvPGWLHOa3fg/4Y8QeBfDWuzeILJ9POqi2aCJ3XzNqrISWUHKn94BtbB6ggVi6zPvndjz3NdUF7mpyRVqkrHPPCyNljx6VbtpGfAYDA75qpc7pzkcD+lNidkdcdupoNj1n4eeBj4gDSM22LGS2Ov51W8W+HJvC+qKmRzyGWul+D3jWw0e2e01A7FPR85xjt+J/nR8YPEOl6q6GwlWRlHzOB16YH161abv5HO781j1D4aa5/bOgxiRiZo12tnP4dfYV8vftJaKNM8cTyqoAuP3o2jjBz6dOc8V7B8A79zc3EOBtcBs/TiuQ/a3slXUrC52jc0e0H6ZzWU1Zsuk7Ox84YpMdRQef8KP59a5jrHRp5jKg4LHAr0y0sLfRfDizSgeYV3Edx+VecWDeXdoTyB2rp797/AFVUjXeY8AAAcVvSsk2TJXsc/fym8uSy55PFen/Dvw4Vt1mu1Co2M7umOtcvomhtZ3KS3inAINegpqw+zLBAuFUdvWtacVe7Mq0na0TvRJY6fCgiEQz1IwM/lUOp3K6zEkFqw2g9Mf4V5o9/d3FyIucZA69a7uxl/sqwAVR5rjt2rZO5xyp8uvUu6hLpuj6YsUarJdnGenHvit/wr4uS20WWa7whVcKehbqcZ4/rXD6dpM99drPdNmPOTk88GsX4p38tpbG3sI2SILt+XoOOtKVrahGKk1FPUp+I/HP23X23TkoHIGOQP/r819HfD2X7R4egl3DlRkZ6f54r4SiZ5LlS3LE9xX2X8CpLlvCUYlHfhvw/xzWHPzRZ0Vaahax6OzcHbn8a8C+M0m7UCuOgHP8AWvfZPu4x2Pavnz4w3IfV5l4O0AcHpTp9TGPxo8uIKndng9aoTKJHySavFjl1TgimeSNpDYJ74pnUnYz5ExjaDmnIrEZYn6VZaJlzwD9KhlRlXIxmgq5agLMoxuJFFVondB159KKCWiHDBGGRimFyVA9KkLqpG0Z4peCASvX2oKE8tlIKHp60q5BJb9KFOxTgH8KFclWLDigBY1RyWBxQSgkGetNjUcMKUplg3b60gF8pmlypx9ac27pxx7UhU4+XA4qVUBiJLfMOaBXGElR3obdwTkg96ZKhZeKsI3+ihe+MdaBkcSbskMcVreH7GS81GKFQCWYDr1/xrPRgkOVyGzzXffBy1S68SQM4OU+bIHv/APqqlYibsmz6F8E6JHpGjQxqqhyAxwO9dNgDJ9sdaggUqqgcYGKsADdnnP1rCTu7mcVZDlAGM88UuRnHWmbwo5Ptmo2mI9MfSpLvY8L8V/s92/jL4j6x4i8Qa/LHY3kwMdpZp+9KCJFBMjlgpDA/KFYYAwVzhfT/AAn4F8L+CLeRfDOkW9kX5ecEySt04MjEtt46ZwPStqed0YFQTzTJZGuLVtvBIpqJMq11Y8r+LF35q7G4wOD/AJ+leCai2+UojZy3c/zr2n4g20rmfzlLEH5fpXitxCUuX5wRmuqS0SRFB3TZXaMpheu79KjnjUICp+arUkbMmQRnFKI0MYVzye9RY3IIGYwZBPHYcU4zuYwBuLA1IsIjPUj0rc8K+HbvW71I7eFmTcAzYJC57nHSiwOVtWep/s72UpmnuGD7QuOeKyf2tLq1MWnW7kfaArMo54Bxz+h/SvSvtumfDTwjvvZgWUcBcZZjzgZr5A+JHi658XeIJr64JwchR6DOQPwziom1uRSTk7nJd6PXHWjtwaOfSubqdRNZJuu415PPFeki5Swso0EYLAfeHc4rhNHtJHLThTtXocV0X9qxvEUkA3qO/WumnotSJ6m+Lv7TDlxj04q5YyqsRXbz61x2lan516IyTtz0rs5IHMKGA8EZOOK1i76mUlbQXS7pYr/cyDcDx6GupuLxpvm2cdfYnFcb/Z1wCso+UZrsfC0azKyTgMQvfitImNW25X0DWrt9XWKRW8nJBHau91TSNN8QwtZtbkTMODj2zz7U/wAN6Xp73pEkYVz3Feg2Wm2NvOjxIN2OoGMVMpcu5zt8zvHQ+X5vhhd2niMRBWKB+BwN30P619S+DNIXRNAgtFxlRnIGM1dksYbmVJGUAr0OKtyYhjwMnbwO9YSatZHQpSlrLoR3rFbaRu4BNfLnxGuHk1y5J4VnPFfTl1Nm0cgE4H5V8vePnWTWZiu7O44ycn86qmtGKDvUOWUDGRigj0HOOKUIQM7iTTunqR61R0WIsll+UDpmopUMnTjHFTM4B/wqNiQ5xkd+9O1xGZLnfgDnvxRT7nB5xzmipNESTRqrDYOnPNQyFy2AMAU4TbYgDSidFX7uSfWjqTqMT5iVbnFPX5ARjikV0AzjBNPDdM9PWgY4vGyAL1pGUjHvTJAFZWz2pZGYlWB6egoEPEbnHBwaMHdtHeneZKU709sBQzcMe1ArkQyvykZFWPKAjOMe+DVfkkknmk3HaUDYzQmOwhkwAvvzXqXwZxb6qkrDGDjP1ry63tWLAnOK9S8CwupTZkEjnHBFVBXMq791n0ja3O9AcfpUyzAYrltMeeOCMZy2ByO9aUZmJ+UEjHNZOFmc8arL006ksqnJHrToneRfu4+tJa2xPLD5s1oJCoGQME1DaRrGLlqyosBBBwT+FKkJA4A681ewSPSjHPGPypXNPZo4vxV4dXUEcquW7g9v85rw3xj4Hv7N2kity8ZJbcvb6+navqRog2c5NRyWsEiYkjVh/tCtI1bKzIVJxd4nxxZ6BqEsmwW8h78qeOR/jXU6b8Mtbu/mNqyr2LHFfTqWdvGRtiQAdAABTpXhtkLyFUUckseKPaLoi3zdXY8DtPg5dy7TcSRxj0wTXV3lzoHwt0PzLp45LnadmANzY9Off60fE/4sWXhi1aPTzDdXZzt+bKqffH5fzr5H8YeKtQ8UalJdX0rtuJIUnpnn/P8AkU3Npe8KMOfroafxI8f6j4y1N5blytuDiOIHhQM4/HB9a4k/e5PNB5PrS5rCUm9WdSSirIOlIee3NHel4z05NRsM9Y+DttpeshtO1B1i35AYnvx7VueO/hS9kj3GmusyNzle3+evH/168V06/uNPl8y1kKN6jjNepeDfGd/NbyfaLg4A5GcZx7V1wlGSsznqRnGXNBnJadoF5Z3fmSxMNh6kcV1GlXdw0wjZcIPUVbufFIIf7XEDgZ3VnWviDT2bcoVWPYD/AOtVpRjswvKW6OhvZrgukMa4Qkc4rdtJbfTLHzHcefj7vcVyWo66sWnedBh+Oo4rH0u8udeDAMS4/Sr5kmZODktdEdPe+Kp1vQbeRsnpX0B8M7ubU9GWW6JdxwSSTk/jXzHomkyPrUUM6/ecAbunPc19c+FdNi0vSLeGNQBtBPH+FZTl7uopRjdJFyVXWZNhIUVamG+PkZ/rU+0E84/E1HJjBC9axuNRtczrvMdjLsAHGa+VvGspfVpsgDDHpX1RrB2afMcfKFya+UfFL79Vm3YzuOa2h8JNNe/YxYySvzfjQ8uOM5pwUDkVDcoWGBTOjoIjAscHj27807JAUdc8cdqihTjkDn361JhvQ9apaiKs6Kp44J6iiluwGKkEA0VDKSKyFZDyOacVUdhjp0qFMAZzyKdI5IXAJ96BjmCnAOB7U+VAqj6ZqORd6hsEUshXYACOmMUCEJEiDLYIpW+WPg802OPfHnpipFz0P0oGEMznrjAqWRw3zMeKgaPL8tx7UTD5cLkjvQxWGiQB93OD2pVZGfdkgmkjjG3LdTW34Z8P3OrXqCOFyu4DAFCVwbSWpc8MaRPf3SrECwyO1e/eFvCLWsEG9fmAycjvV/wT4Dg0a3QyoPOC8kd67+GFUHQADtQ5qKsjlknVfZGfb6aEjUAcjnFaEMAiIwOn406UqhGOD1zUE10qgZbg44rG7ZolGBeCgdKD+FUorkvg5IHoateYMAnuKmxopJ7ElIetIGyOCKpajex2ltJLNII1UE5YgUJX0BySVxb/AFO2sUL3MqKBz1ri9S+KugWj7EmeVs4O1Rge/WvCPi/4xvLrVZVtp90IYrG6dAMnmvNNJkudRvAjMxwc4J7VryRWj3JSlJXbsfTWt/GqCOLNhAMf3mzXP+I/GOpeKdFAs3eMYy4Q9f8A61cRFoQurdI15Y45xXoHgrQZ9FsJZpIwRs+6eelbxgk9jCpJJXvdnzt40e6+17Lonf8A5Nct3HPWvVfiFAmoahKSiq5YkYXjvXA3OiXKv+7jLL7Vz1IO5205XijI46570deetasWiXJP72Ngp56UlxpDxOFUnrg1n7Nml0ZYBPPGKUBi2MHriux0Lw3PKyhozsPeuzsfhw11crsVs5zzyP0rRUW0ZyqxjuL4E+GS6/4RuL1tomjBI4PYZ4964jV9MudESRYgeDg4zX0t4bvbfwfpyaXdYJbqUHTj0rP1/wAA2mvWE1zZfMJF3CMDOeecelbuGhyRxHva7HzVpuppIhgveh796XWdN+yRJPbSF4zzkUeKvDV3oWozwyxttRsbiMUzQ5Wuke0mf5WHGT3/AP11gr/Czs6XR0fhSD+0NHlRjuZRwprV8CRTaPritMm6LfjJ+vNcdot5caFqbDJMZOCAeK918L6EfEenG5tUG8dSvvW0LPfdGNWXKnfZnZeI9D04aQmsWcaiRP3vAzn2NbPw18TXOsxmGSPiPC7u2ateEvDk39iGy1M7kzjaTnPeun0DQbHRYWjtIditljkd6mc1ZpnLTg3qaQQkfXvUXzb8HFZGv+JLTSp4Y5W+eQ8YNa9vMLmFJB0YA89qxcWldmykm7IzPFkiw6Jdsw3DyyMenHavk7W5PMv5DjBzX1B8RJjH4Zu9vBK8nOOvFfK96xa7kbJ5Oea2h8I4fGyBm2jkVFL8xAFSSEHGRkmmKAvG45qkasYq7W29qlkYKvTg+9BQNk96UDPWgClJDySOOcUVO4GeCfwFFOyFexmSgHkDB60zDFPl/wD10juzkA4AqRMKu0t1qCwIkAABokx5YBwD6U4IyfMxOKQ7ZByeAaAEVtsYwOtJvbeAR+VPYHYNuP501XO7BxnpQBJsVm5JBFRGURvtI9hU2GKnAyfQV1Hg3whdazeRbk4J6+lCVyZSUVdkHg3wxfa/qCJFAzISM5BIAr6n8HeEbHw9ZJHbwgzHlznPNSeCvDlroOlxQxRBZAPmY8HPaugLkYA61EpdEZfFrInwF4/AZqOWXYMDr0qGVmIyOtNYYX5iM1nYHKxU1DzJlwg696qJYS7vmc4+uav/AGmIEjcCR3qlfapDbthnUD1rRX2RzyS3ZeiXy1AHapnkKrxkn0rm4/EUEk2wSpnPGDV9tXtwFJcDPahwYRmkjQWcoMuQM8da4fx/YXmtqIrORliB+ZQetdDc6nbyMsaOPQVo6dBEibwQ2fWmvc1C7k7JnhF98PUa3Zbr/WnPzEdKo+GvhpJDfBgm1QSTmvoLUrK2dWkchR65rGWe0gxGkqbgeRmtFNPWwSlOOlzmYfBwtCjp82McYx9a7S309Z9PEboVyMEdKisb9XmAkb92DjkdaNc8U6dpaHdMpOM4BHHT/EUpOT0Jik9Wzz3xB8K1utSMyuvlOc8dvwq/ceBtF0zTl8wIr4+Y9c471i+J/idJEWFs20cgE85/CvOtV8ZX+oHdJM3IHf8ApVq63LUZyWmx1GvabosZ+XbvHGABivOdcsbVZd8JBGc4HWkudQluB8zMfbNUZd8pA3USd1sb04uPU6PRdREQVSuSOK73S9azFuT/AFg7dK8kgYh+Sea1tPv5IJl+bimpW0Yp0lJXPUdO02XxBfq91xz971rVlmvvCeoRK5ZrU8jH8Q9PrXO+HdfWGNGdiGXvXp1heaf4g0wpOF3ov8XUHFOTt6HK007MwdQ8KaV48ja4kTZIQD0HPseOuK+a/if4Uk8Fa69oCC33gy9MHkfzr6n8OS2ek6tJCsoVGbA5+tec/tM+F59TMOrWqgqkexiO5HPp6CsZrWx0YedrXZ852N01zdxJLjBIGfSvtv4QaTFZeE7Z1UZlyemDXw5DutrpDt+ZT+dfanwG1OXUPBsBmJJRsE9vX+tZp+6zestUelqFX7q9KhvrgRQO3GQCadK2xc9OM/SvKvFPjGW01R4duY84zjoP60QhzMxqVOXRHFa3qFzqfjHbMzkLKBg+3tXvmjq0enQKeCFHQV4l4aiOr+LI7qKJsb9zEDoa96hTbCoHAC/jWtbRJEU9WcR8WZAnhpyTgE8+/tivmO6b985APWvoP413nl6ZFCCQGJ/+vzXz27AyEYHX1oj8KNaW7YxwSN361EFyfRvrTpGIbbjjvSBcDK4pmrH4MeC3fpTS5z6D1NPQ5ByCMVExyPnBA9u1AFe6fyfncgZ460Vz3iG/ZJgin7vFFQ52di4wujXYHacVGoO08A471Ky+pOD2pF5UoOO1MkR/NKcfd/WkIPkbcfNnNORWjfD5K09sbuOlAXK8chTgDP40sSs0oIHepI0Vph1xWvZpHkZxjPPNNK4Nl/w9oZuJAX7np3r6K+HWjQWdjGVVdxXqR+leFabfx2joSylR716loPju1t7VfM+Qr0w2P896txvGyOSq5OS7HsWQEx1NMYhcFsce9eS3/wAV7eGFvLjJfpyTjP8AOuQ1X4r6lcpItufLUjaO/wCP+RWPsn1L5m9ke7arrljpwBuZ417/AHutcZ4g+I+nRgxWxL8ckdjXgd/4jvrwsZpXZiSdxPPPXmsd71pJCGZi3qTVqMUHs5S+JnqOs+PZRN/o8rD6Ma5+88ZXdy2GlYke9cP5xMu05pkrMkoYEkfWq52VGjBdDr4/El0Jc+YwA75q3/wl8/llXkfA6ZrjUc4Bx1/Wqyy4kKnoabk0P2cX0O3j8VXEe1hNINtdPbfFG8tbRU3bmXndkg/5/wDrV5LnEZxk9s0xmZoeRn+lJy7i9lB9D0jU/iRquoxlftDqrZ3bcYOetZFt4ouIX3lzuXnGa5G3dkjORxmpDn69+lCbH7OPY7e98b3U8REbbeOg6fWuVvNXuruVmeVjnnBNU8knHb0phYKSpxuPt1ptvqEYRjsiWSUy53ck9TmmbcdCOeMdqQ54/wD1U9flAzxSZY1QCQD/AIU9V+Yr2pNyqenX0oKktuQ5oARhliN3NAdkI6Ee1PViWHGPWkZsEjbz60gLlvqEyD5WOOnNbOk+J7my3GKVlPX5T1OMVyURlMhzwvcVLz/D6dqabE4p7o34PFF4dSWR2b72ec5r6C8G6tZ+LNDa01Dy5GZdroeh9/5V8vqxDcjB+ldJ4Y8RXWkTRvHIQFYNx0ND10ZnOmnrFHo+tfAqC51f7TaXAWItk7skj+les+DdAg8N6SlnAQQvUjvXO+CPHcOsQpHKQswHJ9fpXcGQSRZXoe9ZT5loxKSfXYw/FWr/AGOBkjI8xgR+NeaHSzrmoBpsgseSa3fGMU63iuSSnAx+NUNL1SC21GKMMASQDg5raCtHQ5ZSbdzuPDXhq20mNGSMCQDr3NdMx29hgiordy1ujeoBFK/CMfUVzSbb1OuKUVoeF/HLVBLeLbo3CA5Hpn8fQD868eQggnvXZfE24MviG6wwK+YQMe1camcc9a3emhVJe7fuBwV69aiUEggHjpTpsgcU3LDBBzxQi2PiOBg/liiaRVhYnPSg+pIwKr6n8lk5HHH9aBo4TVpA95IzMCuetFQXGHlfceM59KK5Hqzc7gHCfPwaXcThgcHrRIwDZYg5qTarJlDyOcV0GIjSZOdoz15pyuoI3qc+tND7l2t0Hem4L/hTuFiUPGHJVeB0pyzqPu/jjmqbsW+VTk062YQth1+Y9qaYWLhcnDK+MdeKlW7maIAMR7ZqpLvTLqetRpI7xFTlaLisWPPdnwTlfUUGchtqYJ9aqxPtzluehNSRBUkLM2aQNDxI4znkkVHHIqyHPJ6HinGXMm7HHpTJWG4uO5oCxZikDPnvUMjljjsKlj/dRbvXng1AcSSAj5cntR0BEqSlUwfvGo3BVtx6U6ZVAGDz0xTJZiCgk6GgETwuhjHXA9+ajUP5g27sZqYKFUbDjNKDweQf61VhXHFwcAr17ilTk4P8qYvPOcGkdwOM8mjoISYOsnydKMhycjkHin7mTtnnmmpkuTyQe1HUY5P3qkg9BSs25dpBzmk7HBK59KYgdXwxz/SmBKYwFHWmMXj5Vc/jSnJGAeR701ZDjBJ4pPsBJncAwHXtQ4yAQPam8kgetDMChQjmjYA3ZGPXoSOtNVGV85OCKEUbTySRTJFLtwcYo9QJlYKCvWkyysN2dvfmm5ESjcS1IZSqDjrTA2vDutPpd8jI2AG/rX074E1uPWdKRsjfjnPHNfIpkUAsmQ3bNexfBHWJVvRbs5IZcAZ/z64qX7yszKrG3vHq3jaH/QnkKlsCvG9EtLi98URKpON2efSvoe+tI720ZH/iGK53QPCEFhqTXQYkg5XOOKIVEo6mTg09Op01rH5drEvZRijVZPKsJpDwApPPQcVOy7QBjIFZHjKZbfw7eE4AEZGfwrBas1krRPlfxZJ52sTyAghnJGPrWOo74+tWdQdnvJC3rVcYxXQ9zaCskMY54/lVcvjC8ZPSrLAHJFUXCbyMjdnii9hMtou5fWq+sgLp0i46ipoiTx2HeotSj8yErg0mNHn/AJEjudo4+uKK7Oz0+NQfMHJ7k4orL2RpzoiyZAcjp3qxaNGAwYHGPSmTZGNhyKFbcvyrzVk7jpWAQlRTHkKxgAYzTZBtjAI5/lTHVmUFs4FMLD4kI+fv1FTBuAWU00HKdzxSRsZDsIxigGICxl3H7tSEhmO00BT0HQUzYocBc5pAOKjOSBn1pFUKeBxRIQj7Sc+9PZSAGz1oAfGnBLLximRjfIFAqVpT5QGeT7VCilssmeKYiWVnD47A+lQxORJux0NPgwdysRuqNC8bYOGz3oAex3MWNNk+fBYDj2qR84DbcCmE8cikA4O2AD07U9HCg7ic+1RyMNowDx1qT92wzzup7ATAKV3cY60ybnGOMfrSxsrqeDgUjsmQq9upqmyUSoWAwwz6jNQCTEpU4HpSncpBzwe1DtGZBhTwaVwsSuRGOTnPPTimMwBByAppZF9fwGKiZNwAAxzQ27giVmO4bRx3NJI4TBPOTTHbCgHp7ipNqMmWIAHGaEwFXlQzY5xTZX8tsLjJpCPNUKp4UdMUIg3AODkfjRe4WHKwEfzEBj60khZFBGM+vpTbnkj+9SAOyLuJ2+maL9B26kgAkQFyBmnNhfl7U18GEKM5psb7V2FSfwobEMli2nj8q9E+D08kXiCFSBtJ5rzubKAjqCe3SvT/AILxNJrUUuM46/kKI7kVfgZ9LxYMYPbvT4+AQDjnBpse0RjI9wM4qRQOcY/HnFc40IT0yMHPc1xfxWvPs3hecKdrSnH19q7bqD6fTrXkHx2v1jsILYMAW+Yj0q6a94me1u54NcyedKz4xzmoSMjGetSKR0IqMg5GK1NrDGJRSOuaqPkTc5q6cnoPzrOuAwnA6c9aGxI0YuEBU/lTZW68nPtRanCAHoKc65IPpT6h0E2jYBRSbtvB4GKKNRGUiho8BvrT4wIx1Gc0DEa+oFQStlvl6VBe4+RC7btwx65olLEqvOB0NOZI/soOSHNEKEdT1oAaqPv+U9O9SCT7uVxzSAur5zxipLaQuxBx170xCy7XIKZHrUYILbR1605t6SHp6cVI6+Witjk0gInjAfnk0AfPy3y+lLIw6ngmoRvZh2H6UDQ+4y3TOKdnyYxtbJI6ClBUMEYAkmm3QHmqvagPIfGi/Zy7N856DNMDkKA55NOkULwOf600r5hABoAlDPs9VNDS7htwKYrOvB6U3dz93j1oEPQ7ScjP1p+wKpPWoywXkkZ96dhjFkEEfWgCSGQLGwAOfakk2ZyM7veiN1ELDjd9KZCQUzIPxpiLClfJG5iM81Cy4fK9qWdS2GH3SOwpsbnOF+lAD1mYtgnFOeJt2Q2RjJwailVkYE4Oak3NsG0jGO1K/cCMBmzjOB1pwcPhduMnk02LfHLgkDPvVg+Uo+cjP0/woAi2GCcbDn1qScbV3A8GmxoJM/NkZ460yXcG2M2RT6ABAkG4H5j2qaBmxtkzntUSq0b5HI/KlE4eToMihAEoVXyQR7elCEFgShAHfrSPJn7xBI9qkDRsgTn8KQDLghgpGcGvYPgdbk6kSuSAMnHbtXkRjVTGM55719I/A/Svs2iNOwAaQ5wc8EU72TZnV1jY9TRMR4xj2p2BsyO3XFOzgdOTSE/KD+h9K5yhHbbGx4zXzZ8ZNRF14gmRHLIny4zxXvvinUF07SLmbILhTgV8neILxr7UZZ3Ysztk7up+tbU1ZNkr3p27GZRRS0zoGgVWvk+UNjJq0Bk4FV9RISP1GRQJoLQ7owSeRxVjFUtPl3BgeMGr1MEhpA9KKCcUUCdjAPLZ559af/q+OppVZQFyB9cVHI2XIpDJXTMefSiHJXknANEfyp8x69KJDtUAHHNAhGDKfkJIP6U9nWNB8mGNNjYFcD71OZsKN+CfpQBLbp5w44p8cvlsVbBHT6VArZXKU3YGQMxoEJdvvlzjHepWMflgK2Djnmo0zlsnIpkkeG3npQOwqRndubH4VKRv5IyR61CATGSpI9hSxyHIUmgY95GBI2U63dI/mK8DIoZtqk4pqnMRY80CaB2DLkDAJ6ZqRmVIAAuTVc/NEMDoafGcp+goCw4bXUEjPpzTwxQrxx6Uw4OM+vFKSNwGBQBNJtdhgY/GmMRjapyM8UzzFEoyCRnvT2K7+5WkIcjYBU9Pao5Ap+5wacv3x1waWZfLcHsRmgB2yZol3DIFK8myNQg59qb57g5VuPpSSjbtPPzDNMNx6BiBJJyB2zTyPtC8AZx69agL5XGcemKcr7Y8KSO/FADfMZF2j69aeWYsjEA4qELuPB4qSF1WQbuaTAl+04b7vBNRxgtMZFGBk9aJ8F8rnGKiDEE56U7gP4Y8ZJPcnk1NGB0fhu3HNR7V2grk/pTQCy7s9B0pXEXtNh+0apGi4IyB9favsDwPp66foNrEnZAT2NfMHwy0z7br8GSAN2SPavrSwULAiDJ+UUT0iZSd5pdiy5wArdP/AK1KSACx64zkVFgMTn6/WqPiC9XTtKnmOTsU8Cskr6DcrK7PJPjN4lWV1sbeQEJy+D1J7f59a8VdizEscn1rZ8UXz3+pTyyEksx6n3rDYd66HpoVTjyq/UUHmkLYpuTgcVDcybVPripLuI9zhyAw9BUd4RIinqD71QZi8mcc9qnkLCD6UhkcEjRyKFx1/OtE3ahM+nasn5dvOc803Jzk80x2Lz3pdvRfpRVEEHOO3FFAWP/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Arrow indicates cochlea and vestibule reduced to a single cystic cavity.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Glenn C Isaacson, MD, FAAP, FACS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_32_9728=[""].join("\n");
var outline_f9_32_9728=null;
var title_f9_32_9729="OSullivan OConnor retractor";
var content_f9_32_9729=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F61098&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F61098&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    O'Sullivan-O'Connor retractor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 381px; height: 503px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAH3AX0DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArIm1O6mu5rfSLSG5Nu3lzyzXHlIj4VtgwrMWwwPQDnGc5A165K8tfEeiX19L4ds9O1WyvZvtBt7y9e1e3chQwRhFIHRiC2DtKktyQQFAOhiXUCFaWa0X+8ixM2OOgbcM/XA+lZd/qN5qHm2Pht4GmRminv51Lw27LwV2qVMkmeNoKhcNuYEBWxJ7XxTq2oWlv4hvLXSNOml/wCPXRZneWXau7a903lsqnByscYb5fvgEiu1s7W3srWK2soIre2iUJHFEgREUdAAOAKAOQl8L+JbW1efTfG+pz6mvzqmo21s9pI3GVZI4kdUOCPlcEZzk4wdzwhrg8Q6FDfNb/ZLoM8F3amQSG2uI2KSxFhw211YBhwwwRwRWzXGeEo3sPiB43sQkaW9w9pqqBQAd0sRhfOPU2ufqTQB2dFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGVqbJ/bWjK8oUl5SqbCSxEZ79BgE/n9azfHWrapYro2n6AbJNT1e+FnHPeBnjt0EUk0kmxSC5CRMAuVG5lycZze1GNn8TaMQQAiXDkYzkYUfh1rmPHdzt+Jnw0tMjMl5fS47/JZSj/ANn/AJUAdX4dbUltJbfWri2ury3k8s3NvEYlmG1WDGMs2w/Ngjcc4yMZ2ijYIR8RtcfccHStPGOwxNec/r+lWtDA/tfxD8m0m8TnGN3+jQ8+/p+FUdPfPxO19MDjR9OOces19/hQB09FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGTds3/CU6YoVin2S5JI6A7ocZ/M1yHiuAX3xr8BrDJvk06z1K7njRuY0dYokZxngMS4GepU46HHYXLAeKtOXPzGyuiBk9ng7fjXOeAYTD4v8AHrX6RjVpdSik3bcM9n9njFuQccoCswz03iXvmgDRhvX0nxlPZXlu4t9ak82zukO5DKkKhoXH8LbYmdTyGAYcEDcmmRkfEzxFKTw2lacgGc9Jbw59vvfpU2tyxalr2m6PHHJJJbypqFywUhYY13eX8x7tIAAB1CyelRaVKJPiL4jUAAx2Fgh45Pz3Jzn/AIFj8KAOnoorHuLqW/1d9OspGjhtgGvJ065YZWFT/CxGGY9QpXHLhlANjPOO9FYreFNBePa+lWjNnf5rRgy7/wC/5n39/wDtZz70eGr1pptZsZJZZm0y9+y+bJjcwaGKZRx12iYLnqduTk5JANqiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAxbph/wmemLk5Gn3Zxj/AKaW9Z2o4/4Wp4fPGf7F1LPr/r7GtK4MY8WW8r/L5NhNly2AA0kfX/vjrXJT69b3fxSsp9KRtTjh0W9jj+zMAHcXVsjhWYhWwQASDwVYdeKAOw0TJ1DXTs25vRz/AHsW8Iz+mPwrI8Pgf8LG8XOCP9RYqRnuFlP9RTdLutXNxqD6fplmDNfbplu7to3TESAjCRurHAUD5gPy557R9T1aw8XeNr+6tLD9ylkbtX1Dy4bdVgLMyyNGMqNxZiwXABwD0IB1fj3XI9G0cK0rxS3TrAHjV3dFZgrMqoCxf5gqAA5keNe+RkaJ4M8LXui2uoeEJr/SrS7jW4hm0u8mt1k3KMO8ROxnIxkyIW455Favh2FfENo+s6rZSrFqUUTQaffRLm3hHzKHTLASFiWbuPkU8pmumVQqhVACgYAHAAoA4XxHc6t4J0KfVZfES6jZWseXi1W3RZJm7KJoQgjz3Zo3AGScAEjK+C2vWDaIlrq16IfF2pSNqWoW10rwSvLMAwCJIclFQJGuOMRiq3jTT5/iV4tOgW08KeH9EeOe+doRNHc3AYEW7c8DAIbbhgNynhxnovFNtqeo6PLb+IPCmjaxZBcsqX+G4H3wJI1CEYzkPkevFAHb0V8+xfEDT/D8ZXw/4sigXoum65qFrqES44CpNFcGSMcYyxfHBK9c9zoXxUW9SJtU8KeJLFHTf9otrQ6jb9Bx5ltvPfPKjjmgD0miuDs/iz4Qvta0rTbDUZLmXUk3RSRwP5aEuECuSBtYuQu0jIJGQMiu8oAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigCrqWoWum23n3sojQsFUYLM7HoqqMlmPZQCT2FZctvqOthluXn0rTiRiOGTbczAddzqf3an0U7sYO5Tlaj021to/E959v33Gp8z2s9wAdsDYUpDwAoU4DAc8oWJ3CuioA82k0S5XVNUg125u9XS3EUtm80UZSKJnlVQI8kyFFOGkkBySrADaSW3y7PilpxgiMzDQpMKoydjXsHT/AGQM9ug6dq1vHJuvta32jQGTVtESO+VFXebmBzIksIUfMx2BmUA8yLH2znlrpJrjxdYtbJYeKpb/AEcSQxu6W9uYnuFl8x9qPsgUKgTId3LY+YK7KAdlZ6xZaX9vbU9QsrKJ72Zg93cJHuw2AQSenykc/wB01y9jYJ4o8S+K4rWaKfSrzUdPmunGJI5rdLWKQBDkqyuwRCOQUL+orqPBunW1qZra70izs9VtW34hCyIsTu7RiKTYp2DLqAVUgq3GCC1XwFcLe+KfHF3BL5ltJqEKx46fLaxKT75IPPpigDtq5n4i+JovCnhW71Bi32gq0dsqpvLSbGbhSQDhVZsZGQpA5Irpq8xupD4y+KdraKWOj6Bm5lC4KSzK+2MNzn/XRuQOxtMniRTQAzwkfEWl2Ok+GNN0210rUfsYv7661Wb7VhnYh1jWMp57BsBm3rsDITu3DPSR+BNNurpbzxNNc+IrxW3p/aRDQRHAH7u3AESkc4baX5OWNbWv6bJqFtG9nMLfULZxNbTEZVXHVWHdGGVYehyMEAiTQ9RXVdLguxE8DtlZYX+9FIpKuhPcqwYZHBxkcYoAszWtvPbG3mgiktyNpidAVI9MHjFcFefCPw0t/Ne6DFJoM86hZo9OwkE2MbSYsbVZecMmxhubnmvQ6KAPIbvwb4vhiubKaa01vT5oyrCaU/vTtx8ySZ2NywDKxzncwyBnv/A1nq+neHYbTXp/tFxDJIkUjy+bKYNx8oSvgBpAm0MQOSM5PU79FABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAZHiO0uJLZL3TIkk1SyJlt1Y7fNH8cW7sHXjJ4DbWIO3FX9OvINRsLe8s5BLbXEayRuP4lIyKnJCgliABySe1eJalqnia+uNWt/hd9pOiakzXKX/ANj3eTMSfNNt5rRxNHIxD7ix+cysAwZSADpviF4ktND1iX93Nfah5MD21hbyhDLJGZn/AHkhIWGNdyMzvwF7HpSfBueHU5vEmppcWlw63Fvp6vZSiS2SNLaOby4mHVFlupwv+ztGBivLIvB/iCXUL7T77SrGPUdsM1o82nq0UZkk23Nw4lkdbu4UFSCZJDmQg43cael+J9U0DWIrHw/avqdyBKurXdtbKlrNfctHbzPGTHHP5SqrOmUjcru3LkAA9j0fVLT7HrWvXM+YkdgxVGPlwRDKADGWyCZOATmXAzgV574f8HXXiS61kx63rnhd7HVButtJuREp8yxtHMbjBVgjHCnocsf4hjM8PeLdT1DwbBJfJHZauWhvJLSDLRkeRiGZWAIkixA0wSNiS0bAsFSQV1PgZL2wi166smlufsF9brNbRLk3Uf8AZdju2g4O8EBlzycFeN2QAaniCy8SeG/D+q39r4slurW3tJJD/aVpC0kIVDmRZECDKn5/mRwQMY5zXNfBnw29j4du/Ftis0Nxq863NvaZbD2Ea+XAjgn55GiHmeZwxZxu/iBj+I+v6f8AEHXfC/gTQNStL7TtUmN5rTW0wcpaQbX8l9p3IZGwMghhj0Jr2ZFVEVEUKijAAGABQAkbrJGroQyMAQR0IrBhb+zPGM0BlJh1eM3KK5+7NEqIwX1DJsO3jGxjzuO23plxDDqN3pQLpLF/pEauc74nJOV5+6H3LjjGBxgqTl+NdSFhqfhKJTKbi61cQxpHH5mR5Excsu4HaFB+YZ2nBIIBBAOpooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoopHZURndgqKMkk4AFAGZ4q0geIPC+saM0xgXUbOa0MoXcUEiFN2OM4znFZFrrOtRmx01dCtPt4AW5EN6Ps9soH3gQm7acAKpVSc9MBiLEWpXfiAuuiF7XTA2DqZAJmwefIUggrx/rGG09VDg5G1p9jbafb+TaRCNNxZuSWZj1ZmPLMe5JJPegDyn4t2uoapb3FrqWn+H9TFvbLdQ2ksUwk2vIsUyiQMCBsZvnVdwO0hcgGue0PxHqC+GbTwfp+j6jcR6fAIDZCOR7q7VXAjia4W3jtY7dwOZ9zl4s4Xe2R2vjG1Os/ERtOQCN4tDJFwAWaMy3AK7R0LBrcOFIIYRsp4Oay/Cz6p4du5ILXTbvXrqDTLeaG1tb5TFD5811lle5KMsbLDCNnzFdozuILsAeaahZT+DfDt/c3SwM3hbTpLWZhGhimu5ryC4jXCKAF84SMIxgrF5TNt3lR7n8NIYLbUPGtvaoUgh1sRIpOcBbG0HqfSvIvEuiLqV3NY61p9kmnqzX1zpNpIPJ0syuftE07cebdSZaG3AAHJcAbS1esfCuRprrxrI6spfXncbic4a1tmA59AcfhQB0WoeFtGvrhLmSwiivEuPtS3VvmGYS7NhfemGJKfKckgrwcjinJb6zZu3lXlvqEO35Euk8qXd7yICpHt5YPua2KKAOX1IWWpzwDWbW+0q+tlZobxHKBN3DbZkO3aSB8j43bVJQ4GF8OeEtOsLyHVXvtQ1rUFjZIb7ULozmNG25EYGETO1clVBbHJNdPWTPoNqWllsXn064k6y2b7Oc53FCDGzdeWUmgDWorFM+s2CObi2i1SJcbWtcRTH2KOdpx1JDjPZfW3p2r2Wou8dtMfPTl4JUaKVB6sjAMB6HGD2oAv0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFY2o6tM16+m6NCtxfqAZZJMiC1BwcuR1bByIxyeMlQd1AFvV9VttKgV7gu8kjbIYIl3yzN/dRRyT3PYAEkgAkZZ0e41yQTeJFT7Grh4dLVt0YI+60xx+8bnO3lFIBG4qr1f0vR4bK4e8mdrvU5UCS3koG9lByEUDhEHZRgZ5OWJJ06ACisbxL4k0/w9FF9taWW7uNwtbG2Qy3N0yjJWKMctgdT0UcsQOa5bxNda/caRe3us3E3hzRQgjS000rNqdw7tsVPN5jjdyyKFj3HcQRKvYAbP4s8NL4h8QzXOowpKrw6OqxATTzyxbmdIolVnkK/adpCqcHcDjBrORNZ8TeLNaGiX0nh15dJ0/zvPtke6hXfdlI9oYqhO4sTyQpAAViSvXfDvwpY+EvDdrZWdhbWcxUtMsIB2lnZ/L34BdULlVLc4GTyTVLwuGf4k+OJiwKqLCADn5dsTP/AO1KAMk+GvENtpkOmppWhalbxRhjctq91aTPOVKySN+6lLHsGZ2bHUnJqHwXeappWoeLbe30Q3t4dXWS6ht76MiBmsbQqAZNhZeWAOB9zoOg9IsUEcDBQADLI3AxyXYn+dea2S3/AIb8QwRrD5uo21oto8e8k6xp8RYxyRE/8vMW9ty9G8xuzIUAOlvPF99ZLvufBfifZx80S2s5/wC+Y52b9KZ/wsrwrFcx2+pajLpEsi7k/tizn09W/wB1p0RSfYE10+mX9tqdhDeWEyzW0w3I4BHsQQeQQQQQcEEEHBFWaAIrW5gvLeO4tJop4JBlJInDKw9QRwalrk9Q+Hvhy5uXu7OxbSNRdSpvdIlaymP+8YyA/QcOGHHSoDp/jTRm3aZq9n4htR/y7avGLa46driFdnXsYfq3egDs6qajp1pqMaJewJL5bbo26PG3TcjDlW9wQa5uy8eWCXkdh4ktbvw3qEjBIo9TCrFOxC8RTqWicktgJuD8H5RXX0AYpi1XTGH2djqlkBgxSsFuE4/hfhX7cPg9SXPAq7pep2upxu1rIfMjbbLC6lJIm9HU8qe4z1GCMgg1d9az9T0m3v5Ip2MkF5D/AKq5gbbIg7jPRlPdWBU4GRwKANCisi31C5s5I7fWljDO2yO7hBEUhPQMD/q2PTBJBOAGJO0a9ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUhIUEsQAOST2rmju8WqwBePw5kYdWw2ojvj0g9+svtHgygE6ajPrkxj0Z/L05GKy6hjPmEHBSH1xzmQ/KOg3EkpsWNnBY2qW9rHsiToMkkk8kknliTkknJJJJyamRVRFRFCoowABgAVmeIte03w7YLd6vciGOSRYIUCl5J5W+7HGigs7nBwqgk4NAGlI6xozyMFRQSzMcAAdzXFnX9T8WMYfBbJa6WHaObXbmHej4GP9EjOPN5P+tb93xx5vIEcfh/UfGEs0/jm3SHRRMrWnh/crqQpyHu2UlZWJAIiBMa8Z8wgMO6oA57S9F0bwnaXuoyPibyvMv8AVb6TfNKqDJaSU9FABO0YRf4Qo4ql4etr/X9Vj8Ra3by2dvDuGk6dLlXiRlwZ5l7TMCQF6xoxBwzuBn6Q97461uDWJS1v4OspBLp0BHzapKOlzICOIVODEvVmAkPAjrvqACuO8Ix7PHPjtipy93asGwen2SIY/Agn8a7GucfTdQ07X9T1DSYba4TUkiMkc87ReXMg2buFbKlNuehBTvu+UA19JBFq+VC/v5uAc/8ALVufx61Fr+j2uuaa9neb1Gd8U0R2ywSD7skbfwup5B/pkVZ063e1sooZpjPMozJLt273PLNjtkknHarFAHC2w1zRtTmlkt3u9pDXjwxnZewgYE0ajhLhcgOn/LRRleQFXtbW4hu7WG5tZUmt5kEkciHKupGQQe4INRapZ/b9PnthPNbtIuEmhbDxt1DD3BAODkHoQRkVxfhvWJ9M1d7TVzFC9zceTdQpkRW14y7lePPSG4ALLk8SZQlnchQDvqKKKAIru2gvLaW2u4Yp7eVSkkUqBldT1BB4IrjV8HXnhzdL4Dv/ALHDv3nRr1jJYNlmZhHwXtyS3GwlBj/Vmu3ooA5nw14uh1S8Ol6pZz6L4hjjWSTTrsqSwIyXhkUlZkB4LIcjgMFJxXTVl+I9A03xHYJaavbCeOOVZ4mDFJIZV+7JG6kMjjnDKQeT61mWGo6lot4th4lkS4tJJVis9WVQgkZsBY7hRgJKTwGUBHYgAIzKhAOlkjSWN45UV43BVlYZDA9QRWDI7+GlLyyNLoQ5Z5G+axHqSesOOpPKYycqf3fQUUAFFYFnnQtQj09+NKuTtsiBxbvyTAcdExynYYK8fIDv0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUjsqIzuwVFGSScAClrmbtD4ov5bM8+H7V2juhjIvpRw0J9YlOQ4/ib5CcK6sALAzeKx5skZTw9w0QJ5vxjqw7Q9MDq/fC8P0tFYHi7xLF4fgtoobaTUNYvn8qw0+E/PO/GSTg7I1yC8hGFHqSqkAb4y8UQ+HLaCOK1m1HWb1jHp+mW5Hm3UgHPJ4RFyC0jfKoPPJAMWj+GjJqltr/iUwXniGKNkhMeTBYKwwyW6t0JHDSEb35+6u2NZPC/hw6bcT6rq80d/4ju123N6E2hEzkQwqSdkS9lzknLMSxJroqACuG8bK3irWYfBkEjLYtELvW5I5Cp+zEkJbZXkGYhgeR+7SQdxXY6heQadYXN7eSLFa20TTSyMcBEUEkn6AGua+GdrP/wjx1fUFX+0takOoTkDkK4HlpkgHCxhBg9ORQB1cUaQxJHEipGgCqijAUDoAOwp1NkcRxs7biFBJ2qSfwA5NU5bm7lt91lbIJGxsF05jyOCTgAngE8HByOw5oAvUVjah/aiKgW9jUOQn7iwZnye+S5VRweWGOfpWfbxat/HceImBOcstgAOcY6Z9/8AOKAOpormDJrBkdo49bQKuQsq2Tox+isG/UVrWR1EqftUsBYdVFsyc5B672HTjjP6YoA0a4v4had5ktncRusC3ZGmTzld3ks5zaz44LPHcCMJyNvmuQQea65pJkxugLZx/q3Bwe/XFcx4w1nTp/Deq24nCX6WklzbwTq0MrPHlkdFYBjh1UggHkCgDR8D65/wknhLStWZFinuYFM8S5xFMPllj55+Vwy/hW5XHfDVpIl8T6e7BlstcujGwxys+27HI6/8fNdjQAUUUUAFQ3lrb31pNa3sEVxazIY5YZUDpIpGCrKeCCOxqaigDlbG+k8OaxZaDqLz3Fhebk0y9k3OysqljbTP3YKCUkPLqpDZdd8vVVneIdJi1zRrrTp5ZoVmUbZoG2yQupDJIh7MrBWHuBVPwZrEus6LvvvIGp2k0lnfJDkKs8bbWIB5CtgOoPOx1POc0AaWrWQ1DTp7UyvCZBgSx/ejOchl9CCAQfUVB4ev5r/Tt14kcd7DI8FwkZyokQ4JHcKwwwzztYZrSrnoIl0/xxcCN8Jq1p9oaIDAEsBSNpPcskkS/SJaAOhooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKjuJora3lnuJEihiUu8jnCqoGSSewAoAxvEtzcTvBoumySR3l6G82eI4a0twMPKCeA2SFTqdzbsFUbGrp1lbabYW1lYxLDa28axRRr0VQMAVm+GoJJI5tWuwy3mo7ZCjZHkwjPlRYPIIDEtn+N37YA2qAMrxRrtp4c0eS/vRI/zLFDBEN0lxM7BY4kHdmYgDoOckgAkZXhPw01jqd5r+tMtz4l1FAs0oYtHawqcrbQkgYjXOScAu2XIHCrR8NyDxl4ibxIxZtE095LbRlEqtHcONyTXmF4OfmjjJ/hDsOJa7igAooooA434wybPh5qcZR5FuXt7Ro0IBkWaeOIrz6hyPxrfvtUjtZhaWdvLeXnA8iADEYPQyMeEGOeeTg7Qx4rI+JhRPCZuJpFjhtL+wvJXYgAJFeQyNyfZDU+tavFZKmn2EwFxGyoxeTaq/Lu2GRg3zlRnaA7kHOADuABsRwXEzI93L5eAf3MDHbyF6tgMxBDYI2jDcg4BqDTrpJrqVIFi8jYJEePc4cHuXxtz7AscEHiuQhd9Vn+yTbLgzybmE1tIYQevz26sSBgjPnuCGXhRgCrs+o6uEisVMto4GWZY0afbkYIVVcKOSMKkox1ZTnABq+JtTFjazkvqJYIX/0WNEAXIBzLLiJTwfvODzx2rlbTVry4MTjTFj0+WXY0sviC4kkA3Y4EKSR7vm+6JBzgelOiiN1fG+jzdTR7vImx9pK+vz7isZIB+7NGOhKnobDW9lKkxSAX3nHzY5pXa72DHKSFdsYGM/elPB6kYFAD4fEGgSXiLHbte3FziMCGUyM33lP+sKkgAtzjs3pk9PJrFtaiRJwkMqoJBEZ4gzk5JAyw/M4HNP0ASDT42llVi4DrGiIiRqem0KW4I5+8f6VYurCK5mEkj3Awu3YkzopGc8qDg/4UAZc2q3crSL/YuprAEDLMjWzhsk8hfMJOMA9Oc1yviGC0u9DuNPnmFokkBjD3FlNb2qMVIQeXMrRfe2ngqRgnPXOlrunQfaLiGw08MzKBIBphk3ADgb5Dsbv0zjj8ci4jurV2jtLe5tnC/P5WiyDfxjiWKRSuBx1HTIGMUAVPgzqcT63rFsbsOb+x0/VYI5Jg0mBAtrMGHXeklttfPQlQcGvWK8C1O7m0TX7XVorx47sTs8Fqkc6RtKwCyRu0qfLBOEQO5Zgkyxy9C9e3aFqttrelW+oWW8RSg5SRdskTgkNG69VdWBVlPIIIPSgC/RRRQAUUUUAFcZZn+zPi3qFtGriDWtLS+I3naJ7eQRSPjOAzRy26kjHEQ612dcrqBDfFPQQAxKaNqO4jou6eyxn67T+RoA6qsDxIfK1bw1PjAGoNE7dwr28wA+hfZ+Q9K36wPFTKbnw/Ccb5dTQJz3WOSQ/+Oo1AG/RRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVgeJSt/eafobRrJFelproMSB9ni2lh77naJCp4Ks/pW/WJpWy58Sa3deWgeDybHcDksFTzc+3M+Mf7P0oA265H4g3lzNDYeHNKmmg1LXJDD58BKva2qgG4nDAHawQhEbtJLHXXVx3hsDVvH3iXV3EbJp/l6LakZJAVVmnYH/aeREI/wCmAoA6nTrK303T7WxsYlgtLaJYYYl6IigBVHsAAKsUUUAFFFFAFPWdOttY0i+0y/QvaXkD28yg4yjqVYZ+hNeWeFhqlraNaa9by3Pi22ljsLi8K7nkTLeVcLsKjypEUDexX5llRizKEb1+uR+IPhJ/EUFtd6bMlvrFluEPm5MF1E2PMtbhR96GTaoPBIIDAHBUgEaWltaacI/ESiePT54ZYYoopHCSE7YgCiojtkrhVQBSQTkncaMzw2O+1mjC+bmS5t5QsjgPn76giLdwCGYyuf8AaxmrvgnWmbQ7++1jUlSG2nMU5v2WKe3kXG8T4PlxnldqoNu3a4ZvMBFLw7NoklmLrT7m51i+aVnkvobSR1nlJLF4mfMapk/K24qq7V3YAoAbLNeXluc2oliEg2SXMiuqYbHmEsBEpHICKu4dyDUhtHW9S5u7yOcKTtmnjLIMjI8syEHHTlN+euBwKfarf316LzRrG2+yZ2jUb65cu0RGWaNsMzKe21kXqQSCDUm+0iXbJLfNJIS67S9r57gHAABNw/GT/GD16DgAsC5m2W6z6pdQy4Yqj482TLYBC7FfPXgxke3Q1t6VYwrZyqGnntrkFnS88x3Zjw2RIeFIx8gUAc4HNYNtcyQJIluVsIowXW0toUjyCOrjDv8AjsQ88in2l9aRJHPp+n3V/fcoS073AjPIKiU7guSBkccYJx0oAtahoWj2ULPFpik8GOGCJ0RcYGMRKfryCfwHGYbOwnYSjSrqORlG543vo2GDngiME4/CtW9W1Mbq7PGygzS2880lxIOQFPlI5yuQOnHtyapSW9u0juLa03g4UtoE5x69+aAMuWwjMbGW81yOF/lljuZ5ZIZUx911uYwm09CAVyD1rmdG1G88J+IzeT6k93Y3CM91CWWV7mFVG2VdjuTcwRhQwyWmgAYeY8RFdeI0JAjjigfKkPD4eu4mDY6llcHHTjPFUdV02SS1NtcXt5MvyyRn+z9QZo2UqVkWRnkCurKGB2npg8E5APRLS5gvLSG6s5op7aZFkilicMkiEZDKRwQQQQRUteM+CvEdp4LYW141tbaJcXXlTw2j74NMuZGOJUHJjtJmPG7/AFUpKHgnZ7NQAUUUUAFc/pMhvfF2t3KoPItI4LBHPUyANLJjttxLEP8AeVh2rU1fUIdK0y5vrrcYoELlUGWc9lUd2JwAO5IFV/DFlNY6JbRXiRJevunuViOUE0jF5Np7jezY9qANSuY1xTd+OvDNsGGy0jutRYZ/iVFgUY9xcOf+An8OnrkPB+7U/E/ifXnLGEzrpNnlQB5VsWEh9cm4e4U+ojT60AdfRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVheDiJNMupydzzaheMzY64uHRfyVVH4Vu1i+EI/K0iVNxbF9eckY/5eZaANquS+GcEMWianLEgElxreqSStjl2F7MgJ57Kij8BXW1x3w832t54t0qRlJs9amljAJ+5cKlznB/2pnHplTQB2NFFFABRRRQAUUUUAcd4y8N3Et/F4i8PxQya3aqoa0nYLBqEakkRyEg7XXLmOTqjMc5UsDi2MeqarYW2r+Hr65W0m2JIXhQ6mH37JIJWm3JEEkyzhV+UK6omcE+l1zus2d5pl7LrWhQNcyybftunqyqLtQMb0JwBOqgAEkBlUIxGEZADj7G2t9Gu9RuTqMl1MyGHUbKwu7jUL6R0JZF80EMm0SEBFSPAYEvgYroRpDxW01xeNb2mlhc/YrYjaQQAXd32o2R1DqenU9KvaZaaZr1nHqdrf31xbTO0kflXMtsqfPyhjQphlcMGDjeDuDdwM7XlOk6zpbGSSe4vTLEJ2hM07Squ9Y4cjyoQVVyc4ztHBOWABPptpYjyvsVi07LDlZIk80RnsYpZMRgf7KDGewA5dJqMsk62k1zaSeRIGdEia9uMg5ywjULEw4wSGGfpzm2iXd/cFpo4ryOU8MZmu1R/XcAYkPsIxgd/mqaW1cB/Ndb1VBHlzygRRhOMeWgkX5SOSUGDjkdKAND+2/sbSxvM0l6dh+zX1xDGyA5x8sQZsnB42nOO3NRJcSXcKlra5jvUVpZRLdXkEC46fvDGoIxyRtH071mQeJNMspzGNZhuNq7BBZCMSEnkhl34z77EyMYPNLbRLLbC4gj1B85aIRCcELggKAiwqOpHzMcdz3oAmuPMuZVa0WcjghvtN+6kjPRlABFE6nIkjtr8yYwQ99qMant12Ht7dfzqTXLO3SwW81SWPTrhY/LM9x9nkChSSPmlJ7kkAk4PXjrgDVNNur048eR20BbK+ZJpsn2luf7i5I6cEZ565PAA3U4YLsol0ZLMwxugkuXuLyNlkUB45fPhG+FwAHj8xQQoYYcKy3fhl4juElOgatcR3KRyNBp96lwJ9+xA7W0kg+9KqnerEAyRFXI3rKBWkn0y5CG38UKqfeVo9NJGPXcB79TWBfeEtFub975fHNpYx3SiG+UQLbmTawZJFIdfLmjcB45CCVYnggkUAe4UVgeBNTv8AVvC9pdatEEvN0kTuqFEnCSMizIp5CSBRIAegccnqb+vaidL0yW5jga5uMiOC3VgpmlY7UTJ4GSRkngDJPAoAzb/frHie1sopV+waYRdXigE+ZMf9RHnpheZWHDAiE9GOeirN8PaWNJ04RM4lupXae6mAx50znLt9M8AdlCqOAK0qAOZ+IWr3eleH/J0f/kOanKun6b8hYLPIDiRgFb5Y1DytkY2xtWp4a0Wz8OaBp+jaYhSzsoVgjyBuYAfebAALE5JOOSSa5fw6P+Eo8dah4hmhU6do3m6TpTMOXk3AXcwyoI+dFiBBP+qkPR67qgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKw9Di+x63r1tuXbLPHfRqGzsWRAhGO2Xikb33fWtysPW0+x6xpeqqyoiubK5JOMxykBPqRKIwPQO/rQBuVx2oyjRPiVp1wyEWviC2OnvJgYW5g3ywjr/ABxvcc4/5ZoO4rsaxvF2jtrmhTWsDxx3sbJc2c0i5WK4jYPExHdQ6rkdxkd6ANmis7w7qq61o1tfLGYXcFJoCwYwSoxSSIkcEo6spI4yprRoAKKKKACiiigAooooA5DXNH1HSdTn1zwp5ZlnIa/02Q7YbsgYEowCUlwApYA7lAyGKKKYnirQdXuLe1u7gaZq43G3gvwEZZCpGVBO12HzfLkkYPA5rsqhuLaC5XbcwRTL6SIGH60Acdo09vCijVtcj8QX8AERl0+zZmQkDLMIzIY2YgnIKLyAAMClh8OWhuJJLfwtDNOTuNzrNwJWyc/c/wBawx/d+Qdh7dqAFACgADgAdqWgDG/s3Unt44TqqWar3sLREP0/eeYMfhQvhvT2Ui8+034Y5Zby5eZGPr5bHYOvZRWzRQBSg0nTrdlaCwtImUAKUhVcAdMYFXaKKACiivOvGvia/sp9QeHUGsLe0mktYY4bZZHnmSxa8LO75Cx7FK4VScrnd82FAPRawbJU1rWf7SJdrOxZ4bRWGFeXlZJh34+aNTxx5hGQwNeHaF8ZPFOpalrmja1YWMen2CK99rlik6fZLYgMziNfMJlKbyoB+UqzEFUavQ/Bvxg8B6xqtp4d0jUlt7pgsVnA8ZCSJsygV1yo+XHyMQwPylQwKgA9MrjfiVrN5bWdjoOgytH4h16U2tpKqBvssYwZ7kgsvEcZJHPLlBg5rrbq4htLaW4upUht4UMkkkjBVRQMkknoAO9cZ4BtptY1XUPGeoJg6got9LjdMPBYqcqfYyt+8PtsB+7gAHV6Jplpomj2Wl6bF5NlZwpbwpknaigADJ5JwOp61doooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACq2p2UGpadc2N2pa3uI2ikAYqdpGDgjkH3HSrNFAGP4Wv5b3TWivSx1Gyla0u9yhS0iY+fA4AdSsgHZXHQ8VsVzmvt/Ympx6+vlpYlBb6oxGNsQJMcxbsIyzbug2O7E/IBXR0AcjcxJ4Y8Wfb4Y3Gma9MkN4FyVhu8BIpsdhIAsTH+8sPHLGuuqnrGm2msaVd6bqMXnWd1E0MqZK7lYYOCOQfcYI6iuW8KeJGsLK+0nxhqES6zouxbm7kj8hLuF2IhuEBJHz42sAeJVdQMbcgHa0VgLrWoXtyY9J0Wdrdet3fv9ljbj+BMNISDx8yKPQmno3iODzZZk0u8XqkEO+Fh/wNiwY9uij3FAG5RVLR9Tt9Wshc2pcDcUeORSrxOOGR1PIYen4jIINXaACiiigAooooAKKKKACiiigAooooAK8i8R2P9s+ItU05ipSTW7gH1AOhrHnjr/rT+deu15nYbpPH13cli0cWszhkHOc2drCD9AWx+NAHi/h7wNa/ELxsumXF9c3GkWkCX98sabAbmYOIkdlxkRwxxoTyd4cAgMces+LPhv4b0nwxI0cLGe2RzpsEMvkMLkncgi2kHdvCkKvVhwDwBwPg7QdQj1TVtS8NnUYm0+8uLVbyINLHIsj+f5IiVgyKhlLYKSKxIIKksD0tnY69rGqRlP7cu76WRg17d2ctrBZZXkqZfLfBI5WJR7OhGSAdN4m1NPF+tab4IhuA8EyvPq80RYGSKApviUgD5XkdFZgem4AcnHpcMUcMKRQoscUahURBgKBwAB2FfNfje0vPhf458AR+EpLeXXtRju7fULi6i3RPCWhblFI2xR7XYBSuNpJJJct6joXjTxBfiSEabotxPbeRHcOdQe1BnkUsYUQxuC6gL/Hg7utAHo1FcTD47na3jmk8LauYpFZ0mhubJ4pAv3mVvPB2gZO4hR07lQbg8ZDeEk0DXElK7/L8qJ2A3beQshxyMUAdVRXIv4906G5WC707XrZ2cIu/S5iCSSF+6p6lTj1xWpbeJ9JnvIbRrl7a6nJEMN7BJbPMR1CCVVLH6ZoA2qKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAGTRRzQvFMiyRSKVdHGQwPBBHcVgeG5G0u6fw7cn/j2j8ywctky2oIULzyWiyqMecgxsTlyB0VZfiHSzqVrE9uUTUbOT7RZyvnCSgEDdjkqwZlYDqrHocGgD538Z/ELxb4v8b6tpehXtzofhLRrx7S5urJQLm6KECQLIchcEHaQVA8xN2SyKdXxJpd94O1nwlqC+KLzxLHEJ9Q0+S82y3aBQhmRJMEPFNFIyHdjYfKKHPyNJ4KNhpum6vo+px3dp5d3Pfw3kJMzNDJNIGRlYAk7WI37dpyrYyq5o/2jLrXiLRtPsbFtP0+QR6Xp8UZM5it45Vkk2lW2TM7xQtOylkjiiK7zLKFoA+iNMvrbVNNtNQsJRNZ3cSTwygEB0YBlbnnkEGuO8Ukf8J7pBVWEsMcb7kYqdrThDnsV+bGO5IqX4LzzS/DHQoLpYxNYRvpjGPO1jbSNb7hnnnys/jTPEMMZ8e2srKCTb20bEnGB9p3Lj1+ZVB+ooA1NZhOi6smu2ikW0xWLVI1GQyfdSfHQNHwGbjMec7vLQDpKzbqa31O01exiYs8Ia2mGCuGaINgH/ddeR607w9enUtA0y+brc2sUx/4EgP8AWgDQooooAKKKKACiiigAooooAKKKKACvHLecR6treoJPE8FjrtybqNmCFMG1YDeSsak+XxvYA7scnOPY68T+OPw4TVtG1+8WBrywuAb9reAKt1bXqRLGs8JJCyKyIiyQsRkLuQ78BgDsPgrBt8FPd8/6dqN5cqSE5j891jIKEqQY0QgqSCCMEjBrvKo6Fp0Oj6Jp+mWqhYLK3jto1GSAqKFA59hV6gDxjx9Ilz8XnChXbTtEidmD52eZLKSpXoP9XGxB5YAADBIMlrYCKyAit2eVFcgQtjfcXCKiJk8krCIyX55Ru/FZmnwpq/ivxJqojVJtS1WaMzCQ4SCyAgjPuVkRpcDqSg5yRXZSLDGrw3CPbpCrNIkRx5KMCSg55cAO3+6e+cUAUvssc8tnbFlvYi7SFAhHngLuY47RmNY0A5+cAdQTVVLW4WdWuhJJczh5VhlQq0/ylTK/QDfukQJ/C0kPHSuilvTYyXaP5cN4FK3F2gUfZd6hyse7qFBaYnoQhHJztgW+vpNRt4JZ/siRq91cu2HMSYICsepPmMI9vUiHcMEjABjvaRi53C+Ais8xNNtVS0o+QzE4x8gMtyBxlnY/w7gxtReXRbuEs8kM0psUtrmNZIYBEeY1UgqxjJnG/A3NajJIBJtxI9pb25tktJdUnmRVsWz+6iDEMpIBxhFu0Dd2kAzyKgmX7KIIrG4ZfLaVvPMK5aY5QzY5yNzTTDH3nnQetAHY+F9YmmvpdNvFlV/s8d5bmVgziNyQ0Tn+/GwAJI+66ZLNuNdNXjPgjU1uPjPHpdsGSKx0K4mkjAyIjLPbqiM3d9kCsTjqT1r2agAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5RfC2j65otvb6paNKbSWaOGZZWimjAkZflljIZcgDOCPetLw74X0Xw6sv9jafDbyygCa4OXmmx08yViXfGTjcTipdBLoNQt5GLNBeSgMT1D4lA/ASAfhWpQB4z4J+IOieFdW8UeF/EuqW9tf22v3T2sCqx/0a4b7QjE4xwZH3Y+7jnjBPReJPFukLqFhqFlcDUbBWT7XNYFbj7PGr7g7qhMmzdj5lBAIGeMkcZ49tNVg+Ks+kJc3B0DW0j1SW0ACRXEiqlvMjuOWjCRwloydp805BHFeXfEKzfTtWk1rwrGNM1u1nS4trq1UQqyhUykiD5CA5kAygGAA5wcAA+rNAZDq2tyRSiWK5lhuo3XBUo0CICpB5B8snNJ4DG3wP4dGc4063Gc/9MlryX4A/EKw1pLdYYoLOHUG8h7SNhtsr4K8rRxr95YJUEsqZJCskqZ+6K9a8B/8iP4eHy8afbj5enEajj2oA3aKKKACiiigAooooAKKKKACiiigArF1t1utU0vSwC2+T7ZMAcbY4SGU59fNMXHcBvQ1tVg+FSb9LnXJE2/2lsa3yMMtqo/dA/Xc8mMAjzdp6UAb1YHj7Xm8MeDtW1eGIz3NvCRbQhSxlnYhIo8Dk7pGRePWt+uE8TB/EPxF0HQkGdP0gDXNQODhpMslpHkMB98SS4IPMCdM0AcJ4DjsdF+z6TqA1ITWFpDFOwtWnBuEdgxAhLkKzB2bcQScZwDg9hNrmjWdtcG21aG4uWjZoIQQ78BEVpEPO7BxjHKnpwTXd6hptjqUXlajZW13Fwdk8SyDjpwRWLL4N0/y2SxutTsEZSvlwXshhC4PyiFy0YHPQLigDM0uya7lupYrZZZo22OxI8uQ7meQc92bzBn+5ODyMisNro2htLlVknjlnhKqtuXe4klwGuigH3fKM747GH8Dp3/wn8PXIuWhElpNOzOzwRQoCSMchUAIA4x6DnNc63wWu4IyumeOdftfmbbiWRcISTs/dyJkAk49MDsMUAbMIS4EV7BbXttYSQWy24a2dmgH7oRqSR92NmWQ8kE7852GvP8Axp8QtO8MQSSwOt3qJlSG10m3nRnZvuqMLkqkaoEGQSXwwHNaFx+zlbanNnxB418SalDkkRSSKwHHbzN47ntXdfDv4Q+D/ATrcaNp3nakowL+8IlnHBHynACZDEHYFyOuaAMf9nnwHqHhLw1c6l4mLP4m1hkluy5y0UaLtiiPOMgZJIxy2OdoNesUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFch478Vz6L5em6LbRXWu3ULyxCcsLe2QcebOygnbuIUKOXY4GOWHX15rr4t21jXSsqR3rZaTcFJ8uKHk/MPugz27Y/vMD60AXvAWpz3eszSXd0s51G2Mqr5axMskEzRSnYBkKQ0ONxYjkFjgV3leMazqL+GtRsbh0klNg8N1LHHiSQkrsmwOpYpPIcZJJiTrnJ9jtp4rq3iuLaVJYJUEkciMGV1IyCCOoIoA4P4xWjQaRZeJIIld9Fkd7nIYn7HIhSfhSCQmUmx38gAc14n8WDbrpWtWzzOkyaWt0qRoRvWUTH5se+M56ED1r6ouYIbq3lt7mKOaCVDHJHIoZXUjBUg8EEcYrwG98I3F7eyeEZ7O4mTSbSOwe6SNJp7uyLu1t5avthRgiyK80gx5kWFUkrgA+e/2eUuZPiHEkW9dONvK2pTbeILdAJBLuwdrJIkTKezqnXOK+7/B9teWfhLRLbU0jj1CKyhS5SL7iyhAHC47bs4rlfh/8N7Hw1ptjbvb20ENq3nJYWzF4fOzkTSyMA88o4wzBVXA2opVSPQaACisq/wBf0+x1FbCaSaS9MQnMNvbSTssZJUMwRTtBIIBOM7WxnBwi65E4cxWl+VQElpLcwDj3k2igDWormx4v085AClgSCovLXIA+8f8AW9F71XfxbNJGGtNLkfn5t3mSDGecNBHKDxg9e/saAOsorkovEeqXDqkel+VnksYLtiBx0DwRg8HoWGPwNWY7nxEI2eSJJc/dWOzVG/8AHrn8e3Q0AdJRXiPjr4m+MdE+IdzoXh3RtN1q20+0hubxHDW8rl2ORGxcrjZg8jru6gDPpPgTxppXjTTJLnS2liuIGEd3ZXKGO4tZCM7ZEPI74PQ4ODwaAOlooqjrep2+jaXcX94W8qED5UGXkYkBUQfxOzEKq9SzADk0AY3ip/7XvbfwxA5xdJ5+o7eqWeSChI+6ZWGwdCVEpU5TI6cDAwOlYXhLTLuys5rvWHSTWdQcT3ZQ5SM4AWFD/cRQFB4ydzEAsa3aAKes6laaNpN7qepTCGys4XnnkIJ2ooJJwOTwOg5Nc58MtMvbbRrnVtbiaLW9duDqV3E2CbfcqrFBnap/dxLGhyPvBj3qnr5Pi3xrbeHURm0bR2jv9WYrlJpxh7a2zuByDiZhgjCxA8Oa7ugAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK4fx9od1vfV9IhMtxs8u4t0jyJ0IKMHA+YqVbnaGfMcRVX2eW/cUUAeB6v4ssfEXiVUt7XW7PVWTy5IBFHGqTpJC27zJHUgDylwGQE57H5R3fwjbUdM0w6BrUcULwqbiwRPNwtszf6nMiruMTEJlQFCNEMCvQax/E2nz3VpHd6aB/ati3n2pJA3n+KInoFkXKnOcZDAZUEAGxXJeN9Pube6svFGjW7T6npKSLLbxpmS9tHAMkC/7eVSRPVowvAdjXQ6RqEGq6dDe2u8Ryg/K67XRgSGRl/hZWBUg8ggjtVygCtpt9banp1rf2Eyz2d1Es0Mq9HRgCrD6girNcPBnwT4j+ziJh4X1i4Z45Afk068cjMZHaOZiSp6LKSv/LRQO4oAwLSztLvXte+1wRTOxt0ZZFDgxqm5OD6O0h+tXY9B0eKcTx6VYJMM4kW3QMM9ecZ5wM1BqumXB1BNU0mRI9QSPypI5SRFdRjJWNyASuGYkOASu5uCCQbOkatBqQljVJbe7hx51rOu2WLJIBI6FSVbDAlTg4JwaAL6KqDCKFHoBilorgPBHjHV9aGl3erWNnbafrCq9ktv55kjDRNKgkZ0VGyisCV6NgDIOQAd/RRXF+OvHcHh+4h0rS4YtT8RXHzJZm4WGO3i43T3EhyIoxnjPLsQqgnOADirm1guvjL44aW8ETxafp2Atw0BUYlLciVDwADkHAB6euZrOj3dprqeL/Cl7AviOBcTRLJI8WqQgcxTuDICdoIRzjB25PC7dTwJ9p0i/wBY127vornX9cnjfUZD9l8pFjBWOOJRdZVFXcoJJZsAnkYrr57y5uLlzHqELM2BsVpf0WKZufoB3/AA2/BPinT/ABfoMep6b5iYdobi2mXbNazLw8Mi9VdT1B9iOCDVGz3+KPEQvy0T+H9MkZbRcZ+03Y+Vp8/3I/mRR3Yu2PljauFsvCF/dfFCXUdH1G40qO5s/K142crMl2Bjycb/AJo5tuRvyW2/MuwvlvYbS2gs7SG1s4YoLaFFjiiiQKkaAYCqBwAAAABQBLWB428QP4e0UTWlnLf6pdSi00+yjHNxcMCVUngKoCszMfuorHtitq6uIbO1mubuaOC3hQySyysFRFAyWYngAAZJNcF4Jtx4v19vHd/CptfLNt4ejljdWhtiTvudrdHn4wQoIiVBn5moA6PwP4ai8K6Clis32u8kke6vb1o1je7uZDuklYDuT0HOFCrnAFb9FFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHPXuPD+pvqA3LpV2w+2jqtvJjAn68KcBXwCB8rnaBIx6GmTwxXEEkNxGksMilHjdQyspGCCD1BFYGlSNoN5Dot3IxsZPl024mkyzYBP2dierKASp5LIOclGZgDY1XT7TVtNudP1KBLiyuY2imicZV1IwQa5Xwpcaj4bu4vDXiW+lv0YkaTq0+N93GBnyJj0NwgB5wPMVd45EgXtKp6vptpq9hJZ6hEZbdyrYDsjKykMrKykMrKwDBlIIIBBBFAFyuf8SwW1neWGvGPbdWsi2zyLwWgldUZW9VDFX9inbmqljrk+iX9ro3iu4Qy3DiKw1QgJHfNziNwAFjnwPujCv95MfMkc/xLZY/h34mmYE+TptxMMHBykbMOfqBQBqeISRoGplW2sLWUhs4x8h55rzX4e6LpUnhzwTqQsCLhFtliea2MZAFqfmAI55/iwOgPFel6+C2haiAMk20gx/wE1wXgW7ltNI8EWVzcFbe/tLeeyAUkbhaMZIN3t/rFz23ADCAAA6/x5rbeGvBeuazEqPNY2cs8SSAlXkCnYpxzgtgcetcn4J8K3OiW13a6fqzXGoSPv1O/NzCbi5uCTmR1ML7PRE3YC475Jv/ABuK/wDCtNUV8hJZrWFvmCjD3MSnJPAHPJPbNT6rt1FyU1Syt8EiSOO5uJwee6xyRgcjoQe9ADGZ5AYW1EzTjAGy+mkYkE5wsKp3HPXgdqfNJfWOo2tpaypPqF0paOMy3DiFSOZZFZ8bF5wDjJwoIJyGxxDR5oYbO00vUNenQG3MFoYTEh4aWV2d2CdO+TjABPToPD+jjS4ZJLib7Xqdzhru8ZAjTMBgYA+6g6KuTgdySSQC1pdjHp9qIY3llcndJNM26SV+7MfU47AAAAAAAAW6K8i+O3xOl8K6XeaR4Ya3l8Sm0a5kaSaNBY246y4cjfJ/cjGSeWIIGGANbXpV+IniC58M2NzIPDWmSAa3c254uphz/Z4b0wQ0pXJAwnBZsejgYGB0rG8G2Oj6d4V0q28MrEujC3R7UxnIdGG4PnqS2dxJ5JJJ5NbNABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVV1TT7XVbGWzv4hLbyYyuSpBBBVlYYKsCAQwIIIBBBANWqKAOf0XULu0vhouuSNLebS1re7Aq3sY9cfKsyjG5QAD95QBlU6CqmqadbapaG3vELJuDqVJVkcHKsrDlWB5BFUdMvbq2ul03WmVrls/ZrtU2pdKMnGOiygDJXuAWXgMqAFrXtH0/xBo91pWs2kV5p90myWCUZVh1H0IIBBHIIBGCK4PxVBq+jeD9c0XUjd6toM+l3EMWqh1NzagxsoS4ycuORiZQTwTIBtMjel1h+O2C+CPEDHoNPuO2f+WbUAXteKroeotIMoLaQsM4yNprzLTPE2h6P4W+HFrqV1ItzaafbX0ixWks5hh+yPF5khRT5akvjc2B97sCQyzMmnT67pGlTNBo03mQS6ZLKudPU7laW0b+6qYdrc8D/lmcDY3T+AVsfD3w2ttXm3QpPZrql27tllHkhtpLdQkarGM/woOlAEfxauIrr4eLc2cqTwS3+mSxyxOGV1N9bkMrDggjnIrotT1aQ3p0vSFjm1Mrl2YborNSOHlAIPP8KAgvjqoDMvEazdB/BOlad5cZiF9pyXMsKgRmT7db70gQjDoGfbuHyqCACxBA9F0vTrXS7QW1jEI4txdskszsTlnZjyzE8liSSetAFfQ9Fg0iOVlklub24Ia5vJ9pluGAwCxUAcDooAUdgK06KwvFWvf2RDBbWcYutbvi0VhZ8/vHGMu+OViTILv2GAMsyqwBkfEDxlJokkGjeH7X+0vFd9GXtrQKzpbxZ2tdXGwFlhU+g3O3yrzkjD0G0u/C7NG96t/LPJ5+o3Vza+VJeOwRXc+ZdKoGFAACEIAABjruaF4NuNHtru7k129fW74ibUb6G3h33DhcKqqyMVRBwiDgAnqSSddLS5tr2O2gl1MW+NxkjS1WLJPORtDZ+g70Ac58Dp9vgNNIe8a8m0G8udHeYrt3LDKyxED08oxEfWvQK4jwLNGnjP4hWMcaoU1S3uiAR/y0srcHI7cxsfxrt6ACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKr6jZW+o2ctpeR+ZBIMEbipBByCGGCrAgEMCCCAQQRViigDBj1CfRZVt9dmV7OSQR2+oNhRuYgLHN2VyTgMMKxwPlYqrRfEYb/AALrkJx/pFq9uATjJkGwD/x6sb4r6zrFnb6ZpOghLeXVWnjm1GW2FylrFHC8jYiyPMkYKQq8g4bPSqb+CHns/t0fj7xXtVTIjtc28UA4xtaMQhAoK/dK8c0Acx4q1jU47vXdSs7bTtO8JRXU9rq+pXrkuWVWQFEPzNGHVAVQqzNJtQAgyHK0LxzM+mt4UvtO3y6ZJptmTPM7iKOYwOba6AQ5IAeDzMNudcMqGQB+BktTb+KLAWF1pOsCHVVMeo2TSX12tq8hVLtERzby3e1JN48kyfIJQrkOy+m+JvD3hjSfFEx8FaTc3WvrABrS2crTFYPMSULNknM8zwrGuTuIkkkbITIANDV2luSl1PJOZXvtGcrOVZgH1G1OVZfldMrgFcY2kFVJy3steCWUcV5odncwzG5t4NY037PdRsGWQDVY4Thx95GESEH+MRo5C8CvZvE+vWfhzSJL+/8AMdQyxRQQruluJWO1Io143OzEADgc8kDJABQ8a+K7fwzb2kUdvJqGtahIYNN0yFsS3UuMnn+CNR8zyHhF5OTgHnvDls+n3MmoXus2V/4sveNQnitZbmONFJxbW6qwMcaMTjOSxyzfMa1vDnh26eWXX9aZrbxNfRhJDEySiygzlbWMspG0cFmA+dwW6BVXYu9MnNtITqWpzMoLLHG8UbMeu0EKvXpyfxFAGLNNJq4VpXiljjVion0C6HPQ/ecZ+lLp3h4ERT2troNvLHIC8h0IxM+CDlQZAV+pzzzVy2t3uZVW503XLZQwBkfUsL8vO47JicHvxz3Fc/f/AG3xMg0nwfd3ltok+V1DXjcvK2wdYbQuzbpGzgzDKIM4LOMKAX/hjPDqo8S+ILYRtb6tq0rQSxuHWWKBEtlcEfwsYGYeobPeu1qGztYLGzgtLOGOC1gjWKKKNQqxoowFAHQAADFTUAFFFFABRRRQAUUUUAFA4FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAUtX0uz1ez+y6hCJYt6yLhirI6nKurKQysCMhgQR2Ncl4y8KaXD4ZuvLgeaYy25828ne6dcToflaYsR07Y5x6V3VY3i3/AJA2CCQbm2UgehnjFAHlXxRjutHs/EcmuSXlxE1td3On3HkmWCVArSi3lOCsTK4woYBWVYyrFw4OU1hJoP2nStZ8X6adE3kX6W94Y3hgHnZjKRlVtosoikRxqzu3l7u9eofGRsfDDxCOfnt/L4HXcwX+tc74r+HVha6s8/ha5bQtU8Q3ZSa5iiWQRyiG4k85QcNvJHTcF7gBuSAcpPOk1lpFzb/6Lo0mpaf/AGRaPCLabUit/bZnSEkeVCkaqkakDPmliBuQnsvh9eDx54hufFV7al7Ox32mltw0EZYsJjGckSvgBGlU+X95IywDSPzF94D1Hw4LLUdZ1S01Ge81DTbKYR2sjSy5vrdi0lxPNJIUwhHlqVj5ztzzXuFpbQWdpDa2cMUFtCixxRRIFSNAMBVA4AAAAAoAzV0KG2DDTLm708HPyQOGjHssbhkUZ5+UCpltNQ2NG2pkpggOIFEg4ODn7uQf9nHFaNFAGI/hu0ubnztVlutTIOViu5Mwr6fulAjJHUEqSPWtsDAwOlFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVieMmK6KhXGfttmOeetzFW3WN4sAOlQhsYN9Zj/yZioAwPjacfDDW8uqAiEFm6DMyVteI1Zta8K7XKhdRcsAcbh9juBg+oyQfwFYnxtQyfDLV4xjLtbrz7zx1ueIADrvhgZG4XsjYzzj7NMP6igDH+KpI0vQffxBpg/8AJqOu1rifir/yD/DowTnxBp3/AKUKf6V21ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWL4uDNpUAXr/aFifw+1RZrarI8TuU0+32gnN9aDj/AK+I6AOe+NIVvh3fK4LK1zZKQO4N3CMVuavubxNoCBgFUzyFcjnEe30z/HWT8XVZ/BLIiM7NqOnKFUZJzfQCtS/bPjfRYyP+XG8f8Q9uP/ZjQBz3xePyeDUwTv8AE1iMA+jM3/std/XDfFIM0vgxEz83iK1zzjgJI39K7mgAooooAKKKBnHPWgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKy/EcQmsrdSoYC8tnwWx0mQ5/TpWpWZrpfZYqmfmu4gcDPAOT/KgDH+Jqh/DVsrAsDq+lAj1/wCJhb1oXiFvGekvn5VsLvj1Jktsf1rK8ZXh1PVbDwzp9vNPf+fZ6ncSAbYbW3iukk3SP/efyXVFGSSDnCgsNHxFeDSNQstXukb+zIIZobqZW/49w7RkSuv/ADzGw7m/hByRt3MoBmfEVoxeeDUkggmL69CEMrODGRDM25drDLYU8HIwTkenZVxvxBXfrfgIf9R7PT0srs/0rsqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACqd+2LiwGQMzkc9/3bmrlUtQx9r03P8Az8HH/fqSgDnvAdm0WqeMLu42teXesMZG2BSESGJIl45ICKp5/vE9660gMCGAIPBB71ymsXMvhzxNaXaJHJpes3EdpcooxJHcldscw5+ZSqqjDqNqEdGrY1jUZreeCx0+ATahcIzxhziONFZAzufQb1wo5bpwMkAHJXMawz/D61TcYrXXbm1j3nJ2RWV9GuT3OFHPU9a9BrjvEdsllq/gC3RpJAmsSfPIcs5/s+9JZj3JOSfc12NABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWfqeftuk4B/4+mzz/0xlqn4k8VaT4deCHUJ5XvbgMbeytIXuLmfaCSUijBYgY5bGB3Iribv4mSy3uktJ4B8dwwLcb3lbSQ4jUxuu4rG7NxuGRjOM8Z4oA6jx9EsreGs4yus27DJI5Af+ma0pQp8X2x2/MtjLzjsZI/8K5rXtctfE/hex1vwnP8A2rb6fqVvcTxWoJlCI481PLxuEioxbyyNxxgDJFbugahDrWrXOo2tveLaLbxRRTXNs8HmElmYKrgNgAx84xnI5IOACr4sCv4r8Eg43rqM8g5PayuFP/oVdVXG+KJN3xG8E24XJ/064J9AsKp/OUf5NdlQAUUUUAFFFFABRRRQAUUUUAFFFBFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzPgy3jebWtTmAbU7nUJ4ZnJBZI4pGjhjHdV8sK4X1kZv4zXTVz2pRajpWrtqOk2baha3e1byzjdEkVwNqzxlyqk4Cq6swyqqVIKlXlfX5wrGLQNZlK9QEiX8t0gB/CgDC8XeHrvTtYbxj4SQjWI4wuo2CDCaxAo4Rh2nQf6uTr/Aflb5es0XVLLW9JtdT0q4W4sbqMSRSqCMg+oOCCOhBAIIIIBFVV1a8ZQf8AhH9UGRnBkts/+ja5W2s/E+kaxe3XhrSom0y+ZrifTNUvFgENyzZaSCSIS4D5JdGUDd8ykFmBANDVUin+LfhxTkyWuj6jLx/CWltFXP1Af8vauxrlPB+g6rbapqWu+KLq0uNav0jgEVmhEFnbxlisSMw3uSzuzOcZJA2gKK6ugAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This retractor has an adjustable bladder blade and an adjustable upper abdominal blade.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_32_9729=[""].join("\n");
var outline_f9_32_9729=null;
var title_f9_32_9730="Chagas disease Light";
var content_f9_32_9730=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F71304&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F71304&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 563px\">",
"   <div class=\"ttl\">",
"    Inflammatory response in Chagas' disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 543px; height: 181px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrographs from an animal with experimental Chagas' disease shows lymphocytic infiltration of the myocardium (left panel) and neuronal tissue (right panel).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ricardo Ribeiro dos Santos, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_32_9730=[""].join("\n");
var outline_f9_32_9730=null;
var title_f9_32_9731="Med bronchogen cyst CXR II";
var content_f9_32_9731=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F55788&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F55788&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Infected subcarinal bronchogenic cyst",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 328px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A chest radiograph shows a bronchogenic cyst prior to infection.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_32_9731=[""].join("\n");
var outline_f9_32_9731=null;
var title_f9_32_9732="Montgomery straps";
var content_f9_32_9732=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F69031&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F69031&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Montgomery straps",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 363px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFrAhwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD1JmPJ6movrjPTHpSFgGPPB5xUTMAT1zj86zNR7HAGMeuKazqCSTgD1qMkZzg5H6Uxuck4IPPvSAk3Hbh8HngAdB2pNwXIAHPP1qMMBgbuSM/SkJwOSBnoKBj9wxwOAcU4P8jd8cYHOaiU/KecH0zSEhiOMjGMDpQB1On+HlIEmqnccD/RkOAv+83f6Dj610ChURUjVEjUYVVGAB7CsHwxftPbtazMWngGVY87o88fUjp+VdAgwAzdfStFboZvzFztXJ6moHbJp7tnNQk5qiRwOasQqM5IBqCNatpwKABlGcgUxVw3HBPX0p9BpASdKaTzTeQOOnoaN69xigAY5GCMimOfl5pzVGwyhHf1pgREg81DI23kUshMRGc7T+lQySK3APXvQAouMEhTtPp2rOvpHjmM0UQOf9Yi/wAXuPepJsg/MenQ1RvLtYdhfueaBjdd1SO08LalfwsrlIGCL3ZyMAD3yfwrx3wnAqXkDNa+fcswMcJfjK/ekbHJQdM967X4js0XhyRLU4+3XEMAHPVn7ehI79ODU/hbTbPTrYSQqu1FwrsOXxnGT1IByce9Y1NzansZ8NvNDFm+la4vLh/MdyAAo7KAOgFXMGK1dc4GOSfTvSz7Wug65Z8dT3pLhD9nIdsF+u3oR6GvMm9Wz36StBI5/UdakNy9tp0M17PCAZI7TAdR/vthE9yeR2GayL9fEZiC3+r6VodqxIFtaQ+dKc88u/U+4HNdNIRbRiGBAjO244wcn1A6Z9+tZyQpE8phhSFiSWkAJZj6ljyaSlbodCpOW55xqGj6tfXqItxfXig/62aFIyV9exFdlBFpvhHRJLu/leNSoEkjNuaQjoFHqasSyhG8uJSJCQST19/xrmPG+g3Pi67063hv4YbKBiJtzHcMkfdUfeYgYq1LnaT0Ro6LpRlOKu+12dNoniBtQ0uyuprU2vng7LecglBnhs+4wfasW51WPWtM1c6VJN9os5P3qlSrkKeWA/ukZ966K70+I3KyIGBQBUUgfIB0ArkdN0i+0v4m3d/aozaReh3eQHiIsOY3HYgjI9QeKI2dwndOKWt9G/lv9/5i6Hf3qMkzaPe6iBwr293lgPXaSOK6q38R2d7cG3WWYSIMzWt5GY7qD/a2n76e4zjrVOJFQjyz+7B3YHUe2a0Z7W11aCKPUIkuBG26Nm+WWI+qsOQf09RRePY55wmtbmnBGNkscjZR+QV/z3FcvGv2JHiaOQIrsp8ld3Q9fxGOK6DSI3tIBbzv5giZljkPUr1AP06VnazZq1xcvlgMJMR1XH3TnHTtzWtGWtjhxcbxua3w61NY9Rn0wzRSQupkjAiMZDZ5yp7n24NegbyDjAznge3vXj/h+0ubXxVou6VmtJbhImGSdhYHaT6r7g8V7P8A2Y2crdRE553Kf512xTPJm1cgMgz7D09KN/IA6nkA9qnXSpTjNzBn2VuPpViPSYiMS3Ej5GMKoWq5WRdFMOPQDjr0xS+YAACygnAGR1rWh021Q52NIcY/eNkflVqKCGNiYoY0PcheaaiLmMWOGaUZS3kI7cY/GrEWn3D/ADSGOPnABOTj3xWvjPJ5NLinYVzNXTG2gNOM98JR/ZZ4/wBIGR6pWnjFIadkK7MibT5UXKvG4H8PSqZyh2yAhh2I6VuTnAI9f0rO1J0W2UHbudvkz2wOaTj1GmUsgkZOe3TrQWHYD0HFRbsHqfmNNDZ5XOR+GKkomLjPGPbNIWC+g4zUW4cNxx374pC4wTn3yB2oAmzkg4OR0I70mSD6r2+tRKx4I5yeD2pc4VcbuOeeooAkDdOQGpSxB5wehx3FR7mGdx5J4x/jRuCgkg9MkUAPyB6nHOaDtYdj0bFMBxyScU0nbnJwvqKYiXOQSP5cmgsCexxyOKizj5vT0NAYE4xkDnk9aAHB8ds9844pSQMDnj9aj3E8gjnjjpS5xnGeKAHbgeeh7470pIJGee9RBj6D2xQ3Q8kgDkCgCTd0x97r9KerL1OMn3qHcD24B4pN4wAw5HtQBmu3BGcA9h/nrTMnHHGfSumXw9aD/WT3cpyf4lT+QqdNH02PafsSMQf+Wjs2P1qeVj5kcfuwRz8o6880zeAOuOpx612v9nWGcrYWg9xHTPsVkW/48bX8YxT5GHMcWCSQSe3alOcZGcjGc9K7A2Fgetjan/gGM1C+nacwUGwt+/Yj+tHIPmOWHCEAEY70Z4Jbjb82c9Pc11aaJYSsdtmoHciRgB+tTweHdPWVJZIWYI25UMjFWPuD1HtS5GLmRS8I6bIGj1O4BiBQrBH0LKert7HsPxrp25NNZixyT160pIq0rEt3InNNA5+tOcc/yp0a7TmmIljGBUlRgmnc0ALnNLSUvPegAx7U0gU+mNQBE3y9CRTTJheeRTJTnNN2ttGPrQA9yrrwfwrMuVMRyv3asvn7y/mKjaQFSHHNAyk06t8rHrWT4ghY2pZDyOcVdv4iAWTp1wKqx3CzwvG+Nw9aYHA+N9Rkm0vRBC3yi6+f2J4A+vWumt2b+zrO3Qjc43HtkAc/hmuZ8WwNbvG6RiXbIJEVlyFcDh/qM1v6RObk6c/GI4Ax9933h+fWuapudNIrhwt95akHgEgdAameX5ZGzyoJFUXcHV53L5jViuQeCBwKVzuRlYkDqfcV50tz6GEdF6IZFEhUOnylume1VrlVVDkHPJIqyZPLwxG49Kj2ebOFILDOW564qDpi2tWZsNnlxIQS/Qew7VftrW3tQ8wSOKRz88oUDJ+tGoX0On27Snl2O1QTjLf/AFq5UarqGtTMuiWb31up/eXcrCK3Ru6qT98/TNWk3sF3LV6G/wAPMz7WYg8BT976Gob6yW5LE5STg5U4zj19aw20nVUkLefp+3HEYL/zoj1SewdF1O2kttx2iUNvhkPpu/hP1ppdjSULaxZpLAY3LDIz1HQCrULAqOfk6E9x9aVJFuIlmhIaNxgc9CO1OC4O7bj2pMhSurMtW8+VKsQ2Onc1YSDzb2NlUCQxNF7gZz+IrLQkM2WwxPJ6jFX4x501qY22urbkJOORWlL4kcGLguRjtF08f27H5PyYxMY15UkHBA9Oea9DMrI2M1y2moh1ueQHmIBxxgru7H9a23l554r1ILQ+cm9TVinJAq7BIT3rFt29+laNu3OBVEGohzUoqrCcirKnNAD+1KPpSLzTscUAHamt0NOFMbpmgRXl6YrC1WVjcrGVwIlG3PfPet2TkEjtWXrNu01sssXMsRxj+8pPP5daGrocdzK3bs8ggHkUbvlwccn86TyJiTmMD3JpwtZyOCgJ7k1nysu6ELYPsOtG76denrUqafMxH72ID6E1OmkucFrmPA7BD/jT5WK6KobOMUAg7WI5zj6VfGlL/FdP+CCpV0yAYy8zZ4PQZp8rFdGYMAHbgD0x1p2TuBJ9gCOlaq2NsP4XP1Y9KX7Hb8jyh69TT5WHMZIIOME4PtikJ5yTn+daxtbfnEY/M0htLfGBFyfRjRyhzGSTnOThiME4x+VJ07H6CtR7W1U4aNskYGHPHvWXMpikKvtJU4yOAR60mmhp3FDAAgZBPOBSZI6E4H86YRwwYgjFKeTgHPHp1pAODcZIHPpS5zzTCdy5H5elIc5B4yeCTQA7v8wBo3Ff/rmmj/8AXS9OhpgdY3Wopz8hOelTN1PpVa5YbD05pkiRkMM0xshj1pbXleeMUrD5mamMY2MdOMU2OMyyqidT1PoPWlk+Veav2kJhXL/6xuv+yPSgByBUAVeAvT/GpOoz/KoJDtkapIZM8UhDz6jJpATz608Yx0pefrQBEeRzSdDUmKQrQAv9KkHPWmBemakoAUCg8d+KO1ISBSACcHpSNjmmlqbuzTAhl4NOUfL+FDgtT8cUAZj5ViUqOQ7gcnnNSyDZn61BL93tQUQTA4OMYrndTiaJzPAMkfeXPWt2d2UZIzWZdOrrlfm4o3A5fxBLFf6VKUYCRRlSezD1qpo82p21rpzR2AEsip5zTSBPLXnLYPU9sVF4hnXS7W71RMbbeJpQh6M/Rc/iayvBS3bZmurye8kuoxLKZJC2G65Hp6YHauTEVGnZHrYHB+0purJ6X2NyYYddo4dsD2BqUy7cqo5z2qHd5kgIwTycimzyYyMgA4znvXAz2IrZDoyCAByvQg8AH1qUDyQ8rYG0Ek/4VXR1LMG4IGASOCKnZkm/dliV6Yzw319qls0krHPR6R/wkVzFd6spGmR5NtZk4M5P/LWXHIX+6nccn0roJUHloq4Eca4VFUKFHsBwB7VJJ0AXI7k+9Vrm5KqRH3GCcYp3voKKbdyrJKC3zcMvoeDUUlqlxBJG6LLDINrRsMqw9CKbKCy5DAA8YIFSQTFlAkG1uoOetO5pOJiadA3h3UjBPIW0i6IFtK7ZMEv/ADyc+h/hbv061uyqUfHOevXtRPCl1A8EqK8UilHRhncKdCpS0xI+5kzlsdR6mm3fUxT113Itv8WB7065vEsI1mmUSAAjy/4pWI4RfcmmJJlQpGRjtVXW7Oz1HTzFqckywQkXO6I4bcnTp1HPSrpuz1McRByi4o63RpXeeKU/xxIrHPUj/DpWxM/7zGcsa5bwnc2cmiwz2EjyQchGfhjz39634X3yCRs5bn6V61NpxTR8xWhKFRxktUbELbUUN6VoWpOeayIWzitK2bpVEGtEfTHFWkbNUIj0NXEPHvSEWFIz7U8VAmc1MDQA7NNdc9acBxSHp0oEVZxtINUNRbZYNjlndUA9e9ak670OOo5rD1+WW301ZoYvOCTKZIx94oQclfUj0700BCRwvcZoAx1P0pttNDc2sc9uweJxkMO9OUky7R1HUVXoBOp7k1YRgcGqw6AZ49anh5GR0zQBOAPU+9KKaPangZ/LtSABjPSkY5baoGe/tQ77V46/zoQcZJ5PX2oATAxxSNhQT3xTjgfzqN+TTAhkG45xms6+XFx29On5VrBQBk4qhqqELG+QA3b6UpaoFuUM8DqKQn5c4ORzScjO7ke9KT688etZGguAQMHA6jjrSEjPTjvQPu5HX+VCk8ADt3PWgQHgjnnPagrn+7n/AGqTqRxyRQpVhkAe+aAOwb8M1UuDkYOatvVO5yCMn9KtCG2/BP8ASpyOncnkVVhPzcZxVrnqOtAhsUXmXMSc4Lb2+grQcHJPQmo9PC+UXzmRj83+zjtVlhuGKQFKYHccdaijJBIwRVuRcMCfpUTqCc96AJI2zxmpFNVVJBqVWOeKAJiO9ID6D8aUcj1o5oAUZ704EHr1puKRfSgCWmmgE460GkA0+9NbAGaeBnk9KhkJZuDgUwCRwgLNgAdqqfaJZCxAwvbFWDEmctlj/tGg4DD3oGZMhcnBByPamZx7Vpy8Pz0NV3GeoFBRnS7SvPP1rHvo8ZKNj2ropY1YH5cCsq+tUKk79tIaPLfiDK0HhHV0AB8wJGMjPJbn6dKg8LziysNMkKrJLdOqLGvXDDkgewzzW/4n0hb6zvLRpUdJkx1xz1B/OuXsrmTTPDyX7RmO9it00+RJRtJVZBuZD6MCOfwrhxCfMfT5Y4zwnIt7u/z2/ryOiilWNnwOAx5PoKhnPz5PQjJ9RUkwVJpACOGIJ/8ArVGzZGW+U8ANjr9a5jfZ3GRhmjbbjfnf649TU8B28sAAowBjnHrTSoSQs7AY4wO/1pZSXAKqSzcFfX6e9Q0EpaXLG8up5YE9qr3DIkYdi3lqPmwM/jiqFxqEduArkqzdNx2mqUuoFiQr+Xj7rkZH0qlFhGokakjoAGAzGOjYwKjaMPuK9cgA4rMjvmDnY8aqeTvwRVmO6TeTIyHHHyn731quVmjqpF22k6lmGe+KjnlBJYnaoHUdxVY3IZyFYHj0oWVCCzcgNgjHBPtScbGLkm9CSMsdjNkBuB9PWnXCiS0ZFJDtGyjFIY23B3bgdB/npU8fzXcUfHz4Xn34OaqIpSu0UvhqQPDZAwQtzKAP+BV3VsThea4D4bQNbaPdQsThL2VQD1GCR/Su+txkcfjXp0fgX9dTwMxX+1T+X5I04fatK26j2rMh7Z6VpWnUY/KtDisacHQcVbQ9qqQjgCrSelMksJ3qUfWoUOalFIRIKD6ikB4pT06//XoENYBh/WsnVIy9lIASHR1k468H/wCvWq3ysG7Hg1XvYDPE6IcM6lR9e1NAcbJIun3T3cY22srf6XGBxG54Ei+me49ea09vlSbPxz3NUGIbEgTcjDa6EcHsQadprlUNi7bpIhut3J5eP0+o6fhTejuPc1FyxwOKsxjAxVW25AJ649KtA0xEqfzp5O0A/hTFI6VGzeY+xeg6mkA+P523HoOlSE+gxijaFTAHAFMJP/66EAE+3ekUYakJzx+FSKPwpgNIyT6VU1KLzYpR/wA8wMe5HJq8MDLE8KMmoUHyrv5JySPrQBzwbI6+4pRkMRgE0kiGGV4jwUNN7ADHPXnGKxLHrwPvGjuOPb6UgOMbsAdKXJ+bk4oAB3J47UgLflQSe2Bz0pRjnnH4UAdg5zVScVaJyKrzDAJ9atCK0YxmruMr7VUQfNjrzVxenSgQ+2jLTjY23gk+9W1bnDDDDtTLRNse89X/AJVO6bxkfeFJgRzDMeagI/KpyTtI71EAc8nNAEZTniml9gwRk1O/HCjJ/lUOzuc0APjlzjjmp85GagC9cdakjJHXvQA/HvSH9aXpSE84oAXPpSrk9RxQoyfSgnPA6UAMcgnrTQPcU4ikxxQA1uO1RsMj9akIOBzTO9ADJRuTI7VVdgPrVpu4qjIuGIJoKRBczkZwCax71JZ0YLn2raMRJHGaUQ7VJNKxadjzLW9DvnJeNsH6/wAq43xvaazeaVzZsJIoyXKHcrledwxyM9xXs2qKTkL+dcDrRmFwojZsK3IHGR3FZyjHqddCtVptum7MRGW7SK6RgFmjjkB65yoJ/WlmU9Dj047UzQ4hFZQ2jztKbMmDcVAYrncCR9D+laDx7g3GWxndivLmuWTR7tOpzwUig0W7gEYI/HNPSHJDMOR6nirCohIwWU/pSujdFGMDqKm4OT2Ks8MVwipLGkq56Oobn1GazZdLsPmWOAQNnP7lima1JiG+UMNo9qqzIdowW3fzpptDSMoaZGu1YZ5AwP8AEivx+PeraWUBcK8jvnnIUJj8qcSxZtzDOcEEflmpEBAyQen4n3qlJjlFMjWwihyYxx23Nuz7mormBdvBA5BI7DH9KuA4YAsH3dsdDimOMIc7QeM88GhszS5XoQsT5e44xgYU89KhncxxSSltpRDJz/DjnNWJAXPy5Yr+H4U7yVf5ZEEsZwu31HcH2q46tIOZQTk+hd0GOJLKNrV2lSVmk3nuzdce1dJbFVwMHArOs5WidAsKpGi4VVXCgdgB2rXgvIyR5sQ9MjrXpxXKrHz1WftJufdlq3dSQAea1rZfmqjDDbz4MTAH0NacEDLjuKsxZbiHT+lWo6giGOtWVwOlMgkWpR1qNalFIQ4depxSnNIKd9aBDGGcjjmmIdrYbJAqVlyOaryHB+nFAHF3UL6Rdy2xJkhU7kY91PIz79vwqMhm8ua3OZYm3x9ue6/iOK6jWrBb6z8xB/pEQyD/AHl7qf51zESi3ujFk7JBkexq90BtWlxHPCk8H+rcZweqnuPwq0pGeBWLZuILwg/LDcnB/wBmXsf+BD9RWk8628bNMQNlJdmNk08xUKiffbgAVNbxiOMDqx71TsInYmebPmP0H9welaBPHrQIRmPvTPUnHFKx6/lQo3H0pgORfmzTz144zSU0njHvigAl5i28fMwH1HWk6sWOAM0EEn6c0Y25IGSOQM9aAMfWYwk0cufv/KQPWqDdua2dVj8+2k28snzD2xWECCBzWU1qVEkJGQOPypR7HAHUetMz17ClBOM4x/SkMcD1yKUFuxFM7ckj2FJx7j8cUAdpyRUcoJ9qch59MdqST7tWSQL97NWYxvZV/vHGaqW264uTCgOE5kfsvoPqfStWOGONty7t2MZJzQwJwB2GB0FOBqPr9BR2qQJGVG6kA96j2KDgHikUZJz0FKRzTAdtVu1NZBjjpSKcHipAcikBAV5NAGaew5ppBznjFMAPA60hGSKCSTS4JA44oAdnjAHFA4GTQKGIwM0ANPWkJ9qN3NMPNABnionz2NPLc00fMeKYETbsg85qN4NzkknHWrm0KMsRVO5u1wVQ9KBgyJGCSTVK4lDNhQcfWnLHLcMeoFTpaKg+ZhjvRYpOxi3kW5cnJzXMahYHd90nqa7i+nt7WJ3bkAZrz3xL4ikYHyikQAwD3rKpZI6aN29Ct5JjkcugVnUDjvjoTSg/JjLDH8JrK8P3E15ZXk8wlZWnCxvIMblA5ZfUA8VoIxO5X3KR7ZB+hrzKusmz28NpCxZJDKcADPGOlQMxQvksCT3GcinccuT90AA8ipDHgAiQFeiqw7/WsjeyKhYsdvChuhwcfWmeSpJ4LYHHOM1YzujGFYYPY7sGpgRGu4LkZ5OaC7WM97ZQ24Egnj2phQrJwWOOM+lXnuIhjewKt04zUDFOQEYZHJCcVUYuWyuEpKKvLQpuQePmKjsOoHrUQDABJlBBPB9R2qzIjlQUU7gf4R1FAWbaMRFcdmwP/wBdaeyqL7L+4xdWm9pL70RMApJYY9T6VZ0yeKC9heUgCTMSlvUiq7xsrAykuewGMDvVO+gW7tAXllhCygxSL0yOpI9x0qqV1NGWIa9k/M9Dji2kEjHHOR1q7DDFIPuI3tis7TtQiubeNWIYABc9zWrbR4kHlng16q1PnnoSR2KKcxhl9K1LYumA5yvrUFtJuIUjLelaCxPtLGNguOpBpkNkgXNPH61GjBcA4qUEeooJHr04HWpATmolIqRelAiQdOaUdKavIpwPAOKQC/pVeVQHxng8g1Y4pkyhl56jkGmBBE+xwSPlzzXK6xbbJpVTho2OM+meK6kYzWXq8YN9IOMMqn9KaAwVKTWxMhxu4bHUHsfwNWbdU1NbG8kfeYGMcsY+67fwv+FYuopM12lnA+zzeXIP3V7/AOFakKto+oQB8fYbtRHn+7L2B+o/UUpdxo6FeMignABPcUyI8FWOSvQ+o9aXrj0qkIcMlqkUbRTRgdzSgkDINACmmjPpQTkk0uaAHevrTCRjmjcPwzUMkgBwSOeOaAHDp0z61zU8fkXMsLcbWyCPQ9K6MEYwMnHFZWvRbXim9RsY+ncVM1dDjuZ27nODnPfvSg4JPIJ7k1Fnqc8inE5JGMj1rIslVucUA56DNRc847etKDnOeaAO1/jFJcMwTbHguxCrn1PTND9R7elNZiGVv7pDCtCC3Z20dpbiKMlgCWZz1dj1Y1PnniqyTBs45qRXywzSAsYwKTdjPpTl+ccVDIGDBe56UAWFxtB5GeaY3NKTnqfypdtAiMe1Sjgds+lNFKeBQA09ab1PrQ1Jn8aBid6cOlNJH5VG8mB2xQIkLYPvUbPgVWklyCQD9ap3GpWluP393boScYMgJP4DmqUW9gvY0S+TS59+a56fxJYQ/daedv7scePxJOAKzJ/Ftwc+RZxRp6yOWP5DArWNCb6EucV1OxLDpmnb9iZwT74rz8+KL+YlUuhHxz5MSqR+PPFYeoapqt8Zo7W6YRNw89xcOT7hVHT8K0WFk9yHWiekz3UlzN5cStjPpVhLUQJvnVsnrkV47PrF5Z3CWWm6jfSzsNskplIK5/hUdvqeatxHyowklxK77RuLTM2T+JrX6m+5P1hX2PSLvXI4SUiQZHHWsS616R3wzBV78/4VysaNKPkVimPvHOKdJlISIY2dvVVzTWEit2Ht30RZ1fxLCElSM+dgbSpyM1hWtxFcScQohH3SV3fqaoXWn38826O1uHU8nIAwfTrWjYWMlsgaYJuPO0Nwv1reOHpR6XZDrztvY0J58Rb7li8US8vI3Eajk49B7VFbF3t1knj8syLvKEbdinomPpgnPOaQkFl8yRTtbICxk8joeagniR33AqzcnM4LnPr6UOhTk7uK+4SxFWKspv7y3HcKCRbO7PjkpyB+J4oa9KpmR41x/EOo/EVl3FvPKPn1R1z0RLZSoP0JFZ8+gTTgNNr8wI6f6GgA/DdQ8JQl8UV9w1jcRD4ZP7/+CaE+vwJOUtoYy+PmcjIz6VENSu7ptvnHyx91RwF/AVVh8Ooi4/tctnq5tgOfpmtW10+2txkSyzMf4mwv6CtIUMPS/hxX3EVMTXrfxZt/P9NhrSbY/vEjGCc4/SonkAADOoOe7VZkhVj8ptmOcLvRmNJKmoBGEK2TSfXYMeuSK0TMbGdPchDiNZJD6LGxx+nWnRW+pSDcltIgbnMzhBj8ale41yJAws3uVPG21mU4HryRxVWXV7mH/j60zVYccktauQfxXOad30DTqaMNjccCSSBD6IGP+FTfZEeKSO4mlmjYAFThcY9COawh4qtfNMbvsfrtkBU/jkDFW4NetbnHl3MZbOCFYGonS5/jVyoVeT4Hb0NWztrayGLWN0ycktIzH9TU0+pa3bB5NInsppT92G+BAH+6w4/BuKz0us53NtA65pPtsW0YbI/nWbw8H0L9vPuc7qnxA8SxXZg1e9vdOmBz5PlLbqw/2SBhh9CauWHiq6YZ+234lA4kS6dWP64/StqSeKeE280aXELf8s5UEif98np+FZaaBpSv/oavaYJPlo5dB9AeQPoa0jTglZohzk3udLbeKdXMVvNBq900UoKgShXAcdVbI69x6ir0Pi3W42G+8V/mAIeBCP5VgxWx/s2W1GzYSCAh4OOnuCKi0y587zIZyVnhba59cd6h0oPoi+d9zt7TxlqCErc21pcD1VWiPt0JFatt4ztmbF1Y3EK/3kYSAe+ODXAlMcqx+lLFKxZRuPpzzWUsNTfQtVZI9TsPEej304gt79BOekUqmJj9N1bJBX7wINeKyAyKSVDZPRgDWnp2s39kpFhczooBAjLb48+m1un4YrCeE/lZca3c9XHIpGGR0ritI8dK7KmpwAIRjz7cHg9w0Z5H4ZrsbS5t7y2Se0mSaBujocj6ex9q5Z05U/iRtGSlsRy4Q57etY2v3CQyySngLEpI/Ct6VQQcjiuM8Yh21O1gwdlxFvPvtOMfyNSiinocTSzyXcwO+U556qvYV0U9pFfWUlrcjMUgxkHlT2I9wearWNsIogBVxiQrEdgeadgKWi3Uk9v5NxzdQEoW/wCegH8Q+taMcinOOvvWPaoBFGVIWRWJDdw3+HrV6ZiYoryMYUtsmT+6fX6UttB7lzqc9qf3IpAMAd+9Bz+NAhD2pNwH0pSeeDTfSmAjHAOelVCS7kjJ9Ksyng4yagUBVOevrQAIdp96r6lie0kjXOfvA+4qcqS4OQOMUwx7c9STQBz4fcCcZpQSPQD+VEqGKZ42Iyp4powT9fWsHpoaCg569aXcfX9M00kdfXgGkPBwR9MUAd25zUXUHHJzx9Kdnjp0pmeT/nNaEFZJzBPgn5T3q6k6AGR2AVRkknoKqXEQfqP/AK1Z0mWjnhbIlRd4/wBpc9f6U7Acb8SNT1O81C3h+2TQaS0e+KK2doi0i8MZHB3E85CggeuavfD3xf8A2etzp/iPUHeAYeznujkouPmjaTvg8qT2JGeKdrlp9r010C5kibzY/XI6j8RmuOlt+dwOO/HTFNxDQ910vVdO1ZC+mX0F2qfe8pwSv1FaAPFfOcDzWGoR3unytbX8X3J4xyB6MOjKfQ16x4Q8c2+rbLTU1W01MDkL/q5fUof129R71NgO04NBoByARgg8gjkGg8ipAYevSmMeOeBTnZVA3EA+5rn9Z162s28oPvnP8CjJUepPaqjFydkJtLc07i5SEHJ7VzGreIxFJ5VqiSyEZ3E/Kv8AjXPavrc10xHGzshJxn1I71nI0krgZO4gFj0GK7qeGtrMwlV6RLt9e3N5IfNnkdf4mzgfRQOBVQOsTYjjCsfQc/nTHlBJVC2xedxPU1XY7F+U/OeSCeBXXGNtEYt9R1xc7FODk+9Qq5Cgu8jOeiL6+59KgYucZ2gZ6+tT26PKWk3AKOC7dPwFXaxF7k93Oy2p5VWbgbR1rOlt7xrALC8dvI5JMk+eB6hRyT+VXJrqKLCxkbgMeY3X/wCtVOV5OTbXCq392RdyE/z/ACqopkyYun2kGmwt5Q+0zN96WYY/JR/WiS6uyxKzxQqeeIRUEk19gb44iMnmJsrj8e9MWS4YYLFfqKq3Vk3Bxdvn/iYzgE5yoFRS2jNzcXt7L2/1u0H8BSSSODhHLKOuRUWxpCxxJ9TVpEvUG060bqsjNnq0zA/zoXSbZSP31xH9Lh+P1qeO1cgbi2Oo3HP61aWzyMsWJ7Um/MOVdismmBARHqmogH1nJqeKzmUnbql03HRsGp1tQFJyeOwY1IiYBC56d6nmGlYigQISLi6mkcjjfgL+gqxHIjKBuUn1wKcitj7w9MntTm28CVo2PQccj8qlspCqFPZffvTWEYIUICT0x605UIjYx7F92GBn60kKYUlCHkPJkYYx7AUhjkCQpukxvxwAefw/xpkhd+GwE67Qf51IYyCWOMnrTdoPOcgUDGqgwflI6dDzUsbSRn93I6nHY4NLtUHkn86OnVBn3pXAc0kjhhJl1/2gGH61Wks7GcYmtLKQf7UC/wBBU7e+QfrQBkfdwB60BuZ/9g6TkBbJIsdPJmdCP1xVd/DNm+4wXt9bsfR1kGfxFbO0euKMdzjIp8zXUXLHsc+3hy8C7YNYVhj5vNt9pPsCp4po0jVbdvlMEiDukuCfwIro9x7Dv1pDIowScc/w9aftJByROfRtRiw0lpMir/d+b+XWrdtfRmQSSIgkI+ZnG0n861fMUjdgkdMkYIpkjhyN7bgeP3gDijmvugtbZjTNCITLIyog+8zEAD65pkBSUiaKQPGPlyCCAffHSmpBFE5eKCNT/ei4H5VFNDE8xmhle2uSu1nRQRIv9116MPTuOxpWHcuLukPBG0elOUOrlXX7w+mKpxi6Qf8AH5Cy9leDb+G5Tn9Kme48mLdLAS2CFCuGD+3/AOulYLjb5DGftCqewlX1HZvqKv6Lq97pN0bjT5VdH5kgc/JMPf0P+1VCyuo5rZZlO+BxxvPT1B+nSqyr9jm8oHMDHMTZzwexocVJcrGnbVHtGi6ra6zarJauN+P3kDEeZGe4I/qODSX9rHcqgdA0kJLxMeoOMEfQivIdsUoDPvjYdJI2KOh7YYcg1vaX4x1awmSHWCup2p+7MFWOZR6gj5W9wcH3rgnhGtYHRGv/ADHbIoA4FNbGMD/9VVrDVLHVkaTTZt+OXhZdskf1U849xkUryYxzn0rmaadmbpp6oryxvG7GIEqxzinWNyFu5IZkwkifvAensani3SPknjNVL5HgnjlziNyEk+h6H8D/ADqXsNGykXkKsbOXXoGP8qUnGTTbVxcWpSU/Mo2tjqPQ1GrlZPLlxuHf1pRd9xtEoGc+opx680oHApjfKPfFUIjflsc4HWk25A6Y9qUD5sninqucCgBAmTkikK8cfnUuD+VH8OaAOf12DypI5gAVb5WPoeoNZbNgHJGe3vXWXkAureSPuw+U+h7VyQ4J3AZBw3saymtblRY4ZBO48dfpQSAeRk03JwRkg+wpwB7AH61JR2mcnpSfXHFJnBHNBxgA961IHNjtk8VBcQ+YqvGds0Z3Iex9VPsRxU45A7DFNpoDlg6O7GPOVJVkPVPUGuX+zrPJI1uMx7jsYdCM12Ws2McN6t4UUCRfJlb2PTPt2qu8Ah/dhFQDgADGB7VQjk301+SVxTE0o7gW6g7gRwVPYj3rpJQQD0znj3qscFjk8eppAa3h3xJd6eFttQPnxdA/Qn/6/wChrqZvE+kJYNdtfqYg2zYoJkLf3dg5zXn9xJHFEm4Bmf7in+L/AOtWTL89z5jFTJtxnH6Ct6WH9pq9jOpU5dFudPqni25u1aO3U2MB7qQ0xX3PRc+gyfeuUe6Ygosarls56/iaTB25AyxJ6HgfSokBDE4G7PbtXfCnGCskcspOW5KisXJdtxI6mnzu23y1zt/iPqPT6UqqI0yxy/v2qBpMueDnPFVuLYc7BUCL1P3qh3FnwFJJokYg5wBTSwVGOefX0FUkJjXkBkKHsMswH3QKmdmitkXGGI3Y9M//AFqrQRKLqOCQgPIDPIo6iNeg/Mj6k1NdOXkYk89Rg01uS2VCuWyeOeo5FRvDk53ZHpU+TnnNLJgNlCueKu5BCAqkFHCOaRmaQYLNgcEA4FWWWRl+aIHNTw26kA7AG65HFFwsVILPLZ2gHPXNXY7VEUdzjk1IQVx8oI+v9KFZsLtAx71DbZSQLCP4c4xT/Kxwen1qSFSTuc5PYdqk2jPQfXNTcqxAEAGRk/SnbD1BwBzz0qXBJ6/lUMwGCGB291/vfX2ouOwKFbazlmGM4xgY9TSmTD7VABPfpikAZhlsHPNPWM9gPqaAGbN/LngdB2HvThEAV/rTirZJApsud3JCr19SfwpBYQqQTjpjvScnsWHoO/tQCFAJPXnLGgTFgNpXaRwBTAcEJ6jaTTtgPUtnpTD5jYAVjTlSQjkkfyFIBxVAevApAV525570nljq7jb6AUrNGoUgZ5x9TQAuzeucgj0pNi8569aa827qCQO47UxSxHOfYUWC6JCsfHzH8+lNKoAScge1ByATtX64qMv2J6jjPSmA/cnOD9MVEUiY5VijduKQ4wNyYPt/SlUdcbuPXrTFciZbmMZDkqP4gM/nTRMWGJkUn+8ByKsDfn7wYYxgimPCGHGAT2J/lTv3FbsIFVslCQD0prRLJHiRdwyGGOCCDwQexqFg0RIGfoakSbP3uMdj/SnYVzGurEWTS7Sfss53EjgB/cdj9OtO01lltZlAykcmBg9u9bfmK27cqup4KkZB9jWRa6SNOlu3spWksp/mWFxl4HzyAf4kPvyPeq5rqzFbXQv28uchj24I6N/9erTeXJHsk4Vu46g+o96zLdwZSBnBHrV4D5we+P1qGi0yuWmsrhSXZZE5jmjbBx6g/wBK6Sx8TzMFTUF88D/lsgw5+o6H9KxZI1ni8t8qQcq390+v09RWepeKVo5lCyDjH9R7VMoRqK0kNScNUeu6bPBe2wmsZ0niA52n5k9mXqDUeqlJbZoijymQbPLQZZgfQV5pazSQyrPbu8Uy8CRDgj8RXSaN4pmtpw1/GZ1xhpYuJAPp0P6GuGphJR1hqdMK6fxaHUeHItTNrHJqVm1tKQUcSOMtg4D4HTI5wa0ryxW6MZMrQsh4ZACWHoc1l694os9L8LSa3axnUoVdI1WFto3M20eYT/qwD1JHFcgPiFrcKW+o3el2DaMNv2tIN5liBJBKueGK45XHtnnNc9PDVKivFeRVTE06b5ZPz+R6VHbqp2hnc+/eobmNopAHBUHkZGPwrz74o32rWWoafdQ6rfReF7uBVV9PIjIkIJ+Z8E/MCpU8DgiqXww1O/m1z+zlOp3Wk3FuXke6LSLbSqOJFkYfdbkbQTz+NaLCy9l7W/8AX+Zk8XH2vsrf1/keljGeDxS9+Rz1qsJPKkKPwRxVrO4ZHNc51AeOKAMrj+dIxpRweaYDs7AG7iuP1KIwXs6sBt3FgT3BOa65sEGsLxFDlIbkD7p2Nj0PT9amSuhrcxj6dj3zR9EJ9cGkPAOR9AetGcE4TFYmh22MEGmE9fWpO/54qMqeSBzitzMehOMH0pWwpz6dKYDkg9u9Dt8p+vU0AJcRJcQSRSjKMCCMdRWFaFlMllc8ywcKT/GnY1smQdD0z61k6+jCSK8gBMkXJ/2l7imgKl5bnPAGKzLlhbxs0gz2UZ5Y1uTX1uLAXcrEQkdFGWJ9B/j2rkby+N3dNI67McRrnIVf8fet6NF1Hd7GVSpyrzIpnM0u9wWdsdumOgFVRMJJbhUbIRwrHHQ45AqwJdzD5TnPes/TA0dgpJJklZnYnudxr0oqyONu7LDEkbRwfrkCpbeNVRi2WbsT0+tMTDHk/hipHchQg4PTmh9hod5gxnjPTFU4n3M4/uk5p7YLhQ271461ShkBlnTPO889cU0hNlolGc8k+3pUbXCh2x8wiXex/hB/hB9ee3tTshFYjp6nms+7ge7lg0+NvKMrF53z90Ac49cD9TTSEyzpa+RaXF9I2+a8fO88kqucfgTk/hTGkcliCufcVLdtHhYo0EcKAKiAcKo4AqsCpXH9eatLqQ2PEzAcsgFPWQSSL8q/UVAqLnlTn1q7bxDfwv50OyETDBYLljjtjiptrEL1AAp+BgBSSevA4pGk2nCjLHpWdy7DwmAN2OO9SAA8kE47VCMqxByW6Y7Cp0JCjJFJlIUhmHHyigYB4zTS2e3I9TT1Jxkk4HXjFIBDnn5SfqeBSeQzNulO4j+Hoo/xprzhW4+b6UwSSN0BxmizDQmZRnrgD3oPXKkAAce3vUBJOcsoA79aj88A7Y98r4yAtOwXLEikjc0pVe7Ef0qAy2sA5kLt1JUYFFvpupanC1zFasLIKWa6l+SIKOrZPXHrT9AXQ7oma1A8SFULlLKVMIB6ROVZ/wAM1nOtCGjepUacpapGXqGsWen2P9oXMYjtd+wTyBmBb0Hb+nvVK08WR3sqwhZLW4cbkinjMZkA7rkANj2rofFMbaxBp82nI9xZ3QVQoXYFQsAQyH7uMEFSOK9C8R+G7XxNYtZakUltWcMFkDZjZfuvGwOUb9CCQax+tpdDT2D6M8pOoSDG8lc1IL9t3QH36ius1H4WzRXKt4fvmtYSxLwXJN1Cw9gcOjZ54JGKi/4VxdxMxl1+3jXHEZ0/ODj+9uzitViaTWrM3Rmtkc2t4c49e4qRbwbTnrV2bwRqqAH+3bCTrxHpk+PfkMadZ+BbuZl+2a+0NuWwy2ulukhHs0jEDr1xVfWKXf8AMXsp9ir9pjEe92EaD+JjgfnSLfQyvthniZj/AHXBP5V0S+EhYuj6FpGmXdynIvPEV08z59o1Uqv4Yqxc6Z4yvLfyr2x8BXltkZi8m4Qkeitg7T74rJ4mN9EV7GXU5di/3TwO3FIBySCc11l5oGg2mg3Wp6pY3OiS2y/PHZ3hnVyeFC9mJOABgc1xsM5ZVyV3YGQPWtaVRVVeJE4ODsyfgcdB39KCCANpIpm4Y5weaVcZGD+Ga0JAsed3rUchPBBO32FSbTnpwfWmBvmPB54ANMBonCjbL86Hse1EkJP+pO4H+E9QaHXOOOP5GoEZ43GD9c015CfmCvsbkEgDH0qRJCrAg5Uc59Ke2yYdPmqExlCNvIpiFeFZGMsRCy9SOgb/AANODHhTwehBpqNgnPX1pX/eLuH3wOCO49KVhpkyEA4yRUd5bpcBcKPOX7pPcelRJIOvOB3qznKg474pPQpFBPkUNtbAPY4q4reYoDdD1J70syliZUIJb7ynv71XfaG+TCA9cjjNO9xWsWVfBlb5dsiGORSxAkjI5Vh3Hsa6bQfh1osllDNrUd/LNKoc2j3jCOFT91PlwTxjOT3xXF3t8LVYRMisZJMLzkYHJP8AIfjXovhrXPt8ABbLgZ57iuHF1pQ92Dt3N6NGM/emrnZW4W3ijjtlWKKNBGkaDCqoGAAPQCnO7MMMzMPQmsS613TNKUnVtSsbHgNtuJ1VsHodvXn6VUHjTSpltm01LzUEum2W7xQ+Wkrc5VWfGSNp4ryXNJ6s9OGHqzV4xdvw+819Tt/Mj8xR86j8xVWzmDIFPUV53N8Z088C28NyyQK5WQyXihyAcHaACM/U13VndW19Z22padJ5ljeIJYXxg4PUEdiDkEeoqqdWMtEzTFYDEYWKlWjZP0/Q1fTHrTiPl689agicMhwfyqboa2OMGySOeKgvY1kspYyM5U4Hvjip+3Pr6VG7FmKjp9KAOLQkhSB16085B5J/CrGp232W8kCZKMdy/wCz3xVQsR93oeawas7GidztycHrk009Dilb1zTCeM9q2IFHp6CkP3TzSE/MM5Pemk9cUgKsp2sQeKVx5sLDrgUlyMjA7elRQybSMcfWqA8Q+Mdx4l0TxFp82n6i1to8o32aRJ8vnLy8Uo6N647qfatLQNdHiPS1urSNbZkby7u3BybeXHbP8LdVPpx1Fej+LtIs9a0O7sb9kS0nXf5rceQ68rICehU/oSO9eGQ2l5oN1BfWJj+1ErDKik+XOhPKN6g9Qex5r0sK+aOm6OOuuV3PQVk8sB13HHVmHX2FRW537YLcHAyzuf4QTnH1qC0ngvohc2zvKpbbsY/NE391vQ/z61fClFAGB3IHRveulmKJvupgHjGOKhLeuOKXcV5DEAetQyPtBJ/XvUoY122sQnf9BVEMRqLKqk7zuVV6sfarKozKAVJLnGO5NSGNbd2ZQDcOAryD0HYeg9T3qkIkARSocKzrySG4H+NQwW1vbL9tiSRZ7hMZkkL7UznjPTNFqquxdzmNOXI7+i/jTbl2mk3uMeg6Y9qdtSWyCR2weQai98c05wSM8g/zpAOGYgZ7ZrQklgGXwOTWjGoQZbHHb0rOsyVRTySTzVtCSwLMTnjAqJDRMZichQMHjNSoMDJPWmonJz+XrTnxkE9+gHaoZSHqxO0IAe3FSF1UZLc9u/NMBCKPXvimgDrgc89aQwebIPlrg9cmopI2c4k3E+hbpUjSLGDtA/DvVW5vtiHBUKOSzEAAe5NNLsBZz5Y+TaPoKilnIyqAvIOw7D1rk9X8W2NkreXIbuRef3LbYx/vOf5DJrktR1nUL6VTqf7pJeItPTKRqp/5aTc5bjorcnqcDqTaguaQRTk7I9Ns7yLUL1LWK7gHDM8gcbF29VDdC3sKW18MNqY3+INUluI95K6daDyrYL2EzD55vcZArX8CeFS+iWdw8R/er5i7kwdueOO3rgV3dvoiRDoBXlV8RKpotEdtOjGPqcdFoUJJSe51C8RyAyXNyzRgDoqxDCKo7KBxVvUdDN5YyRWUqWV42Al0sKu8Y77M4w2Oh7V16aZGr5JXAFNmhSLAVSzkcKoyT9BXC0joRheHrTUYNL3a/HbXF4khVRGfKWZB92WTAO1z3UenvXR+HLjUruxMurWdvbuXbYsMhbKZ4PPX8cGrljpLsonuwqHqsbnIUerDufatIwsGcNLuU42qoycVSbXUTsxLaZGYxpKpkXqh4YfhVvaHXDA1l3NmsyhpBPBIp+WQEMR78dKrXOlXU1rk30kV508yGVkWRe24DofcUKTBxRqvbbidxBJ4BI5x/k1naq6abbNcTWNzcor9LSPzX+u3r2rGOk+JreUvY64o4A23LechA9tuQffNaFlL4rRz9rXQp04wYXljJ9c5BqlMnlOSvPiRp8DrFZaDqzzD/WJew/YwmO2ZPvH/AHc1z+s/ETxaLKOew0fSbOIyFHUzNM4GMjDEKn517IHadRHf2kRQ9cMJF/IisnW/CGk6tpl5aJELUXKbS8IAAbOQ23pkEVpGavdolxdrXPnzU/Gmr+IoIDrM19JbW8nmIhshCm/H3iFzuI7c4HpUVjqkVw7CCZZGU4KkFT+RAP5V1fiLw3r/AIeZ3uLNPsKL/wAf1kpkRR7x/eT3JyPeuM1Mrf8AlmPzpTniSMAheOOR0rrhjHDRJWM3h1LqdBb32TtcD0HYiryThsFT/Q15wr6zYFvsd0t1ECd0FyN+0+meGWrlp4riiZI9WtLrTpW4Vx++ic+isOR9CK64YmnU02ZzzoSjqegiZE5LBfepAUkAwwB9K5/TNVtLz5Ibu2nP+xICfxU8/pWnHMoyo+U/3SMVvZPYy1W5dKYGDz3yaruCScdMdfWpon3Dknn36UkynIxwD3pIW5T3GNht796tZLDIAJ9PWoJYyQRnB71HbyBXMZd89snn6VW4tidlDDI4zwcVEGMb/N9w+lWDkjcMehqJwCSG5XvQgaGz/I3mAfK3Bx1B9fpT4XBHGMdDUUeUJjkBZGpgDREpzkdwOoosNMvqdrgHgHgn0FMWIE5IwGOAR0+hHamxuZF5CtnqpPDe9StDczWNydM5mEZVVPUnuo9WxnHvWc5xprmk7IuEXN2irnI+JS0Wq2kodTYXSGC3K/wSKSSCf9scj6YrY8F6q9vdKgfkNxmszVIFv/BjQpHsWNmgyBhlZfmV/Zga5zSL175IjM7x3MZ2z+WcE46n8a86snzyTOyl8Ksd/wCN/AOp6hr02ueH7YX9vqJEswaZBJbS9GGWP+rPBBB+XkdMVN4U8DeI7SV92paRawS/ftyGvcHBGdq8BsHsa9N8Nx6fd6PbTQwRuYwFYuN2DjtnsRzW+GZEGxML04wgFeZKjFyue5DOMRToKgrWWm2v+X4Hmlp8JtPaaSfVL3VL24kfzHZdlpGWPU4GT+Fdzo2jWmkaLb6VYQrDZQbtiBi7Ak7iSx6kkmr3mknh4gfRAZW/TikcYHziY8/8tJBEPyHPFVGEYvQ5MRja+JVqsrrt0+7YQWsMZz83/AmxTT8rlQQR6nvTkySApQ+0MZc/mfWmzKZEwSVccjzJBn8h+VaKWupyWGSN6Usa9SQckVXifnJB4656irO/5citSTK8Qqi2WQu6VmBLHtzXO9B168811lzbG6yp6EY9sVyM4EU8ke8NsbbkdDUVF1KiztmqJnODUkhx7mq7EZJJIqhEuMnnGKPTvTA3IweKd02880hkM44Oemaznco3J/IVpSjg4OfU1l3vBzz+FUhMra/EdQ8M6vbIiySvbs0aNwCy4bGfwryC/kmkheaM4YqHTjk98Y9+lexWc4SZWkUsgYFgD1HcflXiepaTq03iqXw8mPtC3LQq+75Vh+8szAc7QhB+vFd2FqKEZX9TmrRu1brobPhLTLm81ia80+Y29tHDtmZ0DJMzDKREdyvUsOV6d66GdJ7ZgtxCFmk55O5G9we/0610OjaZaaTpttp2nofstsm1SfvOepdv9onJ/Src8EVxbulzGGhbAwwwR6EHsa8t5tJV3K3udv19f+GPUWWRdG32u/6en/DnFyEbV3NuJPHqT9Kq3dxFb4MimSQ/ciX+bHsKva3ZXNhK3lAvbkhVuSuOvZvT696z7O3ie8iidmkdiXc55IHr7dBXu0asK0FUg7o8apTlSlyTWpZtYnBF3dtunZdsUfRYVPce59fT61DcHc20DIxzg1o3TYGSMnrgdqypSXdVCnB65FaxMmXIcC3UADaGJ6d6hmfHT36ipLV/MikwMIr7U9xiobliSQwHFNbiZXlOUBzSpymMUxxnIxnB6U+IDn+n8qsgtWyZOO2fyq7GVBO3oO/aqsQCIpY8damQbwM5C9l71my0TK2SSpwOhOKegVAGyMHuajdhEC7546AcfhWBfatOs7MNohB+7jH60km9itjoTIuRzyTVW4vIoUJdlVO+e9YS6o8xwjKAev1qhf3O3oDJMfuL6+9WoEtpF7Utc2LiNd5P3QTtH+NchrV+8pRbuR7maUhY4lX5QT2C+v5mrrwXVxI62qCW4b7zscIn1PoO9dP4J8Ayasy3zXEsVnK5j+3suJZh/ELVT9xeo848/wB0d6mtWhh43kOnTnXdorQ4CztnOpMjoLm/hPyW0K+asD+rkcbx2TnB69MV0uj/AA/vtT1G3GrZtba4nUS723SlM5dj7kDH417NDo+kaBaJa6XaRWkMS7VjQYA9/Un3PNQ2AZ9XtLgAuqSgkHpt714NbFSqyuz2KeHjThZHdQ+bIoNvamOIAKg4ACjgD8qf9mumx8qZ92zV+HGDjp2qxGOM1i5GZknTpsfe/ADrVy1sTbQN5LAXD9ZHG7Ht24q5uFG4YB7GlcZn/wBml5mkluHlcoV+boufQdBVwwLlGYksq7cjvmpAxzwMD1NRy/NtB5yaNFsF2wf5BkE4+maAytHjIKkY4p5+hppjBOR8rdyB1HvSvqBEsTbQC4Zh7YzQUwecfhTiSJSgGfSnbT6ce1CAjAPQVXuxJCDKjlcDJ75/DvVtjt9x/Kq96QYuvHrVIRkW/ieGK5Ntqkf2V92BMDmFvQk9V/Hj3q7faDpOofvJrGDzSP8AWIux/wDvoVx2rxu2oOFjLqVB49Ohp+kaxPo3yXEV01oeFjZflX3Ru3+6ePpTUu5pyaXiQeKfh7YSqbnfsbhPN6Sc9ASOGH1wa8617wJqNvHNHEYbmBhgpIPlkHpjt9RyK+grDULTU7YvBLHNEflbjof7rDsfrVe50ZMH7KQFP/LNuRj0B7fSr5mSn0kfH+r6N9lzDrNmWjztS5YgPH6Bn7/7351Ttp9b0zzH0vVb2aGEgPBN85UEcblbPPowOG7c8V9Q614at7yN1kiQHoylc49iK8i8S/DufTLsXmi3RsZlBAUqXiZT/CV7Ke4HHcYrshilJWnv3/r+vzMJ4Z3vT+45fSfFmpSvEBBZ3QljMkMsbGLzQOGU9QGHpW7beObKJvL1S0vLY9CyqJFHPXIP9K4vVIbu1vJ0+wiy1CL/AE17UPujmK/engb+IEcOnXHPUGt2W0tdc02C8gI2yrnPXB7qfoeK9ClUjUVk9TjnBwep6FJtdd0Tbl9R3rNv0GN/RxyGrC8L6lNabdPvixMYxHIR99B0B9x0+ldLeRiWD5SCrcj3rVaMzkuotrN5iAt0P5GnsD908kdKxbOdoZzHnK56GttXDqGX7vQU5KzEncicbl46+9NmUtACnyug4+ncVI4w24HPqDSqeRt49frSAZYwvfOyxo3ykea6jhM/1NddDAIo1RBiMcKD1H41S0LyP7PiS2Xy9jFXjU8b+ufxrTVj789BivlsxxM6tVwloo9P1+Z9NgMNCnSU46t9f0+X9djE1mziFleSwxKPtLiW4I4ywGN+Ox9fzrySYwaJrl39pDAzmOIMo+VEJJ3n6HAr3PaEUk4ZfQ9Pce9eZfELw0sqedbklo1Zo1Yf6yPqUz/eXqPWqwmI5/cn/SMcXh+R+0h/TOw+GeumyvDaXDkRONvqdvt7g8/SvV3AEmNqM/QYQyN/hXzT4duJ4LGxmmdRPGMhwchkX7pPvt617x4S1ZdU0tYizbkTKgSFdyehI9D+lW9JWMmrpSN+VnVSJN4HpLKIVP4DmooSr5MOz6wQl8e+5qThX2xKm/PKwW5kP/fTdKSUuDm6Lbeubq6C+33F/lTMx82FO24ZmB4InuAPw2LTYizj9yHI9YLfAP8AwJqRBkZtcjt/o1uMn23t/OkkUFwLllZjwPtFxvJ99i/yoAqauHjxOh77ZAX3MPfj8jSW8+4ANz6VoAfLsAJjI2lVQKCPqaxHjMFw8QPCnj1x2rSD6Es1JJNylF71zuo6e5u3NuwVTyQR371rxSZIyKWVFdgcdqtpPRivYukcc4B61XkPB9c4NWm6+1V5On1NSUR9h6UZG78KTPzDge1Ixy3qKQEjnhsfhWVe4D46DpWgzfKQf0rPuQWPIGSfypoDNbKNkcn6VE1rD/aUl55KLeSxJBJPj5miTlVPoM/09KnmYKRxgkZ9vrSAfKPmxyMVxYuv/wAu4/M78HQ19pL5EyfLgAg5OTinA7VPXbu4CjNInzJ0wPUnig/Jg56ZwF4rzj0WyCQB9ySYkTBVkYcPnqDXOtpsGm3kz20jusqgKjcmIdwG7g1vyuFYBQF6bjntXO3WpWj6oLQ3SC6k3eVExw0gXrj1wO1evlCn7R2eltf0PLzXlVNXWvT9SGX522j5sVQ1SUWVuoGHupDtQdQPU4/lWiziNWY7dijjHc+lYVyTNexzSbuRt619LFXPnmadnuFseck8k+tQT/K2D9cVbH7uEAHgDj0/CsydWdiS4Vd1NbiY1SfmO7jOSTUtvhRk8jrUUaruzuBHrirsKAqSvIHqOKbYiWFCSGbHqBmpwQAecnvUWc9Dk5xzVO8ugkZVDz+tRa5SH3t4A6jAOOcVA81lIo3Kwc8YVc81kC83sQnKnq45GfT3P0q1BDJKM4ZFPUnrV8tgumWm0m1DiTykyejq5H6VS+yb5zFbIVLEb5SMnk4AHuTwK0dQ1HTtD0+ObU7hbS3IJQfekcjrsTqx/T3q/wCA9N1jxHqlvrM1hPpmgWx32UFwAJbpiP8AWyDsPQf/AK65sRi1RXdm1DDOq/I0tB+G9+8wOqz6emmoMrp6s8pkfP3pXAAP+6OB0969B/s6VgBNqMmxQFCwxLEoAGMDqQMVdt0laNY2O1VyfTI7CpUtBnLEk14VSpKpLmk9T1oRUFyoxv7IsIyxjRmYD7zMST+dPhgjjkGFC8Y49a2/KQA/LzVaVNuSFHA45rJstM2LbJhQ9yo/lU8XIIqGHhFSPlsAfSrKKEUAf/rqzmY0pu6k49qf+FFAyc+lCQg/WggAZI6U7pTHYDAIzk4qrWAcSOho6UhzntimBShG3O3uPSlzBYkprD8/akBO4r3FOPQ0gIyD3w1UNRjbyXEZIbGRWkahuOI2OOgzTQHHsqzEtjkLkeozTYI5wMqxMZH3c9++asTQpDcTRxkBDzH7qT0/A0WwcEgJtPqKTNo7FdIHt7j7Ra5guMY3KPvj0I6EfWt/SNW+0n7PcoIblTjbn5XHqp/oarZYLh1yar3FqrhjFtwxyVP+NCk0NxUtzX1llSOKZgzANsOxcnmsiaC2voWUFJQO3cfh1qVrqZ7Fobgs2MbZMfMCOzDv9aoJJHIwLAEg9e4+hob6oIxaVmcf4n8MWjBIr63SfTDIHBYc2z9nUjlT7j8a8ilVNG8Q6nFZwTwaQLgLNbzMGNszcRzKw6xSHgH+FvlPOCfpzZvUFWVlPVX5BHp/+uvIvid4duFUahY26x31vvMcci5SaNvvwN/ejccdeDgjBrWnXlRkpImdJVk11OUlt0myrqQQeGBwQfY1d0q+ktpVtL1vkkOI5QOM/wBDWLol1BPY281s00mmzMY4JJTl4JAMtbS/9NFHQ/xrhuu4DWlhSVSrkbSOp9fX6178KkaseaJ5Li4vlY3XUNtOJkyCeDWppE4lt1I5AWq1/GbjTcEl3VR8x7+9UvC0jeYyZJjwc+xFa7xMdpWOjG3kHP41EylGyOnpUpbueoo+8DntUFE+mXIt7tWY/uZMJICcY54b8DXR7ixYMeVyDjqPwrkgOCMcHrXQafd+faJvJM6ny3IHUjofxH8q8LOcPe1ePo/0/wAvuPbyjEb0H6r9f8/vNJcspBUrjuelVruBZ42ST5TnIKjGw9mH0qeLcychsYwQ3Xg04rhB29AK8NSad0exKKaszyae1bStYksmXbbzs0lt6K45ki+n8S+xNdd4O1WTTr2NlfAznBPBPofY9KteK9HTVdPcK3l3KENFKFyUdTlW/A8H2JFcnYTGZQXTy5d3lSxf3HB5X6dx7EV3qanHmR5zpuD5GfQgZbm3VlJeKRQw+Ygc/ShbXYQYSkPukKk5+rZrkvDurSRIsTtuwABmt2XU5DnaQK1i7nLKNmackCuCJnkfP/PSQn+WKYGt7YfII07/ACqBWJJdSOeXPPpULSep59TVE2NiW/iU/Lg/WsiSUyzTSE5ycCoi465H4VC0wA2oNz88CrhuKRa80Ix+uetXI33LmsyG3clZJsZ9BVvDDgHFXuSa7Eg4zxULknHFPc8DJzUb9eOlSUREHnPbvTWI5wT7ZpXPqfzqEnGexI70DHFsnjj61Qu5ljIJJAOc8ZqwzhFLHovqOSfQVh6hdTO3lwYUg7pBt+UegzWVWoqcbmtKm6krDGme5uHwq9M+w9BVxVyScdhxVexjVeV3Et8zF/X6VNI7QorMgLnOBnj6mvIk23dnsxjtFE6oAAFCBevrTJBtDAEYA9OQOueabHOXDkxhUAH4t7e1FwcDAwMYIz296EVbUzNQvVtbW7nOGEMZcnHtxxXh+vX8tyHmjLLJbsJop0+8jg5BB9a9e158Wt7AM7nhZdw9f8a8xubeFpoYZlCozZx03YGefyr6LJ4r2Un5/oeDmzaqRXl+p3l2ZJ7L5pMTMiuzPHtxkDPA6HOenFVfLDNAIni8sDlmkAx7YPNRaPeLc6Pp/wBouIvtjQjzEeQB8j1/Q1oTJKq/JFLhuNwXP617Ceh5DQXcoKMInVlAAXay5/U1lMGMm3bhuuGZcY+uasyo6AkWzEgddnOKqGKZgQtq5BPTZ1NUtAtcsxsit80kKd8tIvT8Ksrd2gG03lse5Ak/+tWQIXzuMW0+hGMVDLIkbEtJCp9PNVf0zSY+U2p7qMRt9mlt5JQDhfO2AfiRXOzQz3T+Zd3NsIs48iLzGP4nABH0NNbULZRze2oAGTiTJ+vHWsweK9JkcrazXN4RxugtyIz9GbH8qh1lT1bsUqXPodRazWcMWUhllYdBgRj8OuKh1bxK2lwxDyQJ522W9rbLvlmftgnoPeudbxA6quy0ZZZPliTPmOzdhgcV3PgLwlJb6gl/qREuvXSZYk7vsqH+FfQ46n8BXFWxsUrx1Oung3f3tDS+HXw9e91K48ReNRFfanKUVLdeYbZF5EQ/vc4z24xzya9hc5wXI49OAKgto47a3WJMLGg/KkX9+STxF2B4LfX2ryJScndneklotiZD5g+Q/L3NWFwEAHWox6HH0pxb9OtSJg/T39BVZ8vcRxr97hm46elPll2ADaDK33U7fU+1T2EGxizNukblj6mmiW7I0oIxGgHepDQOlBqzERs4460iZC4PJpaDUgJgk5P5UMOQe4PWlAOc9vSkkOMAd6pLuAuD3OaWmb+vY0oJPBx7GloAxo8yh8njoKfzikDA59utLnIpDEFV7tsI3pjmrNVbn5kcexqhGHIimbLk4TJOO/tT7cr5YLgbvVeoqAEyDce3GPcVKGK4baR9DRc0SLRyVOACKT5OhGCecEdKRJQ6jbg/TjFJIWAXaRjqcigBTtzgjPY1SurGOQbonMbfwmrJ5zlSMc8HNRbiAT1X2GcVLRpFlBZZrOZUuAOeePuv9D6+1UPEEgu5DC4LWgj2qvru+8fr/hW/8k0YUhWQnBUj+dZmsacsUElxbv8Au413yRSH7o9VbuPY1nK9tDSDXNqfMviSH/hC/GF611BLcaLf4S+ihbaxx80c8fYSL95T67h0JrpoHAj2zTxXH7pZobqMYju4jwJUHbnhl6q3HpW38XdGS/0WK7X/AFsTLEx9iSUJ+jZH415H4X8QrossWnak0qaWsxmhuIo/Ml06UjDMqn78TdHj7jkEECu/BYnkWpyYyjrdHppacR5jG0Fdo3Dn8BT9EsjYWqo2C4J79fc1BHqJlkCzJALgIG3QyF4pEP3ZI2P3kbsevUHBBFXIpdwznryK92M1KN47HlOLT13NLOenbpnvSdGGCfWoLdgU5zkHGD3qfkfNnJNIQ885HfHbvVrS5Nl6qMTsmGwjPfqp/p+NUQ3A7inEHrnBByCOxrKtSVWm6b6mlGo6U1NdDq4zubuF9u9WM8EnHXOAegrJs5RKFdh94nK54zWpDyhYY2YxgV8XKLi2nuj7BSTSa2IpI3DgxHHrkfzrltU0cx62uoWUYcSYNxBu2liB8rKehYdMHqDXYOrKNucuT06AVUuYw2AxPTkAdPcU4TcGRUp868yro8qTy5gcFlPzIflZT6EHkGt2S4ih4mljjPozDP5etZUFvZtIj3kYa4AxlujD29/Y/hW5ZzWsAAtLdFOe0YGfx616dNKSumeTVTi7NEMcjTEeRDdTA/xJGQv5tipJra7VQdkEOf8AnrJuP/jorSWSeYfM+wevcVIkUakNjcf7zda25UY3ZjQ6dcytue4Yj/YTYv19TWlb2CQAiJcHqSe9XN+T2zTfmZs9j0qkrCuMEQPp9KYYt3IdR+FShfl7k0ogGBwaYhHbAO786haQbyAwHenTlWB3HiqEpJkyD+lQWidnGM7s1EZTkgH2qH5hk5GAfyqKV1WJ2PAXk49KluxSRFqM8oibyyAAehzk+2Kz4dzHLnccZJI6+9MQPcMGkZtvJCtkAZ9B1q6iY5YADHpg15WIrc8rLY9bDUeSN5bk0QyMqTuPfFK0SSJ5cihuQQPf1zTEXchAYqevsPp7Ux337cFio/ya5zqSH4CR4RUVF+6gP61XlPU5xtOcen40rOQy7sDPfrVa6kby3K4DkDaWXIPuaopamH4h3LIgydjKwI7Hj+dcFY2j3d9dXCjcsKeUj/eBdiMqv/Ac5PbpXbeJ5VX7IZGbYspdmXuoU5rmtPDC0g3J5DpHvKDom/kL9duPzNfS5P8AwZev6I+ezdfvY+n6sg1S4js9Pu7mW3j823iPlgp/EeF/U/pXn5ja2hASacOerLKwLH1611vi+8leOwshlpJ3M2wcllXhce24n8qzBprqU8xTJcn7sa84/GvZUb7njSlZmJBc6jGwjXUtQUDkqLh8D261oWxuppE8+7vHABJ3XDn+tdHZ6CsMLtPgv3x696d/ZwjzjHJH4VHIk9ClexgRwKZSm0lR1O4nNWUtoQAfKjGewUH+daX2QIWzjn061UuWEa9SDj0pN2HGJh+JLryNPeKNsSTERJjjBPX9M1HolphF2rwAMAdh2FZ1251LxAkKfMtuNuP9s9fyGBXp/hXRVhiSadBn+EH+ZrxMZWvP0PXwdHS5a8E6SbPUYb+a3NxcENFb2+OWYjr7fX0r2Lw9p/2C3aS6kSS8k+a4m/hz/dHsOgrnvC1jPJdJcQx7mTPJO0BTxyfQ13VrarFtaVvMkXp2Vf8AdH9TzXCpuW511Uk7D0DTYLKVhHIUjl/c/wBBVpeAKjJxwx5PbqTSlo+F5bPUD/GnuYsd5yq2CeOvqfyprPK/3V2D1bkj8Ka06r91MDucU4ykfj7VSsQ7jokWPceWdurNyT+NX7bGOKoKwBxn8au2nUc9apEM0R0ooHSg0zMSkU7m74FLRgCkAjOAOOagbe5BJwM5x0qxSEAgk9KTTY07C0i570pPGetLVCGbBvJGRn0NLgjvn60tLSsAwngnFQOQeM9atVDMme1MDmbfgN5pAIcjAGe9WQqkEKcD2qsV2STruztkORnFTCMbQSCBjvzSNhwiGeevTjinBTztYkd80Ko43MfpSlWIxnOO+eR/jQBG4aMZycY6n+RqF5WXJKkZPPcCrRYgEEAg/rUDkKeBz3U8EfT/AAoBETKsnK5H+0p5qrqTyPYvDIdyblYOPY9CKsSxlm3xcN25xn/69Vp5j5UqTDa2wgPjrUSV0aRdmjl9Vs0vLK5s5sbZlKZHY9j+eDXzL4xsmtb+QMCr554xhs4P8q+pZwu0HAAI29e9eEfHeyFnq9jOFAW+VmP++hGf0INRQl71jXEx9xs5jwdrht0+x3xmfTEyUaIbpbF2OS8QPDKSMvF0bqMNg13iXpt5Iob2SNTOu6GeNt0Nwp6NG/cH0PIPBANeb+FLYy297Io489V/Jf8A69a9vfNp7TWs1st7pM7h7iwkbarN08yNv+Wco7OOvRgRXuYfnpw546+R41Tlk7M9MtJ8nk5ccHn8s1cQnPJyD39K88sr2XTbd77T7mbVdBiwszsoW7sN3QTx/wB3sGBKnse1dZpOrRXcCujpJCeFljJ+b2PoR6da7adWNRaHPODibZGAM9+eKcpw2Mc9QPao0cMDg5x1HTFSA9z1qyDQ0yUrvXeQi/MB3xnmt2B8ccYOO/AFctBJ5ciN1x29R3rctJiAA2NnJAA5r5nNaHs63Otpfn1Ppcrq+0o8r3j+XT+vI1pHxuUdFAyaiKn5uc8YzTWcOjfMMZ449f60gJVVONw7cHj/AOtXks9JkbcjB6fTr9PSrem3JWURuRvPC5O0N+J71A8iYIJZQecYyRUbqJGbeRtI5Q/1rSlVlSd0ZVaMaqszpoplbAz8+OVzyKso3K8gjNcha6k1lIEl3ND2GeVHfB7iuhsLuO7jDwSJKnqnb2I6g16tGvGqtNzyK2HnRfvbGiV3dPwzUijA6e3XpUUTMVG7qamVsqcc5rYwHY6+3OKB9aajbu/OKUnacYz9aBGZOwI6nGcmqpcEt1wPappDyDjgnk1Ulb5T8wGT97sPr7VDNENeRV27yMN/EePzrLunF2WCDEQG3/fAPp6U25mllBRXPlE4zgDP/wBaoj5ihcBQvcZI3fQnpXmYnE392B6mFwtvfnuWY87N/wAwbqVPrSmU+YAWU7hzkEH/AD70yO5RlLSAhmbAYjGfaobhnEjZYZ+8o64964kd9u5YMuxvnzs4OOmfSopLjcSiu3UNweB7YqqkhJIfOSDg/wB4elQmUvhQQWzg89PpVoLF2Rt4HOFB+70FRtMNxJ59jxUQlDEbv4uMdqhkkXOT945B75qkO1jH8UMI005peYvtqpIQM4Uq2PzOBWRbK1xFE5xvuCGBBz16cdvpW1rkSXVnPbuxZZBjPuOh/A4NcOmpSx+BJL+NvLu1ge1DDnbMXKc+4Bz+Ve/lNVRhKD9Tws2p3lGfyL+kWI1SS71rcAtzIba1I52wRnaCD23MGJrZttNjhZmUZbpuI/zxXkWg69qHhxR/ZcwNsTiW0l+aKQjg+6Mf7wrvoteXVbBL3T5n+zvlWjbhoXHVG9x69xzXrUq6kuXqeK4dTbvpoYAIzNGrk8AsOazpHQDI+Ze+3kVy1/KXY78N355/Gsy0uvJvkeN3i3cEoccVbkUkdbdTEc5/PvXOaxfCCGa4k5SNd2B39B+JwK0Lq4bacnORjOMZrjfEt0Hnjt8nYg8+T0z/AAj+Zrnr1OSNzWnG7N/4Z6S0xkvZ8H94VGf4m6sfwzivaNHsxNKFOdo5PHWuQ8Dab9m0SwiKDd5Qc+7N8xP616lpFqsUYOPmPf1r5urPmke9Sh7OCRtaHGIJuBjchUn9a2lJIJHyj1xyfoKoaWkboXKkyK2MHoM9DjvWgzqp+bl/7oqobGNR3kOUfKVjGB355/GnRcthMue2KYFdlOTtB5KjqfxqVHCLxgKBk1aMmyQKMZZkx14Gc1EegPtgUwSeYx2Zx6kf5xT44T7k9yasgVeMjirVk2Wx3qIouMsRip7VNzDYpOO/ahEtmjS0g6e9FXZmQvWkz6CkJAozRyhcQhiwzgLSsCeM4FGc0U0guKRkYzR+NHuDmiiyAKPyo4ooshXDJppJ6cYpaKdkBg3djOs1xIsLSB5NwKPyOPSmQxsGKszDj+IEYroTSMMjB5FS4FqoYZiGOrevAzTcAZO5s+mOla8lrFJyUwT3U4P6VWlsQTlJHUj1GaOXsUpozyc8ZJxxyKikQsOo46cc1bltJ1yVUOuP4Tn9KqSSsoG8ZI9sEfhU7FJ32K53IdwTevRgDz9RSwyI5OcOAMsCOo+lSB1fcFAIPODUMkURkDcqwJxg9KCjnpVDI5HIxvXPbB6f0rzH486eLvwKuoIv73S7tJWOOfLkGxx+eyvVLlBb3ktqW3BQCHxjAIyFJ9RWF4o0wat4e1nTG/5e7KWMf7wG5T/30orlg+WR2T9+Dt1R4F4NtTBo8plwXe4Z9vXZ8o4qe+tQ07OucEcg1B4TeSayfcdpkVJ14/ixhga0J4pmJ3K2c/ga+pw9vZo+cq35zJtpLrTb6O80+4ktLuMFVlTB+U9VIPDKe6kEGtKyxfagJtDe20bXJCP9BY4sdQb0jLH9057IxwT91hwtL9nJyGTA75FQz6Ss6FFGQ4wUYZVqcqCfvR0YKp0ex1Xh3xIt3eS2F9BJY6rbsVnspgVdSOuM9cfmO9dQG4GDnvXk0mp2t5Lb2viU3DLAPKtdZtebuyK/d3f894h6H5wPunjFdSPE0+jzW+neJRbpcyp5ltqVuwazv4j0kRu3uOMHqFPFTCvryVNGEqd1eJ2ikZJHP9a0rKTfHHuBDrkFv8+1c1a6pHLtLYCnoQevvWzYz4cbGBD8fWsMxoe2ou261OvL63sayvs9Dat5XKbWyCPxAxUxLYLbuAoIPqPWs+3k8w9wcg8jirEzskbPEobGFIPH4Cvk2j6lkudwXjochiOPpSSyrGCA5Zienv6VXmlaNFUvtbuR/CvsKiikdyGACJjCg9fxqWNa6ll08zG8LvJxk9AcVEq3FtN50CmKcjazRncSPegO8cgaQHZnBwBge/rUq3Cb1Qlz2BA7/hUqTTuglFSVjVsPEAVtl7iJuBuIwp/PpXSW8m8Bl6HkZriJ2O3BDFT8vzEFT/hSW2p3Wk5WJmNqpJaBj0z6E9P5V6NHGdJnmV8D1pnoC4BPTn+dPznvWRpWq2+oQh4ZCH7rINpzWmm4jNeimmro8xpp2ZhzSiNC/GFBPqQKwrm5e7bDfLCOTz94/h2pZ5zcT/KWKrx0yG9h7e1IySlAZA2wZOAApx6/SvKxOJ5vdjsethsNy+/LccqhVWTaNhJGzbkkeoz1FQ+Y25mVF2jjJAYk/wAhipo0DfvBG7HGSp+br3HccdhUEuEDSFdyk4BxjJ/x9q4Wz0YxGSS4G1zlQck9fyqu7AKI9zsu4suDjr2z29qW63K/ll3CquW6ZJ/pVcbWCnLKuScdR9femixznKkB+QcbSORTYZN+M7QSOnSql3JukULgMj7n56r6ip7dCQq7RhwX4/hFWSifft68v3ANV2faWyCD2Lcc1IzYIBbIGFGKpXEnyFkb5cHdn1FNIp2W5TvpSclSAvXJHFeW3lxJbvrmlYPkTXEF4ozwPvBvz+U/hXeaveBVbJ+vGM/hXmXiKRrzXTbW0gjnngWJ2x90b9xP4KP1r1MA3GaZ5GZJOmZtrby6ndTxQOsdvHhprhvuoPQerHsK0bBk0K73Q7zav8s4JyWHZj7jr9Miut0vTdLj0FrexmSe3fMUu3qrDrnP8XfPeuZ1C3ktpjbXfzNj5ZO0i+o9/UV7ioKEeZb9z5/nu7F69cbSVIII6qchh2P0rDM/lzIxxhSMg9MVNZzEW7W8h5j/ANWf9jt+VZt0CVI9RioqVbJNDSudbcsPLXLcHOSew9T+FcfYRnWtaRVBAvLhVHtH/wDsj9a1NTunm8Lh4j88tuAT7Zw36A1d+GdsJtT+0AHZBEcDH8TfKPyGa5sbU7HVhYczSZ7d4btgXjC/dxxjsO36V28CYUAenHtXPeHYAsAbAxtxkV0kQ4JwSfSvCe57jNSwUi3aQN5aMdgI6tj0q7DHgZC7R71FYpGlvFJv80kblIGAueuB/WrQDMV6rngAdTW8VZJHFN3bYq4yDnJB6dqbP5asfMO2PqEH3m/wFVLy+htc7WVn6Bv4QfQepqO102/1FvMfNvCeskg+dh7L/U1d+iIt1eg6fVFhHyBI0+6MnvViwi1G+YMQ1vB/fcYY/wC6v9TWpp+j2VkyvHFvmHPmyfM/59vwrQJGauMH1MpVFtEhhtIYgMJuP95uSamJAGBSHmgLWple4u6kwe9OAo7UCEx70o4FHel60AFFIODS0AJRQTxwKTNAC0lBpKAFpM0UuaAEzxR9KAPSg470wCkJx70poFACEA9ajlhWRcOAR7jNS+tJnmgDLn0uJzlC6H2ORWfPZXMRYhPPTrlfvCukppAbqM4796lxTKU2jzm7UfbLmUMzb5Nz5PRunPof04quGxLGytjY2cdzg9K7vWNFg1La7l45k+7MmN2O6t2YfX8K5nVNAvrbdLb4vBlciNdrrzydp68ehz7GuOdKUXdao9ClXhJJN2Z80ajp7aJ4m1GyKlorW7eMbf8Anmx3Kfphh+VaWfIjkedgsMY57/QD1rqviJpWNRi1eBSY7tBbynadyTICFLf7yj8xXnHiW/V50gjZREgDMq/xSY5P0FfRYaop0lP+rni14OE3FlqK/e4vtysVQfKEHQ+3/wBeotb1ExYtrbn/AJ7yqeFH9xff1P4VT0e4j+0Z8ufkH5lXcBnufQe9NY4kkZQHiLHaD0x7e1dMfeVzCWjKd9DtiZox8hIdSP4SO1bmhzWV1pDaTrMpj0edt5kC7zYzfw3MY7DPEij7yEnqBWXMjNEVRAoPoc5+lTaBCs0/kGTym6I/off2qZQUnZ9QTa1RGLfVfDt5Pan5Jrdts0Gd8bAjIdD/AHWBDKw4INdPoHiqCMIL0m39Gf8A1Z+jdvoahuIbg2BtbpALzSYC8ZBJ86wzyAf4hCxyO4RyP4a5yON7m6WKID5zjnp9aqmtLdUJ7+R7jb3QaGOVDuUgMSMHrVme4DBHBKhvuKTz759PrXF+HYY9KsFtYg5jB8wKTkNJ2AHYe3rXQxCUqD8hcnJLH5vf6fSvksXTjTrSjDZP+v8AI+vwk5VKMZT3aLUSM8pYcDoB2P1q2u7JwO/4GqMbkHbncTzwMAmrttIzJ+9RQzDGM8GuNnUyTCxkgbk6EnGf06/jUikShQjptPAZGwM9xUUQUYaMtk/ebOc/T8qkcseQQFPIPAJPr71LCwhijIKsroMnJDfp70iwgJsCqUboRx+VSbyVZWKLkYAA5x9aYYN3zFirbRlScgfSkDRWdJ7ST7RbhVZAPlydrezD+VdRp/iWze1U3DtDKOCnBrm5mBPlycNwQ248/wCNZ1xbS+adnkEf9NAQf0rqo4h09OhyV8KquvU6CPP7pN/lZ5ICdR6egqV4I3QpKpJTqu44HfNRx4kGw7dhyAeSCO/0NO+QIqwgBAM/e4Ge1crZ0pWHeaFY7pNj/e4xz9KqTuVRxGwIQ7myOG+n+c0kqqu9iAxBwgHXH/1qbKMqyxodrYLEnHPYn1pFpFRVVj2aXqxPb8ajlUCNx9xc/wDfX19qtPs2xwkbO7Ad/U1UlBcLtUHtx0A7H34qkMqOMlSx2EHAI5LD/CnLIAjKF+6cDPG6oZ8QkZ3KuDz3I9faoJmLbgCRuq0O1i1LKBujbqBkbu4/xrJ1G5CDaOvUHPFMu7j5AiSMJE5DdiRXPanfBEeaRhEijeWPYe9a04XZnUkoq5m+JNWFlayTz5CpwqHqzHoBXDaVZ6jql293DthQkl7mUHbz12jq3pxxWxNGNRuhd6ghKj/UwSciJfcdNx6n8qs3GoMY9keQo4r38LhOVc0z5nGYr2srR2JdCC6dDepFM8pMqO7OAMnaRwB0q3d39pcR+VeFCue/X/61Z/hi2hvn1BLmWSPYUnxnClcFTk9sVflv7G0+SyRJj/eRePzPWvThbl8jz92Yd5pzhkm0y6inVM4DHDD1U9jxVY4IK3UAgYfxc7f1rTubuW4I3IFUdAoqEtIRgqxHpiueVON9DRbGbcow002w6LkLj+JScius+EgX7PfW+7Esd0jMO5RhkfqDWFJbNcqI2t1fcehHA9/aui+HtnHZeOUgt3Yw3lpJvjY52vHhgR+tcWKoy5XLojrwlRRqJHvekxBIEA9B0rZQBcZ6/wCeao2iiOOMtgcdz1rcsNJvLtQyr5ER58yVeT9F6nj1xXipOTsj2ZSUVeRoK9vaWg3SbYlz+8cDn6CiG3vtRXKqbO2cffk/1rj02/wite0sILWKJQpkeNcCSTlv/rVbzXaqfc8yVXsZ+n6TaWWHRPMmH/LWTlvw9PwrQJ/Ok/CjGK0SS2MW3LVhQB3PWl4xRTEH0opDzS0ABxQOM4pKKAHZ4o6UwnA4oznpQA4HnmlGBnH1pvSk3Ad6AH96KQEY4paACkIpaKAE78Unrz9aWigAHejsaM0GgApPaik5pgOIzTCfWnUjjIoAO1JTVPY07PJoEI3FJIgcAGndaWgZyvivwxZ+INPvLad3tbieMqLmMAlWH3XI6MVPI6Gvk/xN4L1XwZdOPF0TRWoJ2X0AMkNz7I3Zj/dbB/CvtWRQ+QfWqGo6dbajYz2N9bQ3VpOu2W3nQPHIPcGtKU/Zu6JmudanxSs0t3AILS2Me7nyl6D03t3Pt0roIdP2WkUZOXReWx1Nem+MfhO+ll7zwdFLcWQBaTSWbMkQ9YGP3h/sMc+h7V53BcxktsYlVba6MpVlPdWU8qfrXr0KsZq6Zx1INaMz5rI4LAcenrWdZoY9QjPIzzj0FdhFLA4w4XJ7YqtPpsTMZYcCQeh4rdpPVGcbou3GnStDb6jo5J1KxYyxQOdyXAxhoj6b1LDHcN9K5vRoLW38QE2jl9La1+1QM33hCckK3+0pDRn3X3rstLDW0EcZYs45LDjJ9ayfGNrHZ6Ne6nbKFdpVWUKMARyt+8b/AL7CsfTc3rWNVun+8XbX9DSCUvcff/hzT8MATRfbpjlpR8iDJVT1JrYuZpEUtCoL5C7ScZBPPNYmh3IFlCqEeWABn19f1rTB3bwrncDjB5FfIVE27s+xpNJWL0Mkci7QXYZwBnHHrWlCx2Kp3MB0U9fqDWRbcHbj5sdRxn/69aEbZ+YMeBgkisGjZamkPmUE5BHp/EO341IrZZvJYEqe/IBNV4ySFDNgE4yvGPanyeXEjOoABPODkP8AWosKw6bdFINxyNvLgYX/ABFIwSUeYrOhP8DpyD357g1NCzSQn5wR0TIycehP8qZgHHykgrkkHPSk0CZFsMsW14t8R+X2J9cdqgeCTdiNnKjgcirWGkVdkwEx5DdCQPWm7J1LfOcsdxxyAfagZeLYMYIcFlyN3Bx3ximzRDByNrKAwKnkg9iO9NDNGjfM6q/Uu2QOP5VGkZkQ7nYs3QIfuJnOAf8AGoGlYbcH96oVNg4PH8RHb6+1EqhuJFO7Odp6/U+lOkKSBg3yKTgKSCSPU1BtVZZRGsijH3t2Qx9RTQXIGYGPDcjG33OfvE1Wccjy9uFypx6/1qc4+0RlVxGi45P8WeBUT43425Kk444OeTmrSGmUJgpZygLPgfNnOPp7VnXLYGzaDjB3Vp3JB+4uQVwo7nmsO9cEPG2MEYI9cVrCNyJTsZ2oSKyEA5UjAwOn0rjNVu/tMyru3RxHj0Z/X8O1dTcK1xIYBjbja4HGF9PxrA1fQXsYmubYSPZL96Pq0Pvn+JffqO9etgoRUry+R42YVZOPLHbqY4y5xkmrdraGRWfG2FOWk/oPU1o6NpC3sInJR4jkhImDH33EHj6Vr3KRJbNDgBiuEUele/CPVnhSZz8PkwxLOkHm27ApNGx5deuc+o61sR2sVzGGtZAVPbGD+VYls/lCa3dfl3dD61a0Wynu2dI7sQPCQDtGXIPQj27ZrVamb0LDWM/9zPqCcVF9jkxkjHtV03Utxqi6ZpMdzqV6Pl8q2jMkkhHfA6AdycCvS/DPwf17UGSfxNew6TbHlra0Ilucehk+4v4BvrWFStTp/EzSMJS2PJp4njeK2t4Zp72dtsVvAhklc+yjk/yr0j4V/CTxGfEtjr/iAJpFpbB9lqxElxNuUr8wGVQc56k8dK9v8KeEdD8KQSJodgkEko/ezsS80vuznk/TpW+SB1NeZiMQ6ui2OulD2evUoabotjp7B4Yt03/PWU72/Anp+FaJP51GX9KQZNcqilojWUnJ3kyQtzilz61H0FBJOMUyR+aCfXpTe3PNJ1HNADi2ATngUZ/Gmg/SjJ9KAH7qUHimFSRz0oTqRnmgB5OKbknpSlT14ooATHr+VJkj6UvsaRio5JAoAbnJ9qackdx9KkXB4AJp2zP3hjPvQBEOT8vH8jUydOfzpDGD0ODSgYoAUnngUmaDmgg0wAGjNNINAUmgBd3NGaMc9eKMGgBcik60YwKXFACcClzkUY4pvT6UAI69x1pA3rSk00jOKBC96kqENjrUp6fhQMj980hHBBoGfwozgUwGOoIwa5Hxv4B0nxWvnXcbW2pouItQt8LMnoG7SL/st74xXYEZHIBB9aQ8nBppuLuhNJ6M+T/GfhnWPBjltdhBsd+2LUbZC0Emem7vE3s3HoTXOfbb11IseJM8b13bh3AHrX2fcQpNDJFKiSQyKUkjkUMrqeCCDwRXjHjD4C6DfXDXHhu4m0W4Ylvs+5pLVvXCghk59DgeldcMW9pGToroeGv4kvbOa3iYec8sgQKjbGGe+D/Ktyx8aWcbG31yCY2U2YZyqBxsYEHIHt3xVPxX4H1fwrrlvBqVsseEaW3vi3m28rjgKjEA7jz8rc/XrWBdwrKds2IJFHzNglD6Z7rWrrzUXLp96IVNN2Oi8J3TQW/2SRiTC5jBY5yB90591KmuvinDOA54IyM9fzrzTTLj7Nc29vc5R3YLFITkP/dUn+R7jiu5Z8qG6t05PArwq0dT6HDTvBeR0ULjKu3zMCSM1o2rjeCAwTuMc/Q1z1hOPJ+Xrjv6961rKXDDJI5yOe3pXJKJ2QkbqEsV3cxnrzjn1qxHhA5fLcZGOo+hrMhlO3bySOcZzz6Ve3GWHMeQeoI7GsmjQsSuIniCy4eT+DHJFMnZUUFZGSXpkkf5NI0qIqTIu2U4HTHGefw9qkIGHBXhTu2cEc9/ek0JOwzc7KhQ4yd5bPOB1H0NNIck52nHQjnNL5TQt5isCHywGeBT47iHb95lI6qpGAfTmpsUKI1kQx4VssWbZk5HYDPemu2xRGw+RWKhw3r24psswIZWZo/4iIxkgf7PoT0pEdAij7OTtBJXdxn1J9fepSG2xhkfeomZGVl2tGIsE+hBHf2oVyFwTmVhucg/KPb2p6xK8cDbflIOQTgCoZNhMgBYMBxgcN71VhXKrSHe6hHER43+vvTSSowMEgdSO/rT7qXbtAwOgYjt9Pes+e4DfICzlTnOenuf8K0jETmRXkxJ44bb0z/OsG/nJLMByAAB6ntV28mzIRvyAuSQKx4FkupfMT5UBIUEZz711UoXOSrUsrliztdsfzMSx5Yk9a6XQrIl/MBPpWTapKGw0RJ9VGa67R0QRDBxxkk8V3wR5dRmde+DNIuiJkso7S8B3JdWf7mRT68cH3BHNcr4j0q+00phkMchwtwiYG4fwkdia9h0+1mvlBs7eS4H99B8n/fR4rRfwTFrFhPba8pjtLhdslvE/wA5GcjLj7p4/h/Ou2lX9nucdSmpHzE1jLPqv2eCOW5vJz8ltCvmTsT/ALA5A9zgV634N+DV/dxxXPiq5OmJsKGysXBmZT/fm6L9Fz/vV7D4d8M6J4atzDoWm21irD52jX55P95z8zfiTWxx2oqY2claGhEaEd5amR4X8M6N4X0/7HoOnwWUJ++Yx88h9Xc/Mx9ya2Og9KaW9Kbkk1xm44v+FN5anKn96njCigQ1U9afimluuOaaXoAfgdsfWmkj8abuJGKACaAEJ5+tOHpSbT1pdp680AKMdqcSB2pu059qftpAA5H4U0rxkdRTsUuKAGq3HNG7ccDmnbVzyM0vT2FAEflkjk4pyoo7Z+tPooAUGikH5UZoAAKGpc0E0ANpcflRkZFBPYUwEOOmeaBjsKMYoPrSAKRc85AAzxj0py8/WlPFMBtFIetBoACcVGTmn455pCtADM+1KM/0pwWlwB2oAjYYYGnMcLjvQ44GfWlI6CmIYAaT605uOTnFAAzmgBp600dSBTz0pp6+lAwPQ+tNI45paMUAU9S0+11Oyms9Qt4bq0mXEkUy7lce49fQ9a82vvhRpttaNb6Km+33Mxsrtt5yTzsl+8OwAYke9ergZIwMVHKmW5A5pqTWgdbny14g+GMM9vdf2BOVcEpJY3SnYWHUA9UYVyum6tPpl6NF8SxzWlzGu2GW4G0kdldujezj8fWvrXXvDsGqzLcRym2vQArSqM+avow7n0PUVyuu/DnSvEemtZ+ITcTJztdFRXi91OCQaiUVNam1Oq6bvE8XidoZgHyuOox1FbVtcLtBBy/qO9dND8ELrT4RDpHitp7UZ2RajaCTyx22urA/h09qydQ8A+L9ILFtOi1OBeTLpswLf9+3w35E1yTos9CnioPrYkt7k71OcEnkZ6n1rRhc7iUOCDk1ycN7tuntJzJBeR/ft7iMxyr/AMAYA1sWtznaQykZwfYY61yyjY7oyujoVfc21ssrHbyeBTHypOzOWBGB13Dpiq0Mm6PIAXjkVIkjK2ANxx1zz0yP/wBdZ2GXABAU3FAHx94/xen/ANemSBfNfkfe6EgY9qjlMbQoVBJdcAj0J6/Sp4mVo13bSwGCXXJNTYq7Qq+au0KpU9GkyGb6+49KIWJjygCgA53fxe9SOqqswkc7WZR854HoAKieLaVR8q8hw2ecL/SpRRVurhFG7zF67QADgnoOlR3hMBUM3zjkt1yewp/KspwFK8BU4x7e/FZuoSLJIRuwEGcdCDVpEyaCeUAsQfmPPzDAP/1qyby4VSQmQRznuarajqW4GNANmcAZ5JHSsdJpry+FlYwXN9fuMm3tYzLIvuwH3R9SK6IQbMKk1Faktwxucxx9z85H8quRbbdU81gueEHdj2CjqT9K7fwv8KtZurYS6xdRaQG5EMarPP8A8CP3FPsN1en+HPB2i+HB5lha77sjDXdw3mzN/wACPQey4FdsYWR5dWumzzzwj4b1a7iEn9nSW0bf8tLweVkf7v3v0Fd9Y+D7CNEbUcXcoOdpXEf029/xrpAw/H1NObmtVoc0ptkYVU2KgCoowFUYAHoBSD5WZfxH0p4Q96HTIH60ySPdQSTTglOwAcigBoQnBp4AFJn/APVRkUABbmk5/ClA54FBHPOKBDR70u32p/ApRQA0KBTscj2pNwzxkn2o5PtSAUnH1oyT0pQAB70Dp7UAGTSjPc/lRRQAd6WkFLQAUA0lHcUALn/69APNIetJmgBc0UlAzQAueaM03PzdDR6daYDqO1Nzg0ufWgBaKTiloAKCTjH86KKAEOcdKQE45HP1paKAEDZ7c0ZOPu0vOfakNABnsRQGHejHSkx9KAHEZHtTScHkcUm30JFIQe3PvQA5gGU4qND2NPBAwDwaaylRkcj2pgOHtSFSTTQcYxSqxOQelADcdKFGM8CnsADweabzyaAHKKYeetPBwKbt/OgBuDmmyJuGSMH1qTp2oPIoAqqDHnH3fT0qXGRuB49aUr81CfKxxTAyvEnhzSPE1osGtWcdxs5ilztlhP8AeRx8yn6GvFPFvha/8DyvcXM733h52Cx3zLh7ZieFnA4x28wcE9QOp+g8ADj8qZPDHc28kFzEksEqlJIpFDK6kYKsDwQRxisp01Nam1GvOk9Nj56s9QUl1ZgCOoPU1pwXAwGyQdu3k9uwrX1X4Pm1mY+GdX+z2jHC2V/GZViGchY5FIYL2w26ud1HTtb8Mg/2/YKliCAt/bv5sAOcfMcBk68bhj3rgqUJR1PXo4mnU0uakTYkX59qqo+X0P8AhT5BK5DAYBHQNVNZ0xlyQAOtWRIctj5gTn6Vz2Oi9izKR5gBY+YTnDHrx1/LjNQSJhFeMyI4XaC2DxnOfr2q1IkRbBIeRPnDZ5BNZOrala2FjJLdXCQonLyynbk0rDc2PuJtsYM0hTnLDAxxXKtc3muaodO0Czlv71h88cI4QesjHiMD1Y59jXX6D4N1bxnKlzqbXOi6AQCqbdl3dj1AP+qQ/wB4/MewHWvYNF0fT9C0yOw0izhsrOMfLFEuB9SerH1JyTXbSw7esjgr4yMPdhqzy7wv8HsBbjxdqBumJybGwYxxfR5Pvv8AhtFepaBo2m6BZCz0axtrG2U/6uBAuT6sepPueauEgdTxSp1YovJ6n1rsUVHY8ydSU9ZMlPUUHp9Kb83qBScdSc0zMUYpwzTcjPFICaYD8+9DHC0w9qDnYaAFJppJyaPSkA5oGLRSgdaXAHU0CAe1L05NIW7AY9zQB3bk0ALu9B+Joxk4PNKBS4AFIAxQDzgdaDzwPxpQAOBQAAYFBPrTv50hGaAA0lLiigBo7+1PB4pv4UZoAdRikz+VLQAhGeM4oxTqPSgBuKTFPxRigBmOaMcU7HNL+FMBmOec0Ac0+kPWgBnfkU4UppAKACikx70c0AFAziil9aAExRQKUUAJSGl6H2pD0oADR+NN+tA9qBCnHSkHAyTg98dKTnnB/CjJ96AEZcnI+WmlSOhp7H5RzzSd/WmMbuYde1OznpS9qbtHOaBCjvS8Hp+VM5B6+/NIW2n5uBQMcc9KO2KTdzxz9KXPHNADcUY5zTjQelACr0xSHjOD3oH60p9qAEIB4I4qCRV2Okyq8LqVbcMjB4IYdxUxzScYNAHmvib4ciFDc+ESkLD5m0yaQi3k7/u25MTeg+77DrXAXGtW+mzPa6srWF7GcSQXZCOp/PBHoRkHtX0IYipLQnB/uk8Gq881mXAu0QSqMYli3ED646VzVMNGbutDvo46cFaWp4jq+upbzW9nZwSXuqXj+VbWduB5s7d8dgB1LHgAZNdl4L8AG0vItX8UyRalqyfNb26DNtYn/Yzy7/7Z/ACsn9neytr3w5f+JLuFZtcub2W0ku35cQoRtjXsi+ygZ75r19RhRgYoo0FHV7k18VKfurRDB5p7BfcnJp3l5++5+g4qTAzTlAxXQcdyNQo6LzTuakUDBoPWgCMqaAv51IOlNNIBOOlGMGl/woxz+FMQ3OOP1oPKml707FIBm2g4Hf8ACnPwvFOUAYOOaYxnJ6DH1oC457+9ONIetAgHFG7AppPNIaBjyePemlyOopo5I+tL2oEL5qkY5FPDqehFQuBjNRd6ALoPSnVUiY7sZOKsDvQA+lxTRTqQBik28U6igYzHpRT6KBDKWnY6UhoASig8A4oHWgBcij8aReQM0oGaAA0UEUdqBhijvS9qO9ACEUYpe1FAhuKAKXtSAnNMAxRjihuBxRmgBDmjHtRnpSE9KAALzS4GKaCeOe1Jk+tADyKTbTeuOTQetAClOgPakK8E5xSdWWnZ5oAbtOeKTbgZb86lHOKQ/e/CgCPaOw60uOtOPBoH9TQBA6YGAB64NRkkdD+dXBVZx96mAxZDnBAx69MVKGHQ8H0JqGpiAU5FADgcdeKOc8Co0JDEA8VL2oAMZ5phXrUv8Jpo5zmkAzHSmFu2TxUrdRUZApgf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Montgomery straps make it possible to care for a wound without removing adhesive strips with each dressing change.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Taylor CR, Lillis C, LeMone P, Lynn P. Fundamentals of Nursing: The Art And Science Of Nursing Care, Sixth Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_32_9732=[""].join("\n");
var outline_f9_32_9732=null;
var title_f9_32_9733="Dronedarone: Patient drug information";
var content_f9_32_9733=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Dronedarone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/3/5176?source=see_link\">",
"     see \"Dronedarone: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F7891987\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Multaq&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9477224\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Multaq&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10019141\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3620362",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are always in atrial fibrillation (Afib). Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10019143\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691662",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat a fast heartbeat.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10019142\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to dronedarone or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703696",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Poor electrical activity in the heart without a working pacemaker, weak heart, very bad liver disease, or slow heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3914742",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had liver or lung problems when taking amiodarone.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3620363",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are not taking a blood thinner, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10019147\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3516748",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have an ECG checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696668",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid grapefruit and grapefruit juice.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10019148\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10019150\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3620364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Pulse that is not regular.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699094",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in your legs or belly.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10019145\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695907",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug with food.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10019146\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10019151\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10019152\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12208 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-61.234.146.186-3636CB1C0C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_32_9733=[""].join("\n");
var outline_f9_32_9733=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7891987\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9477224\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019141\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019143\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019142\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019147\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019148\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019150\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019145\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019146\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019151\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019152\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?5/3/5176?source=related_link\">",
"      Dronedarone: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_32_9734="Lisinopril: Patient drug information";
var content_f9_32_9734=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Lisinopril: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/58/937?source=see_link\">",
"     see \"Lisinopril: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/38/15976?source=see_link\">",
"     see \"Lisinopril: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F189191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Prinivil&reg;;",
"     </li>",
"     <li>",
"      Zestril&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F189192\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Lisinopril&reg;;",
"     </li>",
"     <li>",
"      CO Lisinopril;",
"     </li>",
"     <li>",
"      Dom-Lisinopril;",
"     </li>",
"     <li>",
"      JAMP-Lisinopril;",
"     </li>",
"     <li>",
"      Mint-Lisinopril;",
"     </li>",
"     <li>",
"      Mylan-Lisinopril;",
"     </li>",
"     <li>",
"      PMS-Lisinopril;",
"     </li>",
"     <li>",
"      Prinivil&reg;;",
"     </li>",
"     <li>",
"      PRO-Lisinopril;",
"     </li>",
"     <li>",
"      RAN&trade;-Lisinopril;",
"     </li>",
"     <li>",
"      ratio-Lisinopril;",
"     </li>",
"     <li>",
"      ratio-Lisinopril P;",
"     </li>",
"     <li>",
"      ratio-Lisinopril Z;",
"     </li>",
"     <li>",
"      Riva-Lisinopril;",
"     </li>",
"     <li>",
"      Sandoz-Lisinopril;",
"     </li>",
"     <li>",
"      Teva-Lisinopril (Type P);",
"     </li>",
"     <li>",
"      Teva-Lisinopril (Type Z);",
"     </li>",
"     <li>",
"      Zestril&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10020713\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700281",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10020715\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691388",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to help heart function after a heart attack.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691384",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to help a weak heart.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692146",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It may be given to you for other reasons. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10020714\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702400",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to lisinopril or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4231494",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have ever had a very bad reaction called angioedema. Signs may be swelling of the hands, face, lips, eyes, tongue, or throat; trouble breathing; trouble swallowing; unusual hoarseness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3915366",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes) and are taking aliskiren.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4231030",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease and are taking aliskiren.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701072",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are on a low-salt or salt-free diet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4194403",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This is not a list of all drugs or health problems that interact with this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4194405",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take this drug with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10020719\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2858939",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid driving and doing other tasks or actions that call for you to be alert until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4201327",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To lower the chance of feeling dizzy or passing out, rise slowly over a few minutes when sitting or lying down. Be careful climbing stairs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697207",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), this drug may sometimes raise blood sugar. Talk with your doctor about how to fine tune this.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697100",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a salt substitute that has potassium, potassium-sparing diuretics, or potassium, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug and have high blood pressure, talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4231042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before you drink wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698650",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you have too much sweat, fluid loss, throwing up, or loose stools. This may lead to low blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4194393",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may not work as well in black patients. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4194392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The chance of a very bad or sometimes deadly reaction called angioedema may be higher in black patients. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697004",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are 65 or older, use this drug with care. You could have more side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10020720\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4186184",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       All drugs may cause side effects. However, many people have no side effects or only have minor side effects. Call your doctor if any of these side effects or any other side effects bother you:",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698017",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10020722\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4186185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these side effects:",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4192387",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of liver problems like dark urine, feeling tired, not hungry, upset stomach or stomach pain, light-colored stools, throwing up, or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698627",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4193665",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shortness of breath, a big weight gain, swelling in the arms or legs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4186197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A heartbeat that does not feel normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4270262",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fast or slow heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699103",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unable to pass urine or change in the amount of urine passed.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2699690",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects at",
"       <a href=\"file://www.fda.gov/medwatch\" target=\"_blank\">",
"        file://www.fda.gov/medwatch",
"       </a>",
"       .",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2699689",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may report side effects to Health Canada's Canada Vigilance Program at 1-866-234-2345.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10020717\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2696083",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use this drug as ordered by your doctor. Read and follow the dosing on the label closely.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have trouble swallowing, talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10020718\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10020723\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4194563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check with your pharmacist about how to throw out unused drugs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10020724\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10811 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-7727F3B860-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_32_9734=[""].join("\n");
var outline_f9_32_9734=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189191\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189192\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020713\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020715\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020714\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020719\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020720\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020722\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020717\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020718\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020723\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020724\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?0/58/937?source=related_link\">",
"      Lisinopril: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/38/15976?source=related_link\">",
"      Lisinopril: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_32_9735="Mechanisms of pleural liquid turnover in the normal state";
var content_f9_32_9735=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Mechanisms of pleural liquid turnover in the normal state",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/32/9735/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/32/9735/contributors\">",
"     V Courtney Broaddus, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/32/9735/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/32/9735/contributors\">",
"     Steven A Sahn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/32/9735/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/32/9735/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/32/9735/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 29, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pleural space is bounded by the parietal and visceral membranes covered by a continuous layer of pleural mesothelial cells. Studies of pleural liquid dynamics in the normal pleural space are limited. Available data indicate that pleural fluid is formed from the systemic vessels of the pleural membranes at an approximate rate of 0.6",
"    <span class=\"nowrap\">",
"     mL/h",
"    </span>",
"    and is absorbed at a similar rate by the parietal pleural lymphatic system. Normally, the pleural spaces contain approximately 0.25",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    of low protein liquid. Disturbances in either formation or absorption result in the accumulation of excess pleural fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/53/36695?source=see_link\">",
"     \"Mechanisms of pleural liquid accumulation in disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PLEURAL ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pleural space is a real, not potential, space that is approximately 10 to 20 &micro;m wide and extends completely around the lung to the hilar root (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef66503 \" href=\"UTD.htm?6/41/6801\">",
"     image 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. The visceral pleura covers the lung and interlobar fissures; the parietal pleura covers the chest wall, diaphragm, and mediastinum. Each pleural interface has a surface area of approximately 1000 cm2. Each membrane is covered by a single cell layer of mesothelial cells and each (at least in humans and large mammals) is nourished by a systemic circulation.",
"   </p>",
"   <p>",
"    The visceral and parietal pleural membranes differ in one important respect: only the parietal pleura has lymphatic stomata that open directly into the pleural space. Current concepts of pleural liquid turnover have stemmed in large part from considering the differential anatomy of the two pleural membranes [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Parietal pleura",
"    </span>",
"    &nbsp;&mdash;&nbsp;The parietal pleura has been proposed as the more important pleura for pleural liquid turnover in the normal physiologic state [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/5\">",
"     5",
"    </a>",
"    ]. The reasons for this hypothesis lie in the proximity of the microvessels to the pleural space, the presence of the lymphatic stomata, and the consistent anatomy of the parietal pleura among species. The parietal pleural membrane overlies the intercostal fascial layer and ribs. It is approximately 30 to 40 &micro;m thick, consisting of a superficial mesothelial layer and subpleural layer (",
"    <a class=\"graphic graphic_picture graphicRef55754 \" href=\"UTD.htm?27/58/28577\">",
"     picture 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/6\">",
"     6",
"    </a>",
"    ]. Within the subpleural layer lies loose connective tissue in which run the intercostal arteries, nerves and lymphatics. The intercostal microvessels are about 10 to 12 &micro;m from the pleural space.",
"   </p>",
"   <p>",
"    The most interesting and unusual features of the parietal pleura are the lymphatic stomata, holes of 2 to 6 &micro;m in diameter that open onto the pleural space (",
"    <a class=\"graphic graphic_picture graphicRef60170 \" href=\"UTD.htm?38/33/39443\">",
"     picture 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. These measurements were obtained in the resting state; the diameters likely increase with chest expansion during ventilation. The stomata have been demonstrated on the parietal pleural surface with scanning electron microscopy. Each stoma is formed by a gap in the otherwise continuous mesothelial cell layer, where the mesothelial cells join with the endothelial cells of the lymphatics. Each lymphatic joins others, forming a lake or lacuna (",
"    <a class=\"graphic graphic_picture graphicRef67166 \" href=\"UTD.htm?13/51/14128\">",
"     picture 3",
"    </a>",
"    ); from the lacunae, collecting lymphatics join intercostal trunk lymphatics, which travel to the parasternal and periaortic lymph nodes.",
"   </p>",
"   <p>",
"    The number of stomata over the caudal pleural surfaces (chest wall and mediastinum) in humans is not known with certainty. Estimates based on animal models suggest a range from 100 to 200 stomata per cm2 [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/6,8,9\">",
"     6,8,9",
"    </a>",
"    ]. The distribution of stomata in some animals is nonuniform with a larger number of openings found in dependent regions [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    By microscopy studies, including electron microscopy, these stomata have been shown to connect directly to the pleural space and to contain intact erythrocytes or carbon particles previously injected into the pleural space [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/6\">",
"     6",
"    </a>",
"    ]. Using live imaging with videothoracoscopy in monkeys, researchers have been able to see carbon particles move from the pleural space into the lymphatics in the costal, mediastinal, and diaphragmatic pleura within 15 minutes and to drain to collecting lymphatics within 30 minutes [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Visceral pleura",
"    </span>",
"    &nbsp;&mdash;&nbsp;The visceral pleura in humans is approximately 20 to 80 &micro;m thick and consists of a mesothelial layer and a subpleural connective tissue layer (",
"    <a class=\"graphic graphic_figure graphicRef81664 \" href=\"UTD.htm?34/10/34978\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/3,11\">",
"     3,11",
"    </a>",
"    ]. The thickness varies considerably over the lung, being greatest in the caudal regions and least in the cephalad regions. The subpleural connective tissue layer contains both collagen and elastin, as well as the bronchial artery capillaries and subpleural lymphatics (which do not connect to the pleural space). The alveoli and the pulmonary circulation lie beneath the visceral pleural membrane. Both the bronchial microvessels and lymphatics are farther from the pleural space than in the parietal pleura (20 to 50 &micro;m versus 10 to 12 &micro;m, respectively).",
"   </p>",
"   <p>",
"    The bronchial microvessels drain into the pulmonary veins, a feature that may have two consequences for pleural liquid formation:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Because of the normally low pulmonary venous pressure, the bronchial arterial driving pressure is probably lower than in other systemic microvessels, which have a systemic drainage. This may mean that, in the normal situation, less liquid flows from the visceral pleura than from the parietal pleura.",
"     </li>",
"     <li>",
"      When the pulmonary vascular pressures rise, the bronchial arterial driving pressure and visceral pleural liquid flow could increase resulting in transvascular filtration; pleural liquid formation could increase as a result.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Interestingly, visceral pleural anatomy differs strikingly among species of mammals. In small mammals (mice, rabbits, dogs), the visceral pleura is quite thin (5 to 10 &micro;m), with almost no subpleural layer and no pleural bronchial circulation. One likely possibility for the major difference in anatomy is structural; in large mammals, the thick visceral pleura may offer necessary support for the lung tissues. The visceral pleural connective tissue may withstand and dissipate stresses in the lung, minimize overexpansion of weaker portions of lung (thereby reducing the risk of pneumothorax), and smooth out the relative expansion of different areas of lung and the distribution of ventilation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pleural mesothelial cell",
"    </span>",
"    &nbsp;&mdash;&nbsp;The continuous lining cell of both pleurae is the mesothelial cell (",
"    <a class=\"graphic graphic_picture graphicRef72742 \" href=\"UTD.htm?19/14/19686\">",
"     picture 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/3\">",
"     3",
"    </a>",
"    ]. Not unique to the pleural space, the mesothelial cell lines the other two coelomic spaces in the body, the pericardial and peritoneal spaces. There are no differences yet described among mesothelial cells from these three locations or between the parietal and visceral locations. The mesothelial cell is a flat cell (1 to 4 &micro;m thick) with a variable covering of microvilli (up to 3 &micro;m long). The shape and area of the (visceral) cell change with lung inflation, with a range of diameters of 27 &micro;m at a transpulmonary pressure of 1.5 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O to 39 &micro;m at 12 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O in isolated rabbit lungs [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similar to that of the other two lining cell types, ie, the endothelial and epithelial cells, the mesothelial cell has been found to have many functions [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It produces a wide array of extracellular matrix molecules and may participate in the production of the submesothelial connective tissue [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The mesothelial cell, at least in vitro, is phagocytic [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/16,17\">",
"       16,17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      It may function as an inflammatory cell, directing movement of other inflammatory cells into the pleural space by releasing cytokines and expressing adhesion molecules [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/18-20\">",
"       18-20",
"      </a>",
"      ]. The mesothelial cell may also recruit fibroblasts [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Mesothelial cells may contribute to the balance between procoagulant and fibrinolytic activities in the pleural space [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/22,23\">",
"       22,23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Compared to all these known or potential functions, however, the mesothelial cell has no documented active role in liquid entry or exit from the pleural space. There is no evidence for active transport by the mesothelial cell. Furthermore, the mesothelial surface is leaky to protein and liquid, as, for example, is necessary for successful dialysis in the peritoneal space. A leaky membrane implies a passive role for the mesothelium in the movement of liquid and protein.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PLEURAL LIQUID FORMATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Much of what we know about normal pleural liquid turnover is derived from studies in sheep, which have a pleural anatomy similar to that in humans. Studies of normal liquid turnover have been hampered by the narrowness of the pleural space and its sensitivity to inflammation. Most experiments, therefore, have relied on noninvasive studies of liquid formation, with the assumption that, in a steady-state condition, liquid absorption and formation will occur at the same rate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Normal pleural liquid",
"    </span>",
"    &nbsp;&mdash;&nbsp;The volume of pleural liquid is small, approximately 0.1 to 0.2 mL per kg in different species. One study in normal humans found a mean pleural fluid volume of 8.4 mL per hemithorax, or 0.26 mL per kg [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/24\">",
"     24",
"    </a>",
"    ]. The WBC count in this group of subjects was approximately 1700 per mm3, with a median differential of approximately 75 percent macrophages and 23 percent lymphocytes. The normal protein concentration of the pleural liquid is low, approximately 15 percent of the plasma protein concentration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Rate of formation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In noninvasive studies using equilibration of radiolabeled albumin from the plasma to the pleural liquid, pleural liquid in the sheep formed at 0.01",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per h, or the equivalent of 0.6",
"    <span class=\"nowrap\">",
"     mL/h",
"    </span>",
"    in a 60-kg person. This constituted a turnover rate of 11 percent of the pleural liquid volume per hour.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Origin of pleural liquid",
"    </span>",
"    &nbsp;&mdash;&nbsp;The current consensus of pleural liquid formation is that the liquid originates from the systemic vessels of the pleural membranes, not from the pulmonary vessels [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/5\">",
"     5",
"    </a>",
"    ]. In other words, pleural liquid is interstitial fluid of the systemic pleural microvessels (",
"    <a class=\"graphic graphic_figure graphicRef62020 \" href=\"UTD.htm?4/17/4383\">",
"     figure 2",
"    </a>",
"    ). There are three major considerations that support this hypothesis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The systemic vessels (of both parietal and visceral pleural membranes) are adjacent to the pleural space and are much closer to the pleural space than are the pulmonary vessels.",
"     </li>",
"     <li>",
"      The low pleural liquid protein concentration (1",
"      <span class=\"nowrap\">",
"       g/dL)",
"      </span>",
"      and ratio to the plasma protein concentration (0.15",
"      <span class=\"nowrap\">",
"       g/dL)",
"      </span>",
"      are consistent with a filtrate from high-pressure systemic vessels. If liquid and protein are filtered at high pressure and high flow across a semipermeable membrane, large particles will be sieved and relatively restrained compared to the liquid. Thus, plasma proteins, being large, will be retarded much more than the liquid in their movement across a membrane, and the protein concentration of the resultant filtrate will be low. On the other hand, if liquid and protein are filtered at low pressure and low flow, proteins are retarded less, and the protein concentration of the resultant filtrate is higher. Filtrates from low-pressure pulmonary vessels, eg, lung lymph, have a high protein concentration (4.5",
"      <span class=\"nowrap\">",
"       g/dL)",
"      </span>",
"      and ratio (0.7) compared to filtrates from systemic vessels and to pleural liquid.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Of note in this argument, pleural liquid formation is described as high flow, whereas its measured rate is relatively slow (0.01",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per h). However, it is the filtration at the systemic microvessels that is described as high, or at least higher than filtration across pulmonary microvessels. Some of that filtrate is reabsorbed into the low-pressure postcapillary venules, and some is removed by bulk flow via the local lymphatic vessels. It is only the remainder that then moves into the low-pressure pleural space.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In situations where systemic pressure varies, the pleural liquid protein concentration varies in concert. For example, systemic hypertensive rats have a lower pleural liquid protein-to-plasma protein concentration ratio than do normotensive rats (0.42 versus 0.55), even though their pulmonary pressures are the same [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/25\">",
"       25",
"      </a>",
"      ]. During development from the fetus to the adult, systemic blood pressure generally rises and pulmonary pressure falls. In a study in sheep, the pleural protein ratio decreased with development, as would be expected if the pleural liquid originated from the high-pressure systemic vessels [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Of the two pleural membranes, the parietal is thought to be more important than the visceral for normal pleural liquid formation. The arguments in favor of this view are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The parietal pleural microvessels are closer to the pleural space (10 to 12 &micro;m) than are those of the visceral pleura (20 to 50 &micro;m).",
"     </li>",
"     <li>",
"      The parietal pleural microvessels probably have a higher filtration pressure than do the visceral bronchial microvessels, which are known to empty into the low-pressure pulmonary veins.",
"     </li>",
"     <li>",
"      The parietal membrane has a consistent anatomy and thickness over its extent in the body and among different species; the visceral membrane varies greatly (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Pleural anatomy'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Pleural liquid formation rates are similar among species, even when the species have significantly different visceral pleural structures and circulations. Sheep, with a thick pleura and systemic visceral circulation, have similar pleural liquid formation rates as do dogs and rabbits, which have similar parietal pleural anatomy as sheep, but have very different visceral pleural anatomy (",
"      <a class=\"graphic graphic_picture graphicRef70251 \" href=\"UTD.htm?33/20/34112\">",
"       picture 5",
"      </a>",
"      ). If the bronchial circulation of the thick visceral pleura in sheep did contribute, one would expect the liquid formation rate of sheep to be higher than that of the other two species.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The formation of pleural liquid is dependent upon a balance of hydrostatic pressures (microvascular minus pleural) opposed by the counterbalancing osmotic pressures (microvascular minus pleural). These pressures can be quantified by application of Starling's equation. A balance of pressures has been proposed that estimates an average 14 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O driving pressure for movement of liquid into the pleural space from the parietal pleura versus 9 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O from the visceral pleura [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Alterations of the balance that could increase pleural liquid formation include: an elevation of systemic microvascular pressure (eg, from systemic venous hypertension), a decrease in pleural pressure (eg, in atelectasis), or a decrease in systemic protein concentration (eg, with hypoproteinemia). (The fourth possibility, an increase in pleural liquid protein concentration, is not relevant clinically). The alteration in balance would presumably be transient and followed by a new balance at a different combination of hydrostatic and countering osmotic pressures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/53/36695?source=see_link\">",
"     \"Mechanisms of pleural liquid accumulation in disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PLEURAL LIQUID ABSORPTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because the normal situation is a steady state, the absorption rate of pleural liquid should equal the formation rate. If excess liquid is introduced into the pleural space, however, the rate of absorption increases several-fold, from the baseline rate of 0.01 to 0.02",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per hour to 0.22 to 0.28",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per hour [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The route of exit of the pleural liquid has been debated, in part because of the difficulty studying the pleural space. Various proposals have included reabsorption by the mesothelial cells themselves, and passive flow of pleural liquid into the \"low\" pressure interstitial tissues of the lung. Nonetheless, current evidence supports the conclusion that the liquid exits the pleural space via the lymphatic stomata of the parietal pleura (",
"    <a class=\"graphic graphic_picture graphicRef60170 \" href=\"UTD.htm?38/33/39443\">",
"     picture 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/28\">",
"     28",
"    </a>",
"    ]. This conclusion is based upon knowledge of the physical forces operating at the pleural tissue and the evidence for bulk flow as opposed to diffusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Physical forces",
"    </span>",
"    &nbsp;&mdash;&nbsp;Our current understanding of the physical forces operating at the pleural spaces do",
"    <strong>",
"     not",
"    </strong>",
"    support an important role for active transport or uptake by capillaries in the absorption of pleural liquid.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The intrapleural pressure is lower than the interstitial pressure of either of the pleural tissues. With this pressure difference, a gradient of pressure directs liquid movement into but not out of the pleural space.",
"     </li>",
"     <li>",
"      The pleural membranes are leaky, offering little resistance to the movement of liquid and protein [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/29\">",
"       29",
"      </a>",
"      ], as has been shown for peritoneal mesothelium [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/30\">",
"       30",
"      </a>",
"      ]. Such a condition favors the passive movement of liquid, proteins, and other molecules. This is the underlying characteristic that allows for successful dialysis across the peritoneal membranes.",
"     </li>",
"     <li>",
"      Mesothelial cells have not been shown to generate an electric potential difference, which would be expected if mesothelial cells moved ions by active transport. Although pleural liquid has been reported to be alkaline with a higher bicarbonate concentration than plasma, there is no evidence yet for mesothelial participation in generating a bicarbonate gradient. Furthermore, it is difficult to explain how the mesothelium could maintain a transport gradient since it is a leaky membrane. Another explanation for ionic differences across a semipermeable membrane is by the passive distribution of ions in response to a difference in protein concentration (a \"Donnan equilibrium\") [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Evidence for bulk flow",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of liquid appears to exit the pleural space by bulk flow, not by diffusion. At least four findings underlie this assertion.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pleural liquid protein concentration does not change as a hydrothorax is absorbed [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/28\">",
"       28",
"      </a>",
"      ]. With bulk flow, liquid and protein are removed together, and the protein concentration of the liquid remaining in the pleural space does not change. With diffusion, however, proteins would diffuse at a slower rate than the liquid, resulting in a progressive increase in protein concentration.",
"     </li>",
"     <li>",
"      The absorption rates of pleural liquid are constant despite differences in protein concentration [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/27\">",
"       27",
"      </a>",
"      ]. If diffusion were predominant, the presence of protein would be expected to slow the removal of the pleural liquid because the higher protein osmotic pressure would reduce the pressure gradient for flow out of the pleural space.",
"     </li>",
"     <li>",
"      Absorption rates are constant despite changes in pleural liquid volume, at least once the liquid volume rises above some threshold [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/28\">",
"       28",
"      </a>",
"      ]. If diffusion were the predominant mechanism of absorption, the absorption rate would be expected to change with pleural liquid volume, as the pleural liquid pressure gradient changed.",
"     </li>",
"     <li>",
"      Erythrocytes are absorbed intact from the pleural space and at nearly the same rate as the liquid and protein. This relatively free exit of erythrocytes from the pleural space indicates that the major route of exit is via holes large enough to accommodate erythrocytes (6 to 8 &micro;m for the sheep erythrocytes used in the study). The only possible route then is via the parietal pleural stomata (2 to 10 &micro;m) and the lymphatics.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     LYMPHATIC FLOW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymphatic flow is influenced both by intrinsic contractility of the lymph vessels and by extrinsic respiratory movements [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/32\">",
"     32",
"    </a>",
"    ]. Intrinsic contractility could potentially be altered by hormones, cytokines, or adrenergic stimulation. Respiratory movements may assist lymphatic flow by applying an alternating pressure on the subpleural lymphatics or by expanding and contracting the openings of the lymphatic stomata. Respiratory movements also promote a continuous intrapleural circulation of pleural liquid, which may favor delivery of pleural liquid to the stomata [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/33,34\">",
"     33,34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The pleural space is bounded by the parietal and visceral membranes covered by a continuous layer of pleural mesothelial cells. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The parietal pleura appears to be the more important pleural surface for pleural liquid turnover in the normal physiologic state [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9735/abstract/5\">",
"       5",
"      </a>",
"      ]. This is suggested by several observations about the parietal pleura: parietal microvessels are closer to the pleural surface, lymphatic stomata are found on the parietal pleura, and the parietal pleura has a consistent anatomy among species. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Parietal pleura'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The continuous lining cell of both pleurae is the mesothelial cell. It is phagocytic, may function as an inflammatory cell, and produces a wide array of extracellular matrix molecules. These mesothelial lining cells may participate in the production of the submesothelial connective tissue. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pleural mesothelial cell'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The current consensus regarding pleural liquid formation is that the liquid originates from the systemic vessels of the pleural membranes, not from the pulmonary vessels. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Pleural liquid formation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Current evidence supports the conclusion that liquid exits the pleural space via the lymphatic stomata of the parietal pleura. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Pleural liquid absorption'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lymphatic flow draining the pleural space is influenced by both intrinsic contractility of the lymph vessels and extrinsic respiratory movements. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Lymphatic flow'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Broaddus VC. Fluid and solute exchange in normal physiological states. In: Textbook of Pleural Diseases, 2nd ed, Light RW, Lee YG (Eds), Hodder, Arnold, London 2008. p.43.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/2\">",
"      Lai-Fook SJ. Pleural mechanics and fluid exchange. Physiol Rev 2004; 84:385.",
"     </a>",
"    </li>",
"    <li>",
"     Wang NS. Anatomy of the pleura. In: Diseases of the Pleura, Antony VB (Ed), WB Saunders, Philadelphia 1998. p.229.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/4\">",
"      Albertine KH, Wiener-Kronish JP, Bastacky J, Staub NC. No evidence for mesothelial cell contact across the costal pleural space of sheep. J Appl Physiol 1991; 70:123.",
"     </a>",
"    </li>",
"    <li>",
"     Staub, NC, Wiener-Kronish, JP, Albertine, KH. Transport through the pleura: physiology of normal liquid and solute exchange in the pleural space, Marcel Dekker, New York 1985.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/6\">",
"      Albertine KH, Wiener-Kronish JP, Staub NC. The structure of the parietal pleura and its relationship to pleural liquid dynamics in sheep. Anat Rec 1984; 208:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/7\">",
"      Li J. Ultrastructural study on the pleural stomata in human. Funct Dev Morphol 1993; 3:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/8\">",
"      Shinohara H. Distribution of lymphatic stomata on the pleural surface of the thoracic cavity and the surface topography of the pleural mesothelium in the golden hamster. Anat Rec 1997; 249:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/9\">",
"      Wang NS. The preformed stomas connecting the pleural cavity and the lymphatics in the parietal pleura. Am Rev Respir Dis 1975; 111:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/10\">",
"      Miura T, Shimada T, Tanaka K, et al. Lymphatic drainage of carbon particles injected into the pleural cavity of the monkey, as studied by video-assisted thoracoscopy and electron microscopy. J Thorac Cardiovasc Surg 2000; 120:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/11\">",
"      Albertine KH, Wiener-Kronish JP, Roos PJ, Staub NC. Structure, blood supply, and lymphatic vessels of the sheep's visceral pleura. Am J Anat 1982; 165:277.",
"     </a>",
"    </li>",
"    <li>",
"     Wang NS. Mesothelial cells in situ. In: The Pleura in Health and Disease, Chr&eacute;tien J, Bignon J, Hirsch A (Eds), Marcel Dekker, New York 1985. p.23.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/13\">",
"      Mutsaers SE, Wilkosz S. Structure and function of mesothelial cells. Cancer Treat Res 2007; 134:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/14\">",
"      Jantz MA, Antony VB. Pathophysiology of the pleura. Respiration 2008; 75:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/15\">",
"      Rennard SI, Jaurand MC, Bignon J, et al. Role of pleural mesothelial cells in the production of the submesothelial connective tissue matrix of lung. Am Rev Respir Dis 1984; 130:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/16\">",
"      Jaurand MC, Kaplan H, Thiollet J, et al. Phagocytosis of chrysotile fibers by pleural mesothelial cells in culture. Am J Pathol 1979; 94:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/17\">",
"      Boylan AM, Sanan DA, Sheppard D, Broaddus VC. Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin alpha v beta 5. J Clin Invest 1995; 96:1987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/18\">",
"      Boylan AM, R&uuml;egg C, Kim KJ, et al. Evidence of a role for mesothelial cell-derived interleukin 8 in the pathogenesis of asbestos-induced pleurisy in rabbits. J Clin Invest 1992; 89:1257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/19\">",
"      Jonji�� N, Peri G, Bernasconi S, et al. Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 1992; 176:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/20\">",
"      Nasreen N, Mohammed KA, Hardwick J, et al. Polar production of interleukin-8 by mesothelial cells promotes the transmesothelial migration of neutrophils: role of intercellular adhesion molecule-1. J Infect Dis 2001; 183:1638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/21\">",
"      Kuwahara M, Kuwahara M, Bijwaard KE, et al. Mesothelial cells produce a chemoattractant for lung fibroblasts: role of fibronectin. Am J Respir Cell Mol Biol 1991; 5:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/22\">",
"      Idell S, Zwieb C, Kumar A, et al. Pathways of fibrin turnover of human pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol 1992; 7:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/23\">",
"      Iakhiaev AV, Nalian A, Koenig K, Idell S. Thrombin-thrombomodulin inhibits prourokinase-mediated pleural mesothelial cell-dependent fibrinolysis. Thromb Res 2007; 120:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/24\">",
"      Noppen M, De Waele M, Li R, et al. Volume and cellular content of normal pleural fluid in humans examined by pleural lavage. Am J Respir Crit Care Med 2000; 162:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/25\">",
"      Lai-Fook SJ, Kaplowitz MR. Pleural protein concentration and liquid volume in spontaneously hypertensive rats. Microvasc Res 1988; 35:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/26\">",
"      Broaddus VC, Araya M, Carlton DP, Bland RD. Developmental changes in pleural liquid protein concentration in sheep. Am Rev Respir Dis 1991; 143:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/27\">",
"      Miserocchi G, Negrini D, Mariani E, Passafaro M. Reabsorption of a saline- or plasma-induced hydrothorax. J Appl Physiol 1983; 54:1574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/28\">",
"      Broaddus VC, Wiener-Kronish JP, Berthiaume Y, Staub NC. Removal of pleural liquid and protein by lymphatics in awake sheep. J Appl Physiol 1988; 64:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/29\">",
"      Kim KJ, Critz AM, Crandall ED. Transport of water and solutes across sheep visceral pleura. Am Rev Respir Dis 1979; 120:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/30\">",
"      Nagel W, Kuschinsky W. Study of the permeability of the isolated dog mesentery. Eur J Clin Invest 1970; 1:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/31\">",
"      Gilligan DR, Volk MC, Blumgart HL. OBSERVATIONS ON THE CHEMICAL AND PHYSICAL RELATION BETWEEN BLOOD SERUM AND BODY FLUIDS. 1. THE NATURE OF EDEMA FLUIDS AND EVIDENCE REGARDING THE MECHANISM OF EDEMA FORMATION. J Clin Invest 1934; 13:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/32\">",
"      Negrini D, Ballard ST, Benoit JN. Contribution of lymphatic myogenic activity and respiratory movements to pleural lymph flow. J Appl Physiol 1994; 76:2267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/33\">",
"      Wang PM, Lai-Fook SJ. Upward flow of pleural liquid near lobar margins due to cardiogenic motion. J Appl Physiol 1992; 73:2314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9735/abstract/34\">",
"      Miserocchi G, Pistolesi M, Miniati M, et al. Pleural liquid pressure gradients and intrapleural distribution of injected bolus. J Appl Physiol 1984; 56:526.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6692 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-190.92.87.104-2CE9AB38EC-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_32_9735=[""].join("\n");
var outline_f9_32_9735=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PLEURAL ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Parietal pleura",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Visceral pleura",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pleural mesothelial cell",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PLEURAL LIQUID FORMATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Normal pleural liquid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Rate of formation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Origin of pleural liquid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PLEURAL LIQUID ABSORPTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Physical forces",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Evidence for bulk flow",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      LYMPHATIC FLOW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/6692\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6692|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/41/6801\" title=\"diagnostic image 1\">",
"      Anatomy of the pleural space",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6692|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/10/34978\" title=\"figure 1\">",
"      Anatomy of the visceral pleura",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/17/4383\" title=\"figure 2\">",
"      Pleural liquid turnover",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6692|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/58/28577\" title=\"picture 1\">",
"      Anatomy of the parietal pleura",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/33/39443\" title=\"picture 2\">",
"      Lymphatic stomata in pleura",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/51/14128\" title=\"picture 3\">",
"      Pleural lymphatic lacunae",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/14/19686\" title=\"picture 4\">",
"      Pleural mesothelial cell layer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/20/34112\" title=\"picture 5\">",
"      Thin visceral pleura",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/53/36695?source=related_link\">",
"      Mechanisms of pleural liquid accumulation in disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_32_9736="Pulse oximetry";
var content_f9_32_9736=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pulse oximetry",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/32/9736/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/32/9736/contributors\">",
"     C Crawford Mechem, MD, FACEP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/32/9736/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/32/9736/contributors\">",
"     Polly E Parsons, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/32/9736/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/32/9736/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/32/9736/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 27, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypoxemia is an important and potentially avoidable cause of morbidity and mortality in many hospital settings, including the intensive care unit (ICU), emergency department, procedure suite, and operating room. Rapid, accurate detection of hypoxemia is critical to prevent serious complications; however, oxygenation is difficult to assess on the basis of physical examination alone. Frank cyanosis does not develop until the level of deoxyhemoglobin reaches 5",
"    <span class=\"nowrap\">",
"     g/dL,",
"    </span>",
"    which corresponds to an arterial oxygen saturation (SaO",
"    <sub>",
"     2",
"    </sub>",
"    ) of around 67 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/1\">",
"     1",
"    </a>",
"    ]. Furthermore, the threshold at which cyanosis becomes apparent is affected by multiple variables including peripheral perfusion, skin pigmentation, and hemoglobin concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Blood gas analysis was for many years the only available method of detecting hypoxemia in critically ill patients, but this technique is painful, has potential complications, and does not provide immediate or continuous data [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15894?source=see_link\">",
"     \"Arterial blood gases\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/51/26424?source=see_link\">",
"     \"Arterial catheterization techniques for invasive monitoring\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pulse oximetry allows noninvasive measurement of arterial hemoglobin saturation, without the risks associated with arterial puncture. Over the past 30 years, pulse oximetry has become the standard for continuous",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    noninvasive assessment of arterial oxygen saturation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/4\">",
"     4",
"    </a>",
"    ]. Arterial oxygen saturation determination with pulse oximetry is now in such ubiquitous use that it has been called the \"fifth vital sign\" [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the widespread use of pulse oximetry in clinical monitoring, many practitioners are unaware of the potential limitations of this technology. Theoretical and clinical aspects of pulse oximetry will be reviewed here. The interpretation of arterial oxygen tension is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=see_link\">",
"     \"Oxygenation and mechanisms of hypoxemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carl Matthes invented the first noninvasive oximeter employing an ear probe in 1935 [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/6\">",
"     6",
"    </a>",
"    ]. The device used two wavelengths of light to compensate for variations in tissue thickness and blood content, but did not account for pulsatile flow. The development of oximetry intensified during World War II, when a method was sought to monitor oxygenation in pilots flying at high altitudes in pressurized cockpits [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/3,6,7\">",
"     3,6,7",
"    </a>",
"    ]. These early nonpulsatile devices did not measure true arterial saturation because of interference from capillary and venous blood, and they were unwieldy to use and transport [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In 1970, scientists at Hewlett-Packard developed the first widely used, commercial ear oximeter that preferentially measured arterial saturation by heating the tissue to 41&ordm;C to increase local cutaneous blood flow [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/7\">",
"     7",
"    </a>",
"    ]. In 1974, Takuo Aoyagi found that arterial oxygen saturation could be measured by quantifying pulsations in the light signals coming through tissue. This eliminated the need for heating the tissue, and his device is the ancestor of the current generation of pulse oximeters [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PRINCIPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The theoretical basis for pulse oximetry derives from the Beer-Lambert law. This law states that the absorption of light of a given wavelength passing through a non-absorbing solvent, which contains an absorbing solute, is proportional to the product of the solute concentration, the light path length, and an extinction coefficient. The Beer-Lambert law can readily be applied to co-oximeters used for blood gas analysis, in which a sample of arterial blood can be placed within a cuvette, and factors such as light path length and solute concentration can be controlled [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Application of this spectrophotometric principle to a noninvasive device, where tissue is of varying thickness and blood flows in a pulsatile manner, is more difficult. Modern pulse oximeters address these factors through the use of two wavelengths of light and of complex microprocessors. Deoxyhemoglobin absorbs light maximally in the red band of the spectrum (600 to 750 nm), while oxyhemoglobin absorbs maximally in the infrared band (850 to 1000 nm) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/4,11\">",
"     4,11",
"    </a>",
"    ]. The relative absorbency at these two wavelengths is used to estimate saturation, which is derived from the ratio of oxyhemoglobin to the sum of oxyhemoglobin plus deoxyhemoglobin [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pulse oximeter probes consist of a photodetector and two light-emitting diodes, one emitting at 660 nm and the other at 940 nm. These wavelengths are in the red and infrared bands of the spectrum, respectively. The detector and emitters are positioned facing each other through interposed tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/2\">",
"     2",
"    </a>",
"    ]. Probes are most frequently placed on fingers or ear lobes [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/12\">",
"     12",
"    </a>",
"    ]. In infants, probes may also be placed on the palms, toes, feet, arms, cheeks, tongue, penis, nose, or nasal septum [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The photodiodes are switched on and off several hundred times per second, so that light absorption by oxyhemoglobin and deoxyhemoglobin is recorded during pulsatile and nonpulsatile flow [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/14\">",
"     14",
"    </a>",
"    ]. Absorption during pulsatile flow relates to the characteristics of arterial blood plus background tissue and venous blood, whereas absorption during nonpulsatile flow is due only to the background tissue and venous blood (",
"    <a class=\"graphic graphic_figure graphicRef80895 \" href=\"UTD.htm?25/9/25758\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/11,15\">",
"     11,15",
"    </a>",
"    ]. Absorption at the two wavelengths during pulsatile flow is divided by absorption during nonpulsatile flow, and these ratios are fed into an algorithm in the microprocessor to yield a saturation value. The displayed value is an average based on the previous three to six seconds [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/2,14\">",
"     2,14",
"    </a>",
"    ]. In addition to SaO",
"    <sub>",
"     2",
"    </sub>",
"    , many pulse oximeters also display pulse rate and relative pulse amplitude [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/4,7\">",
"     4,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The microprocessors of pulse oximeters are calibrated using reference tables compiled by exposing healthy volunteers to decreasing FiO",
"    <sub>",
"     2",
"    </sub>",
"    to yield SaO",
"    <sub>",
"     2",
"    </sub>",
"    ranging from 100 to 75 percent by co-oximetry. Because it would be unethical to intentionally generate lower saturations in volunteers, values for an SaO",
"    <sub>",
"     2",
"    </sub>",
"    less than 75 percent are obtained by extrapolation from these volunteer data. Pulse oximeter manufacturers claim that reported values between 70 and 100 percent are accurate to within &plusmn; 2 percent of the true value, while those between 50 and 70 percent are within &plusmn; 3 percent. In practice, the cut-off for acceptable accuracy is felt by many clinicians to be 80 percent (which usually reflects a PaO",
"    <sub>",
"     2",
"    </sub>",
"    of approximately 50 mmHg at a pH of 7.4), and varies depending on the model of pulse oximeter used [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/1,16,17\">",
"     1,16,17",
"    </a>",
"    ]. The high accuracy of one widely used type of pulse oximeter at SaO",
"    <sub>",
"     2",
"    </sub>",
"    values ranging from 82 to 94 percent was confirmed in a study of 100 patients, although the accuracy of the instrument deteriorated at values outside these parameters [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     APPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulse oximetry is indicated in any clinical setting where hypoxemia may occur. These settings include patient monitoring in emergency departments, operating rooms, emergency medical services (EMS) systems, postoperative recovery areas, endoscopy suites, sleep and exercise laboratories, oral surgery, cardiac catheterization, conscious sedation, labor and delivery, interfacility patient transfer, and aerospace medicine [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/2,19-25\">",
"     2,19-25",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a pediatric ICU, using pulse oximetry decreases the number of blood gases obtained and the duration of oxygen therapy, without jeopardizing patient outcome [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In emergency departments, initial pulse oximetry readings in children with asthma exacerbations are predictive of the need for hospitalization [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In postoperative patients, routine pulse oximetry has been shown to decrease the need for rapid response team activation and transfer to the ICU [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In children, there is accumulating evidence that pulse oximetry may have value as a routine outpatient screen for congenital heart disease [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pulse oximetry offers the advantage of providing data on hemoglobin saturation, rather than PO",
"    <sub>",
"     2",
"    </sub>",
"    . SaO",
"    <sub>",
"     2",
"    </sub>",
"    reflects the 98 percent of arterial oxygen content that is normally carried by hemoglobin, while the PO",
"    <sub>",
"     2",
"    </sub>",
"    directly measures only the small amount of oxygen that is dissolved in plasma. PO",
"    <sub>",
"     2",
"    </sub>",
"    commonly is used to estimate arterial oxyhemoglobin saturation and oxygen content because the dissolved and hemoglobin-bound oxygen pools are in equilibrium. However, changes in pH, temperature, and the concentration of 2,3-diphosphoglycerate alter the PO",
"    <sub>",
"     2",
"    </sub>",
"    -SaO",
"    <sub>",
"     2",
"    </sub>",
"    relationship, and may result in misleading calculations of oxyhemoglobin saturation (",
"    <a class=\"graphic graphic_figure graphicRef81216 \" href=\"UTD.htm?2/26/2479\">",
"     figure 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/29/23001?source=see_link\">",
"     \"Structure and function of normal human hemoglobins\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=see_link\">",
"     \"Oxygenation and mechanisms of hypoxemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Delineation of an oxygen saturation below which tissue hypoxia occurs has been difficult because of the large number of variables that contribute to tissue hypoxia. As a result, there is no consensus about what constitutes normal and abnormal oximetry. In our practice, we consider resting oxygen saturation &le;95 percent or exercise desaturation of &ge;5 percent abnormal [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/29\">",
"     29",
"    </a>",
"    ]; however, these values should not be considered in isolation. For example, a resting oxygen saturation of 95 percent could be abnormal if a patient previously had a resting oxygen saturation of 99 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     LIMITATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulse oximetry is a noninvasive technology with limited potential to produce adverse events. However, digital injury occasionally can occur when continuous pulse oximetry is applied for several days; this complication appears more common in patients receiving vasopressor therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/30\">",
"     30",
"    </a>",
"    ]. Other limitations include the inability to measure ventilation or the partial pressure of arterial carbon dioxide (PaCO",
"    <sub>",
"     2",
"    </sub>",
"    ), and the potential for delay in detection of acute hypoxemia. In neonates, pulse oximetry is also unable to detect significant hyperoxia, which can result in oxygen toxicity.",
"   </p>",
"   <p>",
"    While pulse oximetry is a convenient way of measuring arterial oxygenation, it does not assess ventilation. Therefore, its use should be supplemented with arterial blood gas analysis when alveolar hypoventilation is suspected clinically [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/21\">",
"     21",
"    </a>",
"    ]. The use of supplemental oxygen may prevent hypoxemia despite severe alveolar hypoventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. As an example, one inadvertently hypoventilated patient who was administered 100 percent oxygen during hip arthroplasty and monitored with pulse oximetry alone developed a PaCO",
"    <sub>",
"     2",
"    </sub>",
"    of 265 mmHg and an arterial pH of 6.65, despite maintenance of oxygen saturations of 94 to 96 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, because it does not measure PaO",
"    <sub>",
"     2",
"    </sub>",
"    , overreliance on pulse oximetry can delay detection of clinically significant hypoxemia. A large decrease in PO",
"    <sub>",
"     2",
"    </sub>",
"    will not produce a significant fall in SaO",
"    <sub>",
"     2",
"    </sub>",
"    until the steeper portion of the oxygen hemoglobin dissociation curve is encountered at a PO",
"    <sub>",
"     2",
"    </sub>",
"    of approximately 60 to 70 mmHg. This is particularly important in patients receiving supplemental oxygen. As an example, a fall in PaO",
"    <sub>",
"     2",
"    </sub>",
"    in such a patient from 140 to 65 mmHg would be required before a significant decrease in oxygen saturation is detected. Furthermore, pulse oximetry results are signal-averaged over several seconds. Therefore, the pulse oximeter may not detect a hypoxemic event until well after it has occurred [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/8\">",
"     8",
"    </a>",
"    ]. This delay may be of particular significance when the device is being used for monitoring during intubation.",
"   </p>",
"   <p>",
"    Oxygen toxicity in premature neonates can be limited by titrating oxygen to an SaO",
"    <sub>",
"     2",
"    </sub>",
"    of 90 percent, which usually reflects of PaO",
"    <sub>",
"     2",
"    </sub>",
"    of approximately 60 mmHg at a pH of 7.4 [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/8,13\">",
"     8,13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/47/28407?source=see_link\">",
"     \"Oxygen toxicity\"",
"    </a>",
"    .) However, just as pulse oximeters are not ideally suited to detect severe hypoxemia, they are also not well suited to detect hyperoxemia. Due to the shape of the O",
"    <sub>",
"     2",
"    </sub>",
"    -hemoglobin dissociation curve, large changes in PaO",
"    <sub>",
"     2",
"    </sub>",
"    may result in no change in O",
"    <sub>",
"     2",
"    </sub>",
"    saturation if the saturation is already near 100 percent. Therefore, in patients at risk for profound hypoxemia or for hyperoxemia, SaO",
"    <sub>",
"     2",
"    </sub>",
"    by pulse oximeter should be verified by arterial blood gas analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=see_link\">",
"     \"Oxygenation and mechanisms of hypoxemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SOURCES OF ARTIFACT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Interpretation of pulse oximetry readings must account for a variety of factors that may artifactually influence the results. The best defense against these potential sources of error is a high index of suspicion. If a saturation reading is in doubt, a health care worker can perform a quick quality assurance test by putting the probe on his or her own finger as near as possible to the original patient site [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Common sources of artifact include inappropriate probe placement, motion artifact, ambient light, and electromagnetic radiation. Each is discussed in detail below.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Improper probe placement &mdash; Due to partial detachment of the probe, light from only one of the two light-emitting diodes may pass through the tissue, resulting in either a falsely elevated or depressed reading [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/11,33\">",
"       11,33",
"      </a>",
"      ]. A similar problem can occur in infants and small children, because the small size of fingers or other tissues may result in differences in the path length of one light source compared to that of the other. These problems can be minimized by ensuring that the probe is properly attached with the light sources and detectors opposite each other in a nontangential path [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Placement of the sensor on the same extremity as a blood pressure cuff or arterial line can cause erroneous readings and should be avoided [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/35\">",
"     35",
"    </a>",
"    ]. The choice of probe site may also affect accuracy; finger probes appear more accurate than forehead, nose, or earlobe probes during low perfusion states [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/12\">",
"     12",
"    </a>",
"    ]. Transesophageal probes have been developed, and provide data that appear to be less influenced by changes in patient temperature, mean arterial pressure, or peripheral vasoconstriction than probes placed at other sites [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/36,37\">",
"     36,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Motion artifact &mdash; A poor signal-to-noise ratio will cause signal artifact [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/1,7\">",
"       1,7",
"      </a>",
"      ]. This most commonly results from motion due to shivering, seizure activity, pressure on the sensor, or transport of the patient by ambulance or helicopter. Newer pulse oximeters appear to be less influenced by motion artifact [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/38,39\">",
"       38,39",
"      </a>",
"      ]. Many pulse oximeters display a waveform extrapolated from the arterial pulse signal. Artifactual changes or a diminished arterial pulse may be evident in this waveform, and repositioning the probe may improve the signal.",
"     </li>",
"     <li>",
"      Ambient light &mdash; Intense daylight, fluorescent, incandescent, xenon, and infrared light sources have been reported to cause spurious pulse oximetry readings [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/2\">",
"       2",
"      </a>",
"      ]. In such cases, the oximeter will often give a falsely low reading of 85 percent, the saturation at which the ratio of red to infrared light is one. Falsely elevated readings due to ambient light of normal intensity have also been reported, but are rare, particularly among newer devices [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/11,40\">",
"       11,40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Electromagnetic radiation &mdash; Radio frequency emissions from magnetic resonance imaging (MRI) scanners may interfere with pulse oximetry. In addition, second- and third-degree burns beneath pulse oximeter probes have been reported in patients undergoing MRI studies [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/13\">",
"       13",
"      </a>",
"      ]. This complication is believed to result from the generation of electrical skin currents beneath the looped pulse oximeter cables, which act as an antenna. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5689?source=see_link&amp;anchor=H19#H19\">",
"       \"Principles of magnetic resonance imaging\", section on 'Precautions'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other sources of electromagnetic radiation, such as cellular phones and electrocautery devices, can also interfere with pulse oximeters [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/15,34\">",
"     15,34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PATIENT-RELATED ERRORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulse oximetry readings may be inaccurate in certain situations, even if the device is functioning properly and is free from external interference. The results of pulse oximetry should be interpreted with particular caution in the presence of abnormal hemoglobins, nail polish, deeply pigmented skin, hypoperfusion, anemia, venous congestion, or when certain vital dyes are used for clinical purposes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Abnormal hemoglobins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormal hemoglobins or hemoglobin variants may interfere with pulse oximetry if their absorption properties are similar to those of oxyhemoglobin or deoxyhemoglobin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/29/23001?source=see_link\">",
"     \"Structure and function of normal human hemoglobins\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Carboxyhemoglobin &mdash; Carboxyhemoglobin absorbs approximately the same amount of 660 nm light as does oxyhemoglobin. Thus, the pulse oximetry reading represents an inexact summation of oxyhemoglobin and carboxyhemoglobin (",
"      <a class=\"graphic graphic_figure graphicRef65554 \" href=\"UTD.htm?31/38/32365\">",
"       figure 3",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/1,11,12,41-43\">",
"       1,11,12,41-43",
"      </a>",
"      ]. Due to the interference of high levels of carboxyhemoglobin in carbon monoxide poisoning, or in chronic, heavy smokers, a falsely reassuring normal pulse oximetry reading may mask life-threatening arterial desaturation. In such cases, whenever carboxyhemoglobinemia is suspected, co-oximetry (not pulse oximetry) is recommended for the measurement of oxyhemoglobin.",
"      <br/>",
"      <br/>",
"      Co-oximeters use four rather than two wavelengths of light to detect oxyhemoglobin, deoxyhemoglobin, carboxyhemoglobin, and methemoglobin; however, they require a sample of arterial whole blood and a specific laboratory request for its measurement [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/8,22\">",
"       8,22",
"      </a>",
"      ]. Noninvasive pulse co-oximeters capable of photo spectroscopic measurements of carboxyhemoglobin are in development [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/44\">",
"       44",
"      </a>",
"      ]. However, preliminary studies question their accuracy [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/45,46\">",
"       45,46",
"      </a>",
"      ]. Until these devices are validated, they cannot be recommended for routine clinical use for the detection of oxyhemoglobin when carboxyhemoglobinemia is suspected. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10345?source=see_link\">",
"       \"Carbon monoxide poisoning\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Methemoglobin &mdash; Methemoglobin absorbs at both 660 and 940 nm [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/12\">",
"       12",
"      </a>",
"      ]. Up to a methemoglobin level of 20 percent, SaO",
"      <sub>",
"       2",
"      </sub>",
"      drops by about one-half of the methemoglobin percentage. At higher methemoglobin levels, SaO",
"      <sub>",
"       2",
"      </sub>",
"      tends toward 85 percent regardless of the true percentage of oxyhemoglobin (",
"      <a class=\"graphic graphic_figure graphicRef68505 \" href=\"UTD.htm?33/48/34573\">",
"       figure 4",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/1,13,47,48\">",
"       1,13,47,48",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/33/8729?source=see_link\">",
"       \"Clinical features, diagnosis, and treatment of methemoglobinemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sickle hemoglobin &mdash; Sickle hemoglobin generally produces pulse oximeter readings similar to normal hemoglobin, but cases of falsely elevated and falsely low readings have been reported [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/21,49\">",
"       21,49",
"      </a>",
"      ]. Patients with sickle cell disease are at risk of hypoxemia caused by a number of pulmonary complications, which are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/28/27082?source=see_link\">",
"       \"Pulmonary complications of sickle cell disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Fetal hemoglobin &mdash; Fetal hemoglobin gives pulse oximetry readings clinically indistinguishable from those of adult hemoglobin [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/7\">",
"       7",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/29/23001?source=see_link\">",
"       \"Structure and function of normal human hemoglobins\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Hypoperfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulse oximetry readings can be falsely low due to signal failure in the setting of hemodynamic instability or poor limb perfusion from extremity elevation or vasoconstriction [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/50-52\">",
"     50-52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In adults, the accuracy of standard pulse oximeters decreases dramatically when systolic blood pressure falls below 80 mmHg, generally resulting in underestimation of the actual arterial oxygen saturation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/53\">",
"     53",
"    </a>",
"    ]. Measures that may improve the signal in these settings include vigorous rubbing of the affected extremity, application of heat, or the use of topical vasodilators such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/24/11656?source=see_link\">",
"     nitroglycerin",
"    </a>",
"    paste or oil of wintergreen (methyl salicylate) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/2,3,21\">",
"     2,3,21",
"    </a>",
"    ]. Forehead sensors may also be more accurate than other pulse oximetry probes in hypoperfused patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Hypothermia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypothermia may interfere with pulse oximetry because of the associated peripheral vasoconstriction. This can contribute to a delay in the recognition of acute hypoxemia. particularly if finger probes are used [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/55\">",
"     55",
"    </a>",
"    ]. Hypothermic patients should be monitored using either an ear or forehead probe, which are less likely to delay recognition of acute desaturation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/34/15913?source=see_link\">",
"     \"Accidental hypothermia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;In vitro and animal studies suggest that pulse oximetry readings may be affected by profoundly decreased hemoglobin concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/21\">",
"     21",
"    </a>",
"    ]. In vivo, low hemoglobin concentrations appear to cause falsely low readings when the SaO",
"    <sub>",
"     2",
"    </sub>",
"    is below 80 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/13\">",
"     13",
"    </a>",
"    ]. However, this effect is not clinically significant until the hemoglobin level is less than 5",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/51,56\">",
"     51,56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Venous congestion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Venous congestion due to tricuspid valve incompetence or cardiomyopathy may yield falsely low SaO",
"    <sub>",
"     2",
"    </sub>",
"    readings, due to generation of venous pulsations. This results from the instrument treating less oxygenated, pulsatile venous blood as part of the arterial sample, thereby underestimating the actual SaO",
"    <sub>",
"     2",
"    </sub>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Skin pigmentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data regarding the impact of skin pigmentation on pulse oximetry are conflicting [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/15,57\">",
"     15,57",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In theory, skin pigmentation should have no effect, since it should absorb at a constant level and be subtracted out as part of the background in the SaO",
"      <sub>",
"       2",
"      </sub>",
"      calculation. This includes altered pigmentation due to hyperbilirubinemia [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      However, an increased incidence of both signal detection errors and readings erroneously elevated by 4 percent or more have been described in African-American patients [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/13,58\">",
"       13,58",
"      </a>",
"      ]. In addition, erroneously low pulse oximetry readings were reported in a child with bronze baby syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/59\">",
"       59",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/13/22745?source=see_link&amp;anchor=H17#H17\">",
"       \"Benign skin and scalp lesions in the newborn and young infant\", section on 'Bronze baby syndrome'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Nail polish",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of nail polish can potentially affect pulse oximeter readings if the polish absorbs light at 660 nm",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    940 nm [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/1\">",
"     1",
"    </a>",
"    ]. A small study of volunteers wearing black, green, and blue nail polish revealed a drop in SaO",
"    <sub>",
"     2",
"    </sub>",
"    of 3 percent, 5 percent, and 6 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/15\">",
"     15",
"    </a>",
"    ]. This problem can be avoided by mounting the probe on the finger sideways, rather than in a dorsal-ventral orientation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/13\">",
"     13",
"    </a>",
"    ]. Red nail polish does not appear to have an effect on pulse oximetry readings. In addition, later generation oximeters appear to be less susceptible to interference from nail polish than earlier models [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Artificial acrylic nails may also affect the accuracy of pulse oximetry readings, depending on the device used. It is recommended that the probe be mounted on an alternative site or at least one of the acrylic nails be removed [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Vital dyes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vital dyes, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/44/32450?source=see_link\">",
"     indocyanine green",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29108?source=see_link\">",
"     fluorescein",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/10/15522?source=see_link\">",
"     indigo carmine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/26/420?source=see_link\">",
"     isosulfan blue",
"    </a>",
"    (which is used intraoperatively to mark breast and melanoma tumors), can cause erroneously low pulse oximetry readings [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/15,62-67\">",
"     15,62-67",
"    </a>",
"    ]. Methylene blue has the greatest impact, as it absorbs significantly at 670 nm. However, these effects tend to be transient, and resolve rapidly as the dyes are diluted and metabolized [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9736/abstract/7,15\">",
"     7,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pulse oximetry uses the differential absorbance of light by oxyhemoglobin and deoxyhemoglobin to estimate the oxygen saturation (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Principles'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Pulse oximetry is indicated in any setting where hypoxemia may occur (see",
"      <a class=\"local\" href=\"#H4\">",
"       'Applications'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Pulse oximetry has several important limitations. As an example, detection of acute hypoxemia by pulse oximetry may be slow. Pulse oximetry cannot measure ventilation or hyperoxia (see",
"      <a class=\"local\" href=\"#H5\">",
"       'Limitations'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Erroneous pulse oximetry readings can result from technical factors including improper probe placement, motion artifact, ambient light, and electromagnetic radiation (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Sources of artifact'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Erroneous pulse oximetry readings can also result from patient factors including abnormal hemoglobin, hypoperfusion, hypothermia, anemia, venous congestion, dark skin pigmentation, nail polish, and administration of certain vital dyes (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Patient-related errors'",
"      </a>",
"      above).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/1\">",
"      Grace RF. Pulse oximetry. Gold standard or false sense of security? Med J Aust 1994; 160:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/2\">",
"      Hanning CD, Alexander-Williams JM. Pulse oximetry: a practical review. BMJ 1995; 311:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/3\">",
"      Pierson DJ. Pulse oximetry versus arterial blood gas specimens in long-term oxygen therapy. Lung 1990; 168 Suppl:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/4\">",
"      Jubran A. Pulse oximetry. Intensive Care Med 2004; 30:2017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/5\">",
"      Neff TA. Routine oximetry. A fifth vital sign? Chest 1988; 94:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/6\">",
"      Severinghaus JW, Astrup PB. History of blood gas analysis. VI. Oximetry. J Clin Monit 1986; 2:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/7\">",
"      Mendelson Y. Pulse oximetry: theory and applications for noninvasive monitoring. Clin Chem 1992; 38:1601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/8\">",
"      Stoneham MD. Uses and limitations of pulse oximetry. Br J Hosp Med 1995; 54:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/9\">",
"      Severinghaus JW. Takuo Aoyagi: discovery of pulse oximetry. Anesth Analg 2007; 105:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/10\">",
"      Bongard F, Sue D. Pulse oximetry and capnography in intensive and transitional care units. West J Med 1992; 156:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/11\">",
"      Poets CF, Southall DP. Noninvasive monitoring of oxygenation in infants and children: practical considerations and areas of concern. Pediatrics 1994; 93:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/12\">",
"      Mengelkoch LJ, Martin D, Lawler J. A review of the principles of pulse oximetry and accuracy of pulse oximeter estimates during exercise. Phys Ther 1994; 74:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/13\">",
"      Severinghaus JW, Kelleher JF. Recent developments in pulse oximetry. Anesthesiology 1992; 76:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/14\">",
"      The use of pulse oximetry during conscious sedation. Council on Scientific Affairs, American Medical Association. JAMA 1993; 270:1463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/15\">",
"      Ralston AC, Webb RK, Runciman WB. Potential errors in pulse oximetry. III: Effects of interferences, dyes, dyshaemoglobins and other pigments. Anaesthesia 1991; 46:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/16\">",
"      Fanconi S. Pulse oximetry for hypoxemia: a warning to users and manufacturers. Intensive Care Med 1989; 15:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/17\">",
"      Carter BG, Carlin JB, Tibballs J, et al. Accuracy of two pulse oximeters at low arterial hemoglobin-oxygen saturation. Crit Care Med 1998; 26:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/18\">",
"      Chiappini F, Fuso L, Pistelli R. Accuracy of a pulse oximeter in the measurement of the oxyhaemoglobin saturation. Eur Respir J 1998; 11:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/19\">",
"      Pedersen T, Dyrlund Pedersen B, M&oslash;ller AM. Pulse oximetry for perioperative monitoring. Cochrane Database Syst Rev 2003; :CD002013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/20\">",
"      Pedersen T, M&oslash;ller AM, Pedersen BD. Pulse oximetry for perioperative monitoring: systematic review of randomized, controlled trials. Anesth Analg 2003; 96:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/21\">",
"      Lindberg LG, Lennmarken C, Vegfors M. Pulse oximetry--clinical implications and recent technical developments. Acta Anaesthesiol Scand 1995; 39:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/22\">",
"      Tallon RW. Oximetry: state-of-the-art. Nurs Manage 1996; 27:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/23\">",
"      Keim SM, Spaite DW, Maio RF, et al. Risk adjustment and outcome measures for out-of-hospital respiratory distress. Acad Emerg Med 2004; 11:1074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/24\">",
"      East CE, Chan FY, Colditz PB. Fetal pulse oximetry for fetal assessment in labour. Cochrane Database Syst Rev 2004; :CD004075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/25\">",
"      Wagner JL, Ruskin KJ. Pulse oximetry: basic principles and applications in aerospace medicine. Aviat Space Environ Med 2007; 78:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/26\">",
"      Boychuk RB, Yamamoto LG, DeMesa CJ, Kiyabu KM. Correlation of initial emergency department pulse oximetry values in asthma severity classes (steps) with the risk of hospitalization. Am J Emerg Med 2006; 24:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/27\">",
"      Taenzer AH, Pyke JB, McGrath SP, Blike GT. Impact of pulse oximetry surveillance on rescue events and intensive care unit transfers: a before-and-after concurrence study. Anesthesiology 2010; 112:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/28\">",
"      Mahle WT, Newburger JW, Matherne GP, et al. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics. Circulation 2009; 120:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/29\">",
"      American Thoracic Society, American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/30\">",
"      Wille J, Braams R, van Haren WH, van der Werken C. Pulse oximeter-induced digital injury: frequency rate and possible causative factors. Crit Care Med 2000; 28:3555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/31\">",
"      Ayas N, Bergstrom LR, Schwab TR, Narr BJ. Unrecognized severe postoperative hypercapnia: a case of apneic oxygenation. Mayo Clin Proc 1998; 73:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/32\">",
"      Fu ES, Downs JB, Schweiger JW, et al. Supplemental oxygen impairs detection of hypoventilation by pulse oximetry. Chest 2004; 126:1552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/33\">",
"      Guan Z, Baker K, Sandberg WS. Misalignment of disposable pulse oximeter probes results in false saturation readings that influence anesthetic management. Anesth Analg 2009; 109:1530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/34\">",
"      Moyle JT. Uses and abuses of pulse oximetry. Arch Dis Child 1996; 74:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/35\">",
"      Mardirossian G, Schneider RE. Limitations of pulse oximetry. Anesth Prog 1992; 39:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/36\">",
"      Vicenzi MN, Gombotz H, Krenn H, et al. Transesophageal versus surface pulse oximetry in intensive care unit patients. Crit Care Med 2000; 28:2268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/37\">",
"      Kyriacou PA, Powell S, Langford RM, Jones DP. Esophageal pulse oximetry utilizing reflectance photoplethysmography. IEEE Trans Biomed Eng 2002; 49:1360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/38\">",
"      Barker SJ. \"Motion-resistant\" pulse oximetry: a comparison of new and old models. Anesth Analg 2002; 95:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/39\">",
"      Gehring H, Hornberger C, Matz H, et al. The effects of motion artifact and low perfusion on the performance of a new generation of pulse oximeters in volunteers undergoing hypoxemia. Respir Care 2002; 47:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/40\">",
"      Fluck RR Jr, Schroeder C, Frani G, et al. Does ambient light affect the accuracy of pulse oximetry? Respir Care 2003; 48:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/41\">",
"      Barker SJ, Tremper KK. The effect of carbon monoxide inhalation on pulse oximetry and transcutaneous PO2. Anesthesiology 1987; 66:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/42\">",
"      Hampson NB. Pulse oximetry in severe carbon monoxide poisoning. Chest 1998; 114:1036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/43\">",
"      Lee WW, Mayberry K, Crapo R, Jensen RL. The accuracy of pulse oximetry in the emergency department. Am J Emerg Med 2000; 18:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/44\">",
"      Barker SJ, Curry J, Redford D, Morgan S. Measurement of carboxyhemoglobin and methemoglobin by pulse oximetry: a human volunteer study. Anesthesiology 2006; 105:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/45\">",
"      O'Malley GF. Non-invasive carbon monoxide measurement is not accurate. Ann Emerg Med 2006; 48:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/46\">",
"      Touger M, Birnbaum A, Wang J, et al. Performance of the RAD-57 pulse CO-oximeter compared with standard laboratory carboxyhemoglobin measurement. Ann Emerg Med 2010; 56:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/47\">",
"      Barker SJ, Tremper KK, Hyatt J. Effects of methemoglobinemia on pulse oximetry and mixed venous oximetry. Anesthesiology 1989; 70:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/48\">",
"      Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med 1999; 34:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/49\">",
"      Ortiz FO, Aldrich TK, Nagel RL, Benjamin LJ. Accuracy of pulse oximetry in sickle cell disease. Am J Respir Crit Care Med 1999; 159:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/50\">",
"      Van de Louw A, Cracco C, Cerf C, et al. Accuracy of pulse oximetry in the intensive care unit. Intensive Care Med 2001; 27:1606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/51\">",
"      Perkins GD, McAuley DF, Giles S, et al. Do changes in pulse oximeter oxygen saturation predict equivalent changes in arterial oxygen saturation? Crit Care 2003; 7:R67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/52\">",
"      Talke P, Stapelfeldt C. Effect of peripheral vasoconstriction on pulse oximetry. J Clin Monit Comput 2006; 20:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/53\">",
"      Hinkelbein J, Genzwuerker HV, Fiedler F. Detection of a systolic pressure threshold for reliable readings in pulse oximetry. Resuscitation 2005; 64:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/54\">",
"      Schallom L, Sona C, McSweeney M, Mazuski J. Comparison of forehead and digit oximetry in surgical/trauma patients at risk for decreased peripheral perfusion. Heart Lung 2007; 36:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/55\">",
"      MacLeod DB, Cortinez LI, Keifer JC, et al. The desaturation response time of finger pulse oximeters during mild hypothermia. Anaesthesia 2005; 60:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/56\">",
"      Schnapp LM, Cohen NH. Pulse oximetry. Uses and abuses. Chest 1990; 98:1244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/57\">",
"      Jubran A, Tobin MJ. Monitoring during mechanical ventilation. Clin Chest Med 1996; 17:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/58\">",
"      Bickler PE, Feiner JR, Severinghaus JW. Effects of skin pigmentation on pulse oximeter accuracy at low saturation. Anesthesiology 2005; 102:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/59\">",
"      Hussain SA. Pulse oximetry interference in bronze baby syndrome. J Perinatol 2009; 29:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/60\">",
"      Brand TM, Brand ME, Jay GD. Enamel nail polish does not interfere with pulse oximetry among normoxic volunteers. J Clin Monit Comput 2002; 17:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/61\">",
"      Hinkelbein J, Koehler H, Genzwuerker HV, Fiedler F. Artificial acrylic finger nails may alter pulse oximetry measurement. Resuscitation 2007; 74:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/62\">",
"      Houseworth JL, Parks JA, Miguel EA, et al. Transfusion medicine illustrated. Iatrogenic green plasma. Transfusion 2005; 45:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/63\">",
"      Momeni R, Ariyan S. Pulse oximetry declines due to intradermal isosulfan blue dye: a controlled prospective study. Ann Surg Oncol 2004; 11:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/64\">",
"      El-Tamer M, Komenaka IK, Curry S, et al. Pulse oximeter changes with sentinel lymph node biopsy in breast cancer. Arch Surg 2003; 138:1257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/65\">",
"      Koivusalo AM, Von Smitten K, Lindgren L. Sentinel node mapping affects intraoperative pulse oximetric recordings during breast cancer surgery. Acta Anaesthesiol Scand 2002; 46:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/66\">",
"      Vokach-Brodsky L, Jeffrey SS, Lemmens HJ, Brock-Utne JG. Isosulfan blue affects pulse oximetry. Anesthesiology 2000; 93:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9736/abstract/67\">",
"      Rizzi RR, Thomas K, Pilnik S. Factious desaturation due to isosulfan dye injection. Anesthesiology 2000; 93:1146.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1612 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-217.16.9.173-D52E307D49-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_32_9736=[""].join("\n");
var outline_f9_32_9736=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      APPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      LIMITATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SOURCES OF ARTIFACT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PATIENT-RELATED ERRORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Abnormal hemoglobins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Hypoperfusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Hypothermia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Venous congestion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Skin pigmentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Nail polish",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Vital dyes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/1612\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1612|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/9/25758\" title=\"figure 1\">",
"      Pulse oximetry light absorption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/26/2479\" title=\"figure 2\">",
"      Hemoglobin oxygen dissociation curve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/38/32365\" title=\"figure 3\">",
"      Effect of carboxyhemoglobin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/48/34573\" title=\"figure 4\">",
"      Effect of methemoglobin",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/34/15913?source=related_link\">",
"      Accidental hypothermia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15894?source=related_link\">",
"      Arterial blood gases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/51/26424?source=related_link\">",
"      Arterial catheterization techniques for invasive monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/13/22745?source=related_link\">",
"      Benign skin and scalp lesions in the newborn and young infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10345?source=related_link\">",
"      Carbon monoxide poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/33/8729?source=related_link\">",
"      Clinical features, diagnosis, and treatment of methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/47/28407?source=related_link\">",
"      Oxygen toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=related_link\">",
"      Oxygenation and mechanisms of hypoxemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5689?source=related_link\">",
"      Principles of magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/28/27082?source=related_link\">",
"      Pulmonary complications of sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/29/23001?source=related_link\">",
"      Structure and function of normal human hemoglobins",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_32_9737="Cutaneous polyarteritis";
var content_f9_32_9737=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F51874&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F51874&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 552px\">",
"   <div class=\"ttl\">",
"    Cutaneous polyarteritis nodosa",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 532px; height: 233px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Different stages of cutaneous vasculitis lesions in polyarteritis nodosa, which are similar to those seen at extracutaneous sites. Left panel: Involvement of a single small artery in the subcutis by a necrotizing vasculitis which is neutrophilic rich at its inception and then evolves into a predominance of mononuclear cells. Right panel: Inflammatory infiltrate in the adventitia with marked necrosis and fibrin deposition of the vascular wall.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cynthia Magro, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_32_9737=[""].join("\n");
var outline_f9_32_9737=null;
var title_f9_32_9738="Diagnostic approach to the patient with suspected polycythemia vera";
var content_f9_32_9738=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnostic approach to the patient with suspected polycythemia vera",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/32/9738/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/32/9738/contributors\">",
"     Ayalew Tefferi, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/32/9738/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/32/9738/contributors\">",
"     Stanley L Schrier, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/32/9738/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/32/9738/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/32/9738/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polycythemia vera (PV) is one of the chronic myeloproliferative disorders (neoplasms), collectively characterized by clonal proliferation of myeloid cells with variable morphologic maturity and hematopoietic efficiency (",
"    <a class=\"graphic graphic_figure graphicRef56283 \" href=\"UTD.htm?24/16/24835\">",
"     figure 1",
"    </a>",
"    ). PV is distinguished clinically by the presence of an elevated red blood cell mass (RCM). However, an increased RCM alone is insufficient to establish the diagnosis, since this is also observed in conditions associated with chronic hypoxia and with erythropoietin-secreting tumors (",
"    <a class=\"graphic graphic_table graphicRef76036 \" href=\"UTD.htm?30/46/31468\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The approach to confirming the diagnosis of PV will be the subject of this topic review. The prognosis and treatment of PV and the overall approach to the patient with polycythemia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/56/28554?source=see_link\">",
"     \"Prognosis and treatment of polycythemia vera\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/12/24777?source=see_link\">",
"     \"Diagnostic approach to the patient with polycythemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DISEASE INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polycythemia vera occurs in all populations, and all ages, including early adulthood and occasionally in children and adolescents [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. The median age at diagnosis for the first 325 patients entered into the Polycythemia Vera Study Group (PVSG) main protocol was 60 years (range 20 to 85) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence of PV in Olmsted County, Minnesota during the period from 1935 through 1989 was estimated to be",
"    <span class=\"nowrap\">",
"     1.9/100,000",
"    </span>",
"    per year, approximately one-half that for multiple myeloma in the same population [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/5\">",
"     5",
"    </a>",
"    ]. The incidence of PV is slightly higher in men than women (2.8 versus 1.3",
"    <span class=\"nowrap\">",
"     cases/100,000",
"    </span>",
"    per year), and is highest for men aged 70 to 79 years (24",
"    <span class=\"nowrap\">",
"     cases/100,000",
"    </span>",
"    persons per year) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Survival",
"    </span>",
"    &nbsp;&mdash;&nbsp;Median survival of patients with",
"    <strong>",
"     untreated",
"    </strong>",
"    PV has been estimated at 6 to 18 months from the time of diagnosis, whereas survival of treated patients exceeds 10 years [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/6\">",
"     6",
"    </a>",
"    ]. The main causes of death include thrombosis and disease transformation into myelofibrosis with myeloid metaplasia (MMM)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    acute myeloid leukemia (AML) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/56/28554?source=see_link\">",
"     \"Prognosis and treatment of polycythemia vera\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the PVSG-01 major protocol, which compared treatment with phlebotomy, leukeran, or radioactive P-32, the most common causes of death included [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Thrombosis (29 percent)",
"     </li>",
"     <li>",
"      Hematologic malignancies (ie, AML or MDS, 23 percent)",
"     </li>",
"     <li>",
"      Non-hematologic malignancies (16 percent)",
"     </li>",
"     <li>",
"      Hemorrhage (7 percent)",
"     </li>",
"     <li>",
"      Myeloid metaplasia with myelofibrosis (3 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients with PV are discovered incidentally when an elevated hematocrit is noted on a complete blood count obtained for some other reason. The following frequency of symptoms, physical, and laboratory findings were noted by the PVSG (",
"    <a class=\"graphic graphic_table graphicRef54453 \" href=\"UTD.htm?1/43/1723\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Nonspecific complaints",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonspecific complaints such as headache, weakness, dizziness, and excessive sweating were present in 48, 47, 43, and 33 percent, respectively. Acute gouty arthritis has been described in 5 to 20 percent of patients with PV.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pruritus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pruritus, especially following vigorous rubbing of the skin after a warm bath or shower, was present in 43 percent of the patients enrolled in the PVSG and in 31 percent of patients with PV seen at the Mayo Clinic, where it was associated with a significantly lower incidence of arterial thrombosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/9\">",
"     9",
"    </a>",
"    ]. It often represented the patient's chief complaint. The cause of pruritus in PV is unclear. It has been suggested that mast cell degranulation, with release of histamine, fibrinolytic factors, prostaglandins, or interleukin-31 may play a role [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/10-13\">",
"     10-13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An alternative hypothesis is that the release of adenosine diphosphate from red cells or catecholamines from adrenergic vasoconstrictor nerves when the skin is cooled down might cause platelet aggregation in skin vessels, with local production of pruritogenic factors, such as prostaglandins [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/12\">",
"     12",
"    </a>",
"    ]. The observation that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    can relieve pruritus in at least some patients is compatible with an important role for prostaglandins [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Erythromelalgia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Erythromelalgia, or burning pain in the feet or hands accompanied by erythema, pallor, or cyanosis, in the presence of palpable pulses, is common in PV (",
"    <a class=\"graphic graphic_picture graphicRef81121 \" href=\"UTD.htm?17/25/17808\">",
"     picture 1",
"    </a>",
"    ). Erythromelalgia and the associated symptom of acral paresthesias, both of which can be considered to be forms of dysesthesia, are considered to be pathognomonic microvascular thrombotic complications in PV and essential thrombocythemia, and are associated with platelet counts usually",
"    <span class=\"nowrap\">",
"     &gt;400,000/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. These symptoms respond dramatically to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    in low doses or to reduction of the platelet count to normal with low-dose myelosuppressive agents [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]; they may be related to abnormal arachidonic acid metabolism in PV platelets [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Venous and arterial thromboses are common in PV. Although the mechanisms involved in this hypercoagulable state are unclear, abnormalities in blood viscosity, platelets, and leukocytes have been implicated [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/17\">",
"     17",
"    </a>",
"    ]. A prior major thrombotic complication (eg, cerebrovascular event, myocardial infarction, superficial thrombophlebitis, deep vein thrombosis, pulmonary embolus) was present in 15 percent of patients entering into the PVSG studies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/56/28554?source=see_link\">",
"     \"Prognosis and treatment of polycythemia vera\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Major thrombotic events can occur in patients who otherwise have few clinical and laboratory features of PV. Examples include the Budd-Chiari syndrome, and portal, splenic, or mesenteric vein thrombosis, in whom the ensuing portal hypertension and hypersplenism may mask the increase in blood cell counts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/18-23\">",
"     18-23",
"    </a>",
"    ]. PV should be suspected in patients with these diagnoses, particularly women under the age of 45. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/53/31575?source=see_link&amp;anchor=H3#H3\">",
"     \"Etiology of the Budd-Chiari syndrome\", section on 'Myeloproliferative disorders'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Transient visual disturbances (eg, amaurosis fugax, scintillating scotomata, ophthalmic migraine) can occur in PV, similar to those seen in patients with essential thrombocythemia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/28/18890?source=see_link&amp;anchor=H7#H7\">",
"     \"Diagnosis and clinical manifestations of essential thrombocythemia\", section on 'Vasomotor symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Gastrointestinal symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrointestinal complaints are common in PV, with a high incidence of epigastric distress, history of peptic ulcer disease, and gastroduodenal erosions on upper endoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/25\">",
"     25",
"    </a>",
"    ]. These have been attributed to alterations in gastric mucosal blood flow due to altered blood viscosity,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    increased histamine release from tissue basophils, although one study has indicated a high incidence of positivity for infection with Helicobacter pylori [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major abnormal findings on physical examination include splenomegaly, facial plethora (ruddy cyanosis), and hepatomegaly which occurred in 70, 67, and 40 percent of patients entered into the original PVSG protocol, respectively. Other physical findings which might be helpful in pointing to a diagnosis of PV include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Injection of the conjunctival small vessels",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      engorgement of the veins of the optic fundus",
"     </li>",
"     <li>",
"      Excoriation of the skin, which might be extensive, suggesting the presence of severe pruritus, a common complaint in PV",
"     </li>",
"     <li>",
"      Stigmata of a prior arterial or venous thrombotic event (eg, stroke, deep vein thrombosis, superficial thrombophlebitis)",
"     </li>",
"     <li>",
"      Gouty arthritis and tophi",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     LABORATORY FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory findings in PV include an elevated",
"    <span class=\"nowrap\">",
"     hemoglobin/hematocrit",
"    </span>",
"    and red blood cell mass in virtually all patients, a platelet count",
"    <span class=\"nowrap\">",
"     &gt;400,000/microL",
"    </span>",
"    in 60 percent, and a white blood cell count",
"    <span class=\"nowrap\">",
"     &gt;12,000/microL",
"    </span>",
"    in 40 percent. Bone marrow cellularity was increased in 90 percent of patients, and storage iron was absent from the marrow in 94 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22767040\">",
"    <span class=\"h2\">",
"     Bone marrow fibrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a study of 526 subjects who met the WHO criteria for the diagnosis of PV, 74 (14 percent) displayed minor (grade 1) reticulin fibrosis on their initial bone marrow examination, and only two showed higher grade fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/26\">",
"     26",
"    </a>",
"    ]. Presenting clinical and laboratory characteristics, including JAK2V617F allele burdens, between patients with and without fibrosis were generally similar, although palpable splenomegaly was significantly more common in those with fibrosis. While there was no difference between the two patient groups in terms of overall or leukemia-free survival, those with fibrosis were significantly more prone to develop post-PV myelofibrosis (2.2 versus 0.8 per 100 patient-years) and significantly less prone to experience thrombosis during their clinical course (1.1 versus 2.7 per 100 patient-years).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3607109\">",
"    <span class=\"h2\">",
"     Elevated cytokine levels",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plasma levels of a number of cytokines have been found to be elevated in patients with PV, with a pattern differing from that seen in patients with primary myelofibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/27\">",
"     27",
"    </a>",
"    ]. Direct phenotypic correlations in 65 PV patients included levels of IL-2 with hematocrit; IL-1b, IL-2, IL-7, FGF-b, and HGF with leukocytosis; and IFN-alpha and IFN-gamma with thrombocytosis. On multivariate analysis, increased levels of MIP-1beta, older age, and leukocytosis were significantly associated with shortened survival. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/3/36922?source=see_link&amp;anchor=H12714880#H12714880\">",
"     \"Prognosis and treatment of primary myelofibrosis\", section on 'Elevated cytokine levels'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC CRITERIA AND ALGORITHMS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20383267\">",
"    <span class=\"h2\">",
"     Polycythemia Vera Study Group Criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic criteria for PV were proposed in the late 1960s by the Polycythemia Vera Study Group (PVSG) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/4\">",
"     4",
"    </a>",
"    ]. The criteria were based upon a combination of major and minor findings (",
"    <a class=\"graphic graphic_table graphicRef62788 \" href=\"UTD.htm?25/50/26411\">",
"     table 3",
"    </a>",
"    ) (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?38/55/39792?source=see_link\">",
"     calculator 1",
"    </a>",
"    ). They were developed prior to the general availability of assays for erythropoietin, endogenous erythroid colony formation, specific karyotypic, clonal, and JAK2 mutational analyses, and during the time when blood volume studies were routinely available. They are no longer as clinically useful, given the changes that have occurred in the following decades.",
"   </p>",
"   <p>",
"    These PVSG criteria were designed originally to select patients for clinical trials during the period from 1968 to 1974. The major objectives were to make diagnosis possible during an office visit and to collect patients whose disease activity was relatively homogeneous. Because no specific test for PV could serve as a gold standard, the criteria themselves became the gold standard. However, more than 30 years of experience in applying the criteria to a broader range of patients and the availability of genetic and molecular testing have led to a better appreciation of both their accuracy and limitations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Increased red blood cell mass",
"    </span>",
"    &nbsp;&mdash;&nbsp;The original PVSG criterion required a directly measured elevated RCM (&gt;36",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    in men and &gt;32",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    in women), using isotope dilution methodology. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/12/24777?source=see_link&amp;anchor=H16#H16\">",
"     \"Diagnostic approach to the patient with polycythemia\", section on 'Blood volume measurement'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These values were set at approximately 10 to 20 percent above the upper limits of normal and were deliberately chosen to reject patients with relatively early or inactive disease. However, this specific PVSG research protocol requirement does not apply to the general clinical setting, in which it may be preferable to include a broader range of patients. As a result, two revised approaches have been proposed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The International Council for Standardization in Hematology (ICSH) has recommended that blood volumes be calculated in terms of body surface area, since normalization of blood volume to total body weight is less accurate in obese patients [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/28\">",
"       28",
"      </a>",
"      ]. RCM, normalized to body surface area, should be considered elevated if it is more than 25 percent above the mean expected value [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      It has been our experience and that of others that the majority of female patients with a hemoglobin concentration &gt;16.5",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (or hematocrit [HCT] above 50 percent) and all male patients with a hemoglobin concentration &gt;18.5",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (or HCT above 56 percent) have an increased RCM [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/30,31\">",
"       30,31",
"      </a>",
"      ]. Slightly different cutoff values were found in reports from Belgium and Sweden (HCT greater than 55 [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/32\">",
"       32",
"      </a>",
"      ] or 60 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/33\">",
"       33",
"      </a>",
"      ] in women and greater than 60 percent in men [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/32,33\">",
"       32,33",
"      </a>",
"      ]).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, direct determination of RCM may be unnecessary in patients with hemoglobin or hematocrit concentrations exceeding the above-noted values, especially since it is felt that direct determination of the RCM is prone to error, has suboptimal sensitivity, and that the diagnosis of PV can be made via alternative clinical and laboratory tests [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/30,34\">",
"     30,34",
"    </a>",
"    ]. This position is not universally held [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/31,33,35-37\">",
"     31,33,35-37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Palpable splenomegaly",
"    </span>",
"    &nbsp;&mdash;&nbsp;Palpable splenomegaly was present in 70 percent of 325 patients entered into the first PVSG protocol [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/4\">",
"     4",
"    </a>",
"    ]. Since splenomegaly may not always be detectable by physical examination, other diagnostic criteria accept the finding of a nonpalpable spleen that is enlarged on an imaging test as a minor or secondary criterion [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/29,38\">",
"     29,38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Thrombocytosis and leukocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A platelet count",
"    <span class=\"nowrap\">",
"     &gt;400,000/microL",
"    </span>",
"    or a total white blood cell (WBC) count",
"    <span class=\"nowrap\">",
"     &gt;12,000/microL",
"    </span>",
"    in the absence of fever or infection are PVSG minor criteria (",
"    <a class=\"graphic graphic_table graphicRef62788 \" href=\"UTD.htm?25/50/26411\">",
"     table 3",
"    </a>",
"    ). However, the total WBC may not accurately reflect disease activity, since neutrophils and not lymphocytes or monocytes are increased in PV. Thus, newer criteria have replaced the total WBC count with an absolute neutrophil count",
"    <span class=\"nowrap\">",
"     &gt;10,000/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/29,38\">",
"     29,38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Leukocyte alkaline phosphatase and serum B12 studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;An elevated leukocyte alkaline phosphatase (LAP) score, and elevated serum B12 or unbound serum B12 binding capacity are minor PVSG criteria (",
"    <a class=\"graphic graphic_table graphicRef62788 \" href=\"UTD.htm?25/50/26411\">",
"     table 3",
"    </a>",
"    ). Although an elevated LAP score is reasonably sensitive for PV (approximately 70 percent), it is not specific. B12 studies are neither sensitive nor specific. The LAP score and B12 studies are not included as major or minor criteria in any of the newer published algorithms (see",
"    <a class=\"local\" href=\"#H20383514\">",
"     'Other diagnostic algorithms'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     False positive results",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because secondary causes of an elevated RCM are much more common than PV, the criteria should only be applied to populations in which other causes have been excluded. It has been estimated that the practicing hematologist sees 10 cases of relative or secondary polycythemia for every new patient with PV [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Application of the PVSG criteria has led to false positive results in patients with cirrhosis who smoke heavily. Cirrhosis may be associated with splenomegaly (one of the major criteria), while concomitant smoking may lead to an elevated RCM (another major criterion) due to high levels of carbon monoxide.",
"     </li>",
"     <li>",
"      Similarly, since splenomegaly, leukocytosis, and thrombocytosis are common to all of the chronic myeloproliferative diseases (",
"      <a class=\"graphic graphic_figure graphicRef56283 \" href=\"UTD.htm?24/16/24835\">",
"       figure 1",
"      </a>",
"      ), a patient with chronic myeloid leukemia, essential thrombocythemia, or primary myelofibrosis who has an elevated hematocrit for another reason (eg, hypoxia, smoking) may be falsely diagnosed as having PV. This is an important distinction clinically because each of these disorders is treated in a different manner.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite these concerns, it has been estimated that the false positive rate using the PVSG criteria is only about 0.5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     False negative results",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to the relatively low rate of false positive results using the PVSG criteria, false negative results occur in approximately 10 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/4\">",
"     4",
"    </a>",
"    ]. A number of factors can contribute to this problem:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Calculation of the red blood cell mass may be falsely low in patients who are obese.",
"     </li>",
"     <li>",
"      Patients with PV who have had significant recent gastrointestinal blood loss (\"bled down\" polycythemia) may present with a normal hematocrit. Such patients may be incorrectly diagnosed as having iron deficiency or essential thrombocythemia since their high platelet counts, low red blood cell indices, and low serum ferritin concentrations may be the most striking features.",
"     </li>",
"     <li>",
"      Patients who have PV and are also hypoxic for unrelated reasons (eg, coexisting chronic lung disease) will not fulfill the PVSG criteria. These patients were generally excluded from the original PVSG studies through the requirement of a directly determined arterial oxygen saturation at rest &gt;92 percent.",
"     </li>",
"     <li>",
"      An increased red cell mass may not be apparent in patients with early PV, less severe disease, or an elevated plasma volume [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/39\">",
"       39",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Increased red blood cell mass'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with the Budd-Chiari syndrome often present without classical features of PV and may not fulfill the PVSG or revised WHO criteria. The diagnosis can be suspected because many are positive for the JAK2 mutation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/53/31575?source=see_link&amp;anchor=H3#H3\">",
"       \"Etiology of the Budd-Chiari syndrome\", section on 'Myeloproliferative disorders'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Other available diagnostic tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Criteria other than those originally proposed by the PVSG have been used to make the diagnosis of PV. These are enumerated below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Bone marrow aspiration and biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;An increased number of megakaryocytes in a moderately to markedly hypercellular marrow has been considered one of the diagnostic hallmarks of PV [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/38,40\">",
"     38,40",
"    </a>",
"    ]. Although specific bone marrow findings were not included as either major or minor PVSG criteria, 281 pretreatment bone marrow biopsies were obtained in the first PVSG study and the following observations were noted [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/41\">",
"     41",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The most common abnormality was the absence of stainable iron in 94 percent of patients",
"     </li>",
"     <li>",
"      Cellularity varied from 36 to 100 percent (mean 82 percent, normal: 35 to 50 percent)",
"     </li>",
"     <li>",
"      The numbers of megakaryocytes and amount of reticulin were variable, although both were generally increased",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    At the Mayo Clinic, this constellation of bone marrow findings is considered a PV-related feature (",
"    <a class=\"graphic graphic_algorithm graphicRef52465 \" href=\"UTD.htm?8/56/9103\">",
"     algorithm 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef65297 \" href=\"UTD.htm?8/63/9200\">",
"     algorithm 2",
"    </a>",
"    ), although the diagnostic value of this feature, as with the determination of red blood cell mass, is not universally held [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Clonal markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone marrow examination can also be used to identify clonal markers that have been associated with PV, such as karyotypic changes and, in women, X-linked inactivation patterns or restriction length polymorphisms. As an example, deletion of the long arm of chromosome 20, trisomy for chromosomes 8 or 9, or loss of heterozygosity on the short arm of chromosome 9 are found in up to 30 percent of previously untreated patients with PV [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/42-47\">",
"     42-47",
"    </a>",
"    ]. Of interest, chromosome 9p24 houses the JAK2 gene, which carries a somatic point mutation in virtually all patients with PV (see",
"    <a class=\"local\" href=\"#H24\">",
"     'JAK2 mutations'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    These clonal features initially helped to establish the malignant character of PV, but were not incorporated into the PVSG criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/48\">",
"     48",
"    </a>",
"    ]. Increased appreciation of the malignant nature of PV has led to their inclusion into some, but not all, diagnostic criteria, because of the low incidence of such findings [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Serum erythropoietin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with PV usually have low serum erythropoietin (EPO) concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/49-53\">",
"     49-53",
"    </a>",
"    ]. Although this was known when the PVSG criteria were developed, assays were difficult to perform and not widely available. Standardization of methods for measurement of serum EPO levels has now permitted a better understanding of their role in the diagnosis of PV.",
"   </p>",
"   <p>",
"    In two studies, for example, serum EPO levels in 42 patients with PV were compared with control subjects with other causes of polycythemia (eg, hypoxia) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/49,54\">",
"     49,54",
"    </a>",
"    ]. The sensitivity and specificity of serum EPO levels below the reference range of normal for the diagnosis of PV (using the PVSG criteria as the gold standard) were 64 and 92 to 99 percent, respectively. The sensitivity increased to 72 percent in patients who were tested on two occasions, as low serum EPO values were noted on a repeat study in some patients with normal levels on the initial examination. The serum EPO concentration remained low even when the red cell mass was normalized following phlebotomy. Accordingly, most newer diagnostic criteria for PV have included a low serum EPO level (see",
"    <a class=\"local\" href=\"#H20383514\">",
"     'Other diagnostic algorithms'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    While low EPO levels are highly specific for PV, levels above normal are unusual and suggest secondary erythrocytosis, with a specificity of 98 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/54\">",
"     54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/12/24777?source=see_link\">",
"     \"Diagnostic approach to the patient with polycythemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A rare disorder that can mimic the basic findings of PV (ie, increased RCM with low serum EPO) is an activating mutation in the EPO receptor [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/55-57\">",
"     55-57",
"    </a>",
"    ]. Patients with this disorder may also have endogenous erythroid colony formation, as described in the next section [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/58\">",
"     58",
"    </a>",
"    ]. However, colony growth in these patients can be distinguished from true PV because the colonies demonstrate in vitro EPO hypersensitivity rather than EPO independence [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/55-57\">",
"     55-57",
"    </a>",
"    ]. A positive family history, early age at disease onset, and the lack of PV-associated clinical findings should provide adequate information to distinguish this familial disorder from PV.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Endogenous erythroid colony formation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A common feature of several myeloproliferative disorders is the demonstration, using in vitro culture techniques, of the formation of erythroid colonies in the absence of added (exogenous) erythropoietin (ie, endogenous erythroid colonies [EEC]). However, the measurement of EEC is not a standard FDA-approved test and is available only in a limited number of research laboratories that are especially interested in PV and hematopoiesis.",
"   </p>",
"   <p>",
"    The presence of EEC strongly supports the diagnosis of PV if other criteria are present. One study, for example, evaluated EEC formation in 89 patients with various forms of polycythemia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/58\">",
"     58",
"    </a>",
"    ]. EEC formation was found in 100 percent of PV patients with no prior cytotoxic chemotherapy, 50 percent of PV patients with prior cytotoxic therapy, and in no patient with secondary polycythemia.",
"   </p>",
"   <p>",
"    Thus, in polycythemic patients who have not had prior cytotoxic chemotherapy, the sensitivity and specificity of EEC formation for the diagnosis of PV is approximately 100 percent. This observation has been confirmed in other series [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/59,60\">",
"     59,60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     JAK2 mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;When sensitive quantitative assays are employed, 95 to 99 percent of patients with PV have a JAK2 mutation involving either exon 14 or 12 [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/61-65\">",
"     61-65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h4\">",
"     Exon 14 mutation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In multiple studies, 95 to 97 percent of patients with PV have the V617F mutation in exon 14 of the JAK2 gene, which is absent in normal subjects as well as those with secondary polycythemia. Thus, this mutation, when present, enables one to distinguish patients with PV from those with secondary polycythemia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/36,66,67\">",
"     36,66,67",
"    </a>",
"    ]. The finding of the JAK2 V617F mutation is not specific for PV, since it is also present in a substantial proportion of patients with ET as well as primary myelofibrosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/52/21322?source=see_link&amp;anchor=H13#H13\">",
"     \"Overview of the myeloproliferative neoplasms\", section on 'JAK2 mutations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a study of 63 patients with PV evaluated at the Mayo Clinic, the JAK2 mutation was present in 58 (92 percent); 45 and 13 were heterozygous or homozygous for this mutation in peripheral blood granulocytes, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/68\">",
"     68",
"    </a>",
"    ]. A comparison between the heterozygotes and homozygotes did not reveal significant differences with regard to duration of disease or incidence of thrombosis or bleeding. However, homozygotes had higher hemoglobin levels, a greater incidence of pruritus, a higher rate of fibrotic transformation, and higher PRV-1 transcript levels in peripheral blood granulocytes than the heterozygotes.",
"   </p>",
"   <p>",
"    In other studies, high levels of this mutation were found to correlate with higher granulocyte counts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/69-71\">",
"     69-71",
"    </a>",
"    ], potentially linking this mutation to the higher incidence of thrombosis seen in PV patients with leukocytosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/72\">",
"     72",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/56/28554?source=see_link&amp;anchor=H3#H3\">",
"     \"Prognosis and treatment of polycythemia vera\", section on 'Thrombotic events'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A higher rate of homozygous V617F JAK2 mutations may be present when testing is performed in erythroid burst-forming units (BFU-Es) rather than peripheral blood granulocytes. In one report using this technology, homozygous V617F JAK2 mutations were found in all 17 patients with PV, both patients with ET after polycythemic transformation, and none of the 15 patients with ET alone [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h4\">",
"     Exon 12 mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;In one study, four different mutations in exon 12 of the JAK2 gene were found in 10 of 11 patients clinically diagnosed as having PV who had tested negative for the exon 14 V617F mutation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/61\">",
"     61",
"    </a>",
"    ]. The mutations were frequently present at low levels in granulocyte DNA but were readily identifiable in clonally-derived erythropoietin-independent erythroid colonies. When transduced into",
"    <span class=\"nowrap\">",
"     BaF3/EpoR",
"    </span>",
"    cells, all four JAK2 exon 12 mutations caused growth factor hypersensitivity and activated biochemical pathways associated with erythropoietin signaling.",
"   </p>",
"   <p>",
"    In a second report of 114 patients fulfilling the PVSG diagnostic criteria for PV, 111 ultimately tested positive for the exon 14 V617F mutation (97 percent); a JAK2 exon 12 mutation was present in the remaining three subjects (3 percent), suggesting that either an exon 14 or 12 JAK2 mutation is present in virtually all patients with PV [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/74,75\">",
"     74,75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A third study reported on 106 patients with PV and exon 12 mutations, in which 17 different mutations were identified [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/76\">",
"     76",
"    </a>",
"    ]. Irrespective of the mutation, two-thirds had isolated erythrocytosis, with the remainder having erythrocytosis plus leukocytosis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    thrombocytosis. The panmyelosis observed in the bone marrow of most patients with PV is typically absent in those with exon 12 mutations. Compared with JAK2 V617F-positive PV patients, those with exon 12 mutations had similar incidences of thrombosis, myelofibrosis, leukemia, and death [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/65,76\">",
"     65,76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Exon 12 mutations were not found in granulocyte DNA in any of 55 patients with V617F-positive PV, any of 25 patients with V617F-negative ET, or any of 12 patients with V617F-negative primary myelofibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/61\">",
"     61",
"    </a>",
"    ]. However, exon 12 mutations have been found in patients with myeloproliferative disorders presenting with isolated erythrocytosis, familial PV, and, in two cases, splanchnic vein thrombosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/77,78\">",
"     77,78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Investigational diagnostic methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several markers are being investigated for their utility in diagnosing PV",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    differentiating PV from secondary polycythemia (SP):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The observation that EPO-independent erythroid cell growth in PV is associated with overexpression of Bcl-xL, an apoptosis-inhibiting oncoprotein, suggests a role for Bcl-xL determination in diagnosis [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/79\">",
"       79",
"      </a>",
"      ], and a possible role for a small-molecule Bcl-xL inhibitor as treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/80\">",
"       80",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with PV have reduced levels of the thrombopoietin (TPO) receptor c-mpl in platelets and megakaryocytes, compared with those with secondary erythrocytosis as well as normal controls [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/81,82\">",
"       81,82",
"      </a>",
"      ]. Thus, proliferation of platelets in PV may be independent of TPO, in the same manner that red blood cell proliferation is independent of EPO. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/18/16680?source=see_link\">",
"       \"Biology and physiology of thrombopoietin\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Overexpression of the PRV-1 gene in peripheral blood granulocytes has been noted in PV, essential thrombocythemia, and primary myelofibrosis, but not in patients with secondary thrombocytosis or secondary erythrocytosis [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/46,83-86\">",
"       46,83-86",
"      </a>",
"      ]. These differences were not seen when the assay was performed on cells from the bone marrow [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/87\">",
"       87",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a prospective study, the median and range of platelet-rich plasma (PRP) serotonin concentrations in 27 patients with PV were significantly lower than those in 22 patients with secondary polycythemia (SP) [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/88\">",
"       88",
"      </a>",
"      ]. PRP serotonin measurement performed as well as the PRV-1 assay in distinguishing PV from SP.",
"     </li>",
"     <li>",
"      In one study, gene expression profiling correctly discriminated 40 patients with PV from 12 patients with secondary erythrocytosis [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/89\">",
"       89",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20383514\">",
"    <span class=\"h2\">",
"     Other diagnostic algorithms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the limitations of the original PVSG criteria (see",
"    <a class=\"local\" href=\"#H12\">",
"     'Diagnostic criteria and algorithms'",
"    </a>",
"    above), newer strategies for establishing the diagnosis have been proposed [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/28,38,90,91\">",
"     28,38,90,91",
"    </a>",
"    ]. Many of these are similar; all require the following basic criteria to be met:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Demonstration of an increased red blood cell mass as determined either by blood volume studies or the presence of a very much increased hemoglobin concentration or elevated hematocrit",
"     </li>",
"     <li>",
"      Disorders causing secondary erythrocytosis are absent, including hypoxia, familial polycythemic disorders, high-affinity hemoglobins, truncated EPO receptor, and inappropriate EPO production by tumor",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20383521\">",
"    <span class=\"h3\">",
"     WHO criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The original WHO criteria established the diagnosis of PV when, in addition to the two basic criteria listed above, one or more of the following is also present: splenomegaly, a clonal genetic abnormality other than the Philadelphia chromosome (or BCR-ABL fusion gene), or spontaneous EEC [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/90\">",
"     90",
"    </a>",
"    ]. If these are not present, the diagnosis can be made in the presence the two basic criteria plus two (or more) of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Platelet count",
"      <span class=\"nowrap\">",
"       &gt;400,000/microL",
"      </span>",
"     </li>",
"     <li>",
"      White blood cell count",
"      <span class=\"nowrap\">",
"       &gt;12,000/microL",
"      </span>",
"     </li>",
"     <li>",
"      Low serum EPO levels",
"     </li>",
"     <li>",
"      Bone marrow showing panmyelosis with prominent erythroid and megakaryocytic proliferation",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20383528\">",
"    <span class=\"h3\">",
"     Revised WHO criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;A revised set of WHO criteria for the diagnosis of PV includes the following (",
"    <a class=\"graphic graphic_table graphicRef77810 \" href=\"UTD.htm?40/43/41659\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/91-95\">",
"     91-95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The two",
"      <strong>",
"       major criteria",
"      </strong>",
"      include an increased hemoglobin level or other evidence of increased red cell volume and presence of a JAK2 mutation",
"     </li>",
"     <li>",
"      The three",
"      <strong>",
"       minor criteria",
"      </strong>",
"      include typical findings on the bone marrow",
"      <span class=\"nowrap\">",
"       aspiration/biopsy,",
"      </span>",
"      a serum EPO level below the reference range for normal, and endogenous erythroid colony formation in vitro",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnosis of PV requires the presence of both major criteria and one minor criterion, or the presence of the first major criterion together with two minor criteria.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     ESTABLISHING THE DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Consensus has not yet been achieved for the optimal diagnostic criteria for PV. Although several diagnostic approaches have been proposed since the original PVSG studies, most have similar components. These diagnostic criteria should be applied only to patients who have undergone the appropriate diagnostic evaluation to exclude secondary causes of polycythemia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/96\">",
"     96",
"    </a>",
"    ]. However, the presence of the signs and symptoms described above should raise suspicion for the presence of PV in any patient with polycythemia (",
"    <a class=\"graphic graphic_table graphicRef54453 \" href=\"UTD.htm?1/43/1723\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/12/24777?source=see_link\">",
"     \"Diagnostic approach to the patient with polycythemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis of polycythemia vera (PV) is considered established in patients who fulfill the original PVSG criteria (",
"    <a class=\"graphic graphic_table graphicRef62788 \" href=\"UTD.htm?25/50/26411\">",
"     table 3",
"    </a>",
"    ) or the revised WHO criteria (",
"    <a class=\"graphic graphic_table graphicRef77810 \" href=\"UTD.htm?40/43/41659\">",
"     table 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the only indication of PV is an elevated hemoglobin concentration (or hematocrit), this test should be repeated. Further testing is unnecessary if the",
"      <span class=\"nowrap\">",
"       hemoglobin/hematocrit",
"      </span>",
"      returns to normal.",
"     </li>",
"     <li>",
"      Serum EPO levels should be repeated in patients with a single normal test; the second value will be low in more than one-quarter of these patients [",
"      <a class=\"abstract\" href=\"UTD.htm?9/32/9738/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with nondiagnostic bone marrow studies",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      absence of a JAK2 mutation should have repeat measurement of the hemoglobin or hematocrit and serum EPO concentrations in three months. A diagnosis other than PV should be entertained in such patients.",
"     </li>",
"     <li>",
"      Some patients with PV may not fulfill the major PVSG or WHO criterion of an increased",
"      <span class=\"nowrap\">",
"       hemoglobin/hematocrit",
"      </span>",
"      or increased red cell mass because of a prior bleeding episode. Additionally, when blood volume measurements are not done, some patients with a simultaneous increase in red cell mass and plasma volume due to an increase in splenic size may not have an elevated",
"      <span class=\"nowrap\">",
"       hemoglobin/hematocrit.",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H18\">",
"       'False negative results'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20383870\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic possibilities in a patient who has fulfilled either the PVSG criteria or the revised WHO criteria for PV are vanishingly small, and are likely confined to patients with one of the other myeloproliferative neoplasms (ie, chronic myeloid leukemia, essential thrombocythemia, primary myelofibrosis) who have an unrelated secondary cause for polycythemia (",
"    <a class=\"graphic graphic_table graphicRef76036 \" href=\"UTD.htm?30/46/31468\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H17\">",
"     'False positive results'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The differential diagnosis for a patient with polycythemia but without the other major or minor PVSG or WHO criteria is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/12/24777?source=see_link\">",
"     \"Diagnostic approach to the patient with polycythemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?12/14/12513?source=see_link\">",
"       \"Patient information: Polycythemia vera (PV) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Suspecting the diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polycythemia vera (PV) should be suspected in any patient with an increased red blood cell mass or increased",
"    <span class=\"nowrap\">",
"     hemoglobin/hematocrit",
"    </span>",
"    and an arterial oxygen saturation &gt;92 percent. Additional evidence suggesting the diagnosis of PV includes the following. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Clinical presentation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Splenomegaly",
"     </li>",
"     <li>",
"      Thrombocytosis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      leukocytosis",
"     </li>",
"     <li>",
"      Thrombotic complications",
"     </li>",
"     <li>",
"      Erythromelalgia or pruritus",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Making the diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;For establishing the diagnosis of PV, the patient must satisfy a combination of the following criteria (",
"    <a class=\"graphic graphic_table graphicRef77810 \" href=\"UTD.htm?40/43/41659\">",
"     table 4",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Establishing the diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Disorders causing secondary erythrocytosis are absent (eg, hypoxia, familial polycythemia, high-affinity hemoglobins, truncated EPO receptor, tumor)",
"     </li>",
"     <li>",
"      An increased hemoglobin level or other evidence of an increased red cell mass",
"     </li>",
"     <li>",
"      A low serum erythropoietin concentration",
"     </li>",
"     <li>",
"      Presence of a JAK2 mutation. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'JAK2 mutations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Endogenous erythroid colony formation in vitro",
"     </li>",
"     <li>",
"      Bone marrow biopsy showing hypercellularity with prominent erythroid, granulocytic, and megakaryocytic proliferation",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/1\">",
"      Passamonti F, Malabarba L, Orlandi E, et al. Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia. Haematologica 2003; 88:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/2\">",
"      Teofili L, Giona F, Martini M, et al. Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia. J Clin Oncol 2007; 25:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/3\">",
"      Cario H, Schwarz K, Herter JM, et al. Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera. Br J Haematol 2008; 142:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/4\">",
"      Berlin NI. Diagnosis and classification of the polycythemias. Semin Hematol 1975; 12:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/5\">",
"      An&iacute;a BJ, Suman VJ, Sobell JL, et al. Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989. Am J Hematol 1994; 47:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/6\">",
"      Berk PD, Goldberg JD, Donovan PB, et al. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin Hematol 1986; 23:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/7\">",
"      Rozman C, Giralt M, Feliu E, et al. Life expectancy of patients with chronic nonleukemic myeloproliferative disorders. Cancer 1991; 67:2658.",
"     </a>",
"    </li>",
"    <li>",
"     Berk PD, Wasserman LR, Fruchtman SM, et al.. Treatment of polycythemia vera: A summary of clinical trials conducted by the polycythemia vera study group. In: Polycythemia Vera and the Myeloproliferative Disorders, Wasserman LR, Berk PD, Berlin NI (Eds), WB Saunders, Philadelphia 1995. p.166.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/9\">",
"      Gangat N, Strand JJ, Lasho TL, et al. Pruritus in polycythemia vera is associated with a lower risk of arterial thrombosis. Am J Hematol 2008; 83:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/10\">",
"      Steinman HK, Kobza-Black A, Lotti TM, et al. Polycythaemia rubra vera and water-induced pruritus: blood histamine levels and cutaneous fibrinolytic activity before and after water challenge. Br J Dermatol 1987; 116:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/11\">",
"      Jackson N, Burt D, Crocker J, Boughton B. Skin mast cells in polycythaemia vera: relationship to the pathogenesis and treatment of pruritus. Br J Dermatol 1987; 116:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/12\">",
"      Fjellner B, H&auml;germark O. Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement. Acta Derm Venereol 1979; 59:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/13\">",
"      Ishii T, Wang J, Zhang W, et al. Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders. Blood 2009; 113:5942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/14\">",
"      Michiels JJ. Erythromelalgia and vascular complications in polycythemia vera. Semin Thromb Hemost 1997; 23:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/15\">",
"      van Genderen PJ, Michiels JJ. Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera. Semin Thromb Hemost 1997; 23:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/16\">",
"      Landolfi R, Ciabattoni G, Patrignani P, et al. Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. Blood 1992; 80:1965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/17\">",
"      Landolfi R, Di Gennaro L, Falanga A. Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation. Leukemia 2008; 22:2020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/18\">",
"      Acharya J, Westwood NB, Sawyer BM, et al. Identification of latent myeloproliferative disease in patients with Budd-Chiari syndrome using X-chromosome inactivation patterns and in vitro erythroid colony formation. Eur J Haematol 1995; 55:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/19\">",
"      De Stefano V, Teofili L, Leone G, Michiels JJ. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost 1997; 23:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/20\">",
"      Chait Y, Condat B, Cazals-Hatem D, et al. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. Br J Haematol 2005; 129:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/21\">",
"      Patel RK, Lea NC, Heneghan MA, et al. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology 2006; 130:2031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/22\">",
"      Boissinot M, Lippert E, Girodon F, et al. Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis. Blood 2006; 108:3223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/23\">",
"      Primignani M, Barosi G, Bergamaschi G, et al. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology 2006; 44:1528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/24\">",
"      Michiels JJ, van Genderen PJ, Jansen PH, Koudstaal PJ. Atypical transient ischemic attacks in thrombocythemia of various myeloproliferative disorders. Leuk Lymphoma 1996; 22 Suppl 1:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/25\">",
"      Torgano G, Mandelli C, Massaro P, et al. Gastroduodenal lesions in polycythaemia vera: frequency and role of Helicobacter pylori. Br J Haematol 2002; 117:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/26\">",
"      Barbui T, Thiele J, Passamonti F, et al. Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome. Blood 2012; 119:2239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/27\">",
"      Vaidya R, Gangat N, Jimma T, et al. Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis. Am J Hematol 2012; 87:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/28\">",
"      Pearson TC, Guthrie DL, Simpson J, et al. Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology. Br J Haematol 1995; 89:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/29\">",
"      Pearson TC, Messinezy M. The diagnostic criteria of polycythaemia rubra vera. Leuk Lymphoma 1996; 22 Suppl 1:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/30\">",
"      Sirhan S, Fairbanks VF, Tefferi A. Red cell mass and plasma volume measurements in polycythemia: evaluation of performance and practical utility. Cancer 2005; 104:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/31\">",
"      Alvarez-Larr&aacute;n A, Ancochea A, Angona A, et al. Red cell mass measurement in patients with clinically suspected diagnosis of polycythemia vera or essential thrombocythemia. Haematologica 2012; 97:1704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/32\">",
"      Ferrant A. What clinical and laboratory data are indicative of polycythemia and when are blood volume studies needed? Nouv Rev Fr Hematol 1994; 36:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/33\">",
"      Johansson PL, Safai-Kutti S, Kutti J. An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: a study of patients with polycythaemia vera and apparent polycythaemia. Br J Haematol 2005; 129:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/34\">",
"      Fairbanks VF. Myeloproliferative Disease: Polycythemia Vera: The Packed Cell Volume and The Curious Logic of The Red Cell Mass. Hematology 2000; 4:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/35\">",
"      Spivak JL. Diagnosis of the myeloproliferative disorders: resolving phenotypic mimicry. Semin Hematol 2003; 40:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/36\">",
"      Tefferi A, Spivak JL. Polycythemia vera: scientific advances and current practice. Semin Hematol 2005; 42:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/37\">",
"      Cassinat B, Laguillier C, Gardin C, et al. Classification of myeloproliferative disorders in the JAK2 era: is there a role for red cell mass? Leukemia 2008; 22:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/38\">",
"      Michiels JJ, Juvonen E. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group. Semin Thromb Hemost 1997; 23:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/39\">",
"      Lamy T, Devillers A, Bernard M, et al. Inapparent polycythemia vera: an unrecognized diagnosis. Am J Med 1997; 102:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/40\">",
"      Thiele JM, Kvasnicka HM. Diagnosis of polycythemia vera based on bone marrow pathology. Curr Hematol Rep 2005; 4:218.",
"     </a>",
"    </li>",
"    <li>",
"     Peterson P, Ellis JT. The bone marrow in polycythemia vera. In: Polycythemia Vera and the Myeloproliferative Disorders, Wasserman LR, Berk PD, Berlin NI (Eds), WB Saunders, Philadelphia 1995. p.31.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/42\">",
"      Najfeld V. FISHing among myeloproliferative disorders. Semin Hematol 1997; 34:55.",
"     </a>",
"    </li>",
"    <li>",
"     Pierre RV, Whang-Peng J. Cytogenetics. In: Polycythemia Vera and the Myeloproliferative Disorders, Wasserman, LR, Berk, PD, Berlin, NI (Eds), WB Saunders, Philadelphia 1995. p.91.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/44\">",
"      Westwood NB, Gruszka-Westwood AM, Pearson CE, et al. The incidences of trisomy 8, trisomy 9 and D20S108 deletion in polycythaemia vera: an analysis of blood granulocytes using interphase fluorescence in situ hybridization. Br J Haematol 2000; 110:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/45\">",
"      Najfeld V, Montella L, Scalise A, Fruchtman S. Exploring polycythaemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detected. Br J Haematol 2002; 119:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/46\">",
"      Kralovics R, Buser AS, Teo SS, et al. Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders. Blood 2003; 102:1869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/47\">",
"      Andrieux JL, Demory JL. Karyotype and molecular cytogenetic studies in polycythemia vera. Curr Hematol Rep 2005; 4:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/48\">",
"      Adamson JW, Fialkow PJ, Murphy S, et al. Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med 1976; 295:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/49\">",
"      Messinezy M, Westwood NB, Woodcock SP, et al. Low serum erythropoietin--a strong diagnostic criterion of primary polycythaemia even at normal haemoglobin levels. Clin Lab Haematol 1995; 17:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/50\">",
"      Birgeg&aring;rd G, Wide L. Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatment. Br J Haematol 1992; 81:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/51\">",
"      Cotes PM, Dor&eacute; CJ, Yin JA, et al. Determination of serum immunoreactive erythropoietin in the investigation of erythrocytosis. N Engl J Med 1986; 315:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/52\">",
"      Najean Y, Schlageter MH, Toubert ME, Podgorniak MP. Radioimmunoassay of immunoreactive erythropoietin as a clinical tool for the classification of polycythaemias. Nouv Rev Fr Hematol 1990; 32:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/53\">",
"      Remacha AF, Montserrat I, Santamaria A, et al. Serum erythropoietin in the diagnosis of polycythemia vera. A follow-up study. Haematologica 1997; 82:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/54\">",
"      Messinezy M, Westwood NB, El-Hemaidi I, et al. Serum erythropoietin values in erythrocytoses and in primary thrombocythaemia. Br J Haematol 2002; 117:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/55\">",
"      Juvonen E, Ikkala E, Fyhrquist F, Ruutu T. Autosomal dominant erythrocytosis caused by increased sensitivity to erythropoietin. Blood 1991; 78:3066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/56\">",
"      Dainiak N, Hoffman R, Lebowitz AI, et al. Erythropoietin-dependent primary pure erythrocytosis. Blood 1979; 53:1076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/57\">",
"      Arcasoy MO, Degar BA, Harris KW, Forget BG. Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene. Blood 1997; 89:4628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/58\">",
"      Shih LY, Lee CT, See LC, et al. In vitro culture growth of erythroid progenitors and serum erythropoietin assay in the differential diagnosis of polycythaemia. Eur J Clin Invest 1998; 28:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/59\">",
"      Weinberg RS, Worsley A, Gilbert HS, et al. Comparison of erythroid progenitor cell growth in vitro in polycythemia vera and chronic myelogenous leukemia: only polycythemia vera has endogenous colonies. Leuk Res 1989; 13:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/60\">",
"      Zwicky C, Theiler L, Zb&auml;ren K, et al. The predictive value of clonogenic stem cell assays for the diagnosis of polycythaemia vera. Br J Haematol 2002; 117:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/61\">",
"      Scott LM, Tong W, Levine RL, et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med 2007; 356:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/62\">",
"      Wang YL, Vandris K, Jones A, et al. JAK2 Mutations are present in all cases of polycythemia vera. Leukemia 2008; 22:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/63\">",
"      Pardanani A, Lasho TL, Finke C, et al. Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera. Leukemia 2007; 21:1960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/64\">",
"      Lasho TL, Pardanani A, Tefferi A. LNK mutations in JAK2 mutation-negative erythrocytosis. N Engl J Med 2010; 363:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/65\">",
"      Scott LM. The JAK2 exon 12 mutations: a comprehensive review. Am J Hematol 2011; 86:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/66\">",
"      Tefferi A, Sirhan S, Lasho TL, et al. Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia. Br J Haematol 2005; 131:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/67\">",
"      Spivak JL. Narrative review: Thrombocytosis, polycythemia vera, and JAK2 mutations: The phenotypic mimicry of chronic myeloproliferation. Ann Intern Med 2010; 152:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/68\">",
"      Tefferi A, Lasho TL, Schwager SM, et al. The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera. Cancer 2006; 106:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/69\">",
"      Dupont S, Mass&eacute; A, James C, et al. The JAK2 617V&gt;F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera. Blood 2007; 110:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/70\">",
"      Vannucchi AM, Antonioli E, Guglielmelli P, et al. Clinical profile of homozygous JAK2 617V&gt;F mutation in patients with polycythemia vera or essential thrombocythemia. Blood 2007; 110:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/71\">",
"      Silver RT, Vandris K, Wang YL, et al. JAK2(V617F) allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapy. Leuk Res 2011; 35:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/72\">",
"      Gangat N, Strand J, Li CY, et al. Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation. Br J Haematol 2007; 138:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/73\">",
"      Scott LM, Scott MA, Campbell PJ, Green AR. Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia. Blood 2006; 108:2435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/74\">",
"      Scott LM, Beer PA, Bench AJ, et al. Prevalance of JAK2 V617F and exon 12 mutations in polycythaemia vera. Br J Haematol 2007; 139:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/75\">",
"      Butcher CM, Hahn U, To LB, et al. Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients. Leukemia 2008; 22:870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/76\">",
"      Passamonti F, Elena C, Schnittger S, et al. Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations. Blood 2011; 117:2813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/77\">",
"      Colaizzo D, Amitrano L, Tiscia GL, et al. A new JAK2 gene mutation in patients with polycythemia vera and splanchnic vein thrombosis. Blood 2007; 110:2768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/78\">",
"      Pietra D, Li S, Brisci A, et al. Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders. Blood 2008; 111:1686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/79\">",
"      Silva M, Richard C, Benito A, et al. Expression of Bcl-x in erythroid precursors from patients with polycythemia vera. N Engl J Med 1998; 338:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/80\">",
"      Zeuner A, Pedini F, Francescangeli F, et al. Activity of the BH3 mimetic ABT-737 on polycythemia vera erythroid precursor cells. Blood 2009; 113:1522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/81\">",
"      Moliterno AR, Hankins WD, Spivak JL. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med 1998; 338:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/82\">",
"      Tefferi A, Yoon SY, Li CY. Immunohistochemical staining for megakaryocyte c-mpl may complement morphologic distinction between polycythemia vera and secondary erythrocytosis. Blood 2000; 96:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/83\">",
"      Teofili L, Martini M, Luongo M, et al. Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia. J Clin Oncol 2002; 20:4249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/84\">",
"      Liu E, Jelinek J, Pastore YD, et al. Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin. Blood 2003; 101:3294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/85\">",
"      Klippel S, Strunck E, Temerinac S, et al. Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis. Blood 2003; 102:3569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/86\">",
"      Tefferi A, Lasho TL, Wolanskyj AP, Mesa RA. Neutrophil PRV-1 expression across the chronic myeloproliferative disorders and in secondary or spurious polycythemia. Blood 2004; 103:3547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/87\">",
"      Bock O, Serins&ouml;z E, Neusch M, et al. The polycythaemia rubra vera-1 gene is constitutively expressed by bone marrow cells and does not discriminate polycythaemia vera from reactive and other chronic myeloproliferative disorders. Br J Haematol 2003; 123:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/88\">",
"      Koch CA, Lasho TL, Tefferi A. Platelet-rich plasma serotonin levels in chronic myeloproliferative disorders: evaluation of diagnostic use and comparison with the neutrophil PRV-1 assay. Br J Haematol 2004; 127:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/89\">",
"      Goerttler PS, Kreutz C, Donauer J, et al. Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF-E2. Br J Haematol 2005; 129:138.",
"     </a>",
"    </li>",
"    <li>",
"     Pierre R, Vardiman JW, Imbert M, et al. Polycythemia vera. In: World Health Organization Classification of Tumours. athology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues., Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds), IARC Press, Lyon 2001. p.32.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/91\">",
"      Spivak JL, Silver RT. The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal. Blood 2008; 112:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/92\">",
"      Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 2007; 110:1092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/93\">",
"      Tefferi A. JAK2 mutations in polycythemia vera--molecular mechanisms and clinical applications. N Engl J Med 2007; 356:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/94\">",
"      Tefferi A, Pardanani A. Evaluation of \"increased\" hemoglobin in the JAK2 mutations era: a diagnostic algorithm based on genetic tests. Mayo Clin Proc 2007; 82:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/95\">",
"      Tefferi A, Skoda R, Vardiman JW. Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics. Nat Rev Clin Oncol 2009; 6:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/32/9738/abstract/96\">",
"      Blacklock HA, Royle GA. Idiopathic erythrocytosis--a declining entity. Br J Haematol 2001; 115:774.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4517 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-D8E5382BBA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_32_9738=[""].join("\n");
var outline_f9_32_9738=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H32\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DISEASE INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Survival",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Nonspecific complaints",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pruritus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Erythromelalgia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Gastrointestinal symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      LABORATORY FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22767040\">",
"      Bone marrow fibrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3607109\">",
"      Elevated cytokine levels",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DIAGNOSTIC CRITERIA AND ALGORITHMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20383267\">",
"      Polycythemia Vera Study Group Criteria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Increased red blood cell mass",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Palpable splenomegaly",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Thrombocytosis and leukocytosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Leukocyte alkaline phosphatase and serum B12 studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - False positive results",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - False negative results",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Other available diagnostic tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Bone marrow aspiration and biopsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Clonal markers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Serum erythropoietin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Endogenous erythroid colony formation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - JAK2 mutations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Exon 14 mutation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Exon 12 mutations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Investigational diagnostic methods",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20383514\">",
"      Other diagnostic algorithms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20383521\">",
"      - WHO criteria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20383528\">",
"      - Revised WHO criteria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      ESTABLISHING THE DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20383870\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Suspecting the diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Making the diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/4517\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4517|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?8/56/9103\" title=\"algorithm 1\">",
"      Diagnosis erythrocytosis I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?8/63/9200\" title=\"algorithm 2\">",
"      Diagnosis erythrocytosis II",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4517|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/16/24835\" title=\"figure 1\">",
"      Organiz heme malignancies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4517|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/25/17808\" title=\"picture 1\">",
"      Erythromelalgia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4517|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/46/31468\" title=\"table 1\">",
"      Causes of erythrocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/43/1723\" title=\"table 2\">",
"      Related features of polycythemia vera",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/50/26411\" title=\"table 3\">",
"      Diagnostic criteria P vera",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/43/41659\" title=\"table 4\">",
"      Proposed criteria for PV",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?38/55/39792?source=related_link\" title=\"calculator 1\">",
"      Calculator: Polycythemia vera diagnostic criteria (Original PVSG diagnostic criteria)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/18/16680?source=related_link\">",
"      Biology and physiology of thrombopoietin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/28/18890?source=related_link\">",
"      Diagnosis and clinical manifestations of essential thrombocythemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/12/24777?source=related_link\">",
"      Diagnostic approach to the patient with polycythemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/53/31575?source=related_link\">",
"      Etiology of the Budd-Chiari syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/52/21322?source=related_link\">",
"      Overview of the myeloproliferative neoplasms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?12/14/12513?source=related_link\">",
"      Patient information: Polycythemia vera (PV) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/56/28554?source=related_link\">",
"      Prognosis and treatment of polycythemia vera",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/3/36922?source=related_link\">",
"      Prognosis and treatment of primary myelofibrosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_32_9739="Contraindications to breastfeed";
var content_f9_32_9739=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F71837&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F71837&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Contraindications to breastfeeding",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Maternal",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Abuse of street drugs or alcohol",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Human immunodeficiency virus infection",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T-cell lymphotropic virus infection",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Untreated miliary tuberculosis (breastfeeding may be initiated approximately two weeks after initiation of antituberculous therapy)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Antimetabolite chemotherapy and ongoing radiation therapy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Active herpetic breast lesions",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Infant",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Galactosemia",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: American Academy of Pediatrics. Pediatric Nutrition Handbook. 6th edition, 2009. &nbsp;Policy statement on Breastfeeding and the use of Human Milk. Pediatrics 2012; 129:e827.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_32_9739=[""].join("\n");
var outline_f9_32_9739=null;
var title_f9_32_9740="Specific anogential findings";
var content_f9_32_9740=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F64069&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F64069&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Anogenital findings specific for trauma in the evaluation of child sexual abuse*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Moderate specificity for abuse",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute lacerations or extensive bruising of the labia,",
"peri-hymenal tissues, scrotum, or perineum (may be from unwitnessed",
"accidental trauma)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Scar of posterior fourchette (the assessment of scars",
"is difficult unless there was documentation of acute injury at the same",
"site)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fresh laceration of the posterior fourchette, not",
"involving the hymen (must be differentiated from dehisced labial",
"adhesion or failure of midline fusion; may be caused by accidental",
"injury)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Perianal scar not in the midline (the assessment of",
"scars is difficult unless there was documentation of acute injury at",
"the same site; may be due to other medical conditions such as Crohn's",
"disease, or previous medical procedures)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        High specificity for",
"abuse",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute laceration of the hymen (partial or complete)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ecchymosis (bruising) of the hymen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Perianal lacerations extending deep to the external",
"anal sphincter (not to be confused with partial failure of midline",
"fusion)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hymenal transection (healed) (ie, an area where there",
"is no hymenal tissue remaining between the vaginal wall and the fossa",
"or vestibular wall [also called a complete cleft]. The finding should",
"be confirmed using additional examination techniques such as a swab,",
"prone knee-chest position, Foley catheter, water to float the edge of",
"the hymen)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Absence of hymenal tissue (wide areas in the",
"posterior/inferior half of the hymenal rim with an absence of hymenal",
"tissue, extending to the base of the hymen, which is confirmed using",
"additional positioning or other methods)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     *Findings which, in the absence of a clear, timely, plausible history of accidental injury, should be reported to child protective services.&lt;span style=\"font-style: italic;\"&gt;",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Adams, JA. Medical evaluation of suspected child sexual abuse. J Pediatr Adolesc Gynecol 2004; 17:191.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_32_9740=[""].join("\n");
var outline_f9_32_9740=null;
var title_f9_32_9741="HLA C relapse leukemia post HCT";
var content_f9_32_9741=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F54913&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F54913&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Impact of HLA-C matching on relapse of leukemia after hematopoietic stem cell transplantation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 365px; height: 209px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Kaplan-Meier curves for the relapse of leukemia after bone marrow transplantation in 202 patients matched by DNA typing at HLA-C and 87 patients mismatched at HLA-C. All patients were serologically matched at HLA-A, B, and DR. There was a trend toward a higher rate of relapse in patients matched at the HLA-C locus (23 versus 12 percent at one year, P = 0.06).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from:&nbsp;Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. N Engl J Med 1998; 339:1177.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_32_9741=[""].join("\n");
var outline_f9_32_9741=null;
var title_f9_32_9742="Blood volume in pregnancy";
var content_f9_32_9742=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F61948&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F61948&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Total blood volume, plasma volume and red cell volume in normal pregnancy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 438px; height: 425px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Shnider, SM, Levinson, G. Anesthesia for Obstetrics, 3rd ed, Williams &amp; Wilkins, Baltimore, p. 8.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_32_9742=[""].join("\n");
var outline_f9_32_9742=null;
var title_f9_32_9743="Sporotric mold 25 degrees C";
var content_f9_32_9743=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F64948&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F64948&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sporothrix schenckii as a mold",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 261px; height: 292px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Growth of Sporothrix schenckii on Sabouraud dextrose agar at 25&ordm;C. At this temperature, S. schenckii grows as a mold.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol A. Kauffman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_32_9743=[""].join("\n");
var outline_f9_32_9743=null;
              